1	CDS	Pancan-no-skin-melanoma-lymph	SPI1:TP63:SALL4:JAG1:SALL1:EZH2:SMC3:DDX6:CNOT2:HES1:BCL9:PRRX1:ARID1A:SOX4:SOX9:TBX3:KLF4:SMAD4:NOTCH1:ZFP36L2:BRAF:CTNNB1:LDB2:CDH2:SMAD2:GATA2:POLR2A:MED12:LDB1:HNF1B	GO:0098727  |  maintenance of cell number	NA	8.68e-16	NA
2	CDS	Pancan-no-skin-melanoma-lymph	SPI1:TP63:SALL4:JAG1:SALL1:SMC3:DDX6:CNOT2:HES1:BCL9:PRRX1:ARID1A:SOX4:SOX9:TBX3:KLF4:SMAD4:NOTCH1:ZFP36L2:BRAF:CTNNB1:LDB2:CDH2:SMAD2:GATA2:POLR2A:MED12:LDB1:HNF1B	GO:0019827  |  stem cell population maintenance	NA	6.4e-15	NA
3	CDS	Pancan-no-skin-melanoma-lymph	SPI1:TP63:SALL4:SALL1:HES1:BCL9:SOX4:SOX9:KLF4:SMAD4:ZFP36L2:BRAF:LDB2:SMAD2:GATA2:POLR2A:LDB1:HNF1B	GO:0035019  |  somatic stem cell population maintenance	NA	1.12e-10	NA
4	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:UBE2D1:PSMC5:EP300:PSMA2:NFE2L2:VHL:TP53:TAF1:NOTCH1:CITED2:RPS6KA3:JUN	GO:0043620  |  regulation of DNA-templated transcription in response to stress	NA	7.46e-05	NA
5	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:UBE2D1:PSMC5:EP300:PSMA2:NFE2L2:VHL:TP53:TAF1:NOTCH1:CITED2:JUN	GO:0043618  |  regulation of transcription from RNA polymerase II promoter in response to stress	NA	0.000394	NA
6	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:HNF1A:NR5A1:TAF1:NOTCH1:TAF5:CTNNB1:NR1D2:NR2F1:JUN:POLR2A:MED12:POLR1D:ESRRG:TCF4:HIST1H4C:HIST1H4K:HNF1B:HIST1H4E	GO:0006352  |  DNA-templated transcription, initiation	NA	0.00568	NA
7	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDC27:HSPA5:UBE2D1:PSMC5:AXIN1:PSMA2:SUFU:FBXW7:ARRDC3:RPL5:TAF1:CDKN2A:CTNNB1:PTEN:DAXX	GO:1903320  |  regulation of protein modification by small protein conjugation or removal	NA	0.0404	NA
8	CDS	Pancan-no-skin-melanoma-lymph	RPL5:RPL11:CDKN2A	GO:2000434  |  regulation of protein neddylation	NA	0.0206	NA
9	CDS	Pancan-no-skin-melanoma-lymph	RPL5:RPL11:CDKN2A	GO:2000435  |  negative regulation of protein neddylation	NA	0.0206	NA
10	CDS	Pancan-no-skin-melanoma-lymph	NDE1:RNF43:DGCR8:TBX3:SIX3:ASCL1:NOTCH1:TERT:CTNNB1:NF2:NF1	GO:0072089  |  stem cell proliferation	NA	0.0238	NA
11	CDS	Pancan-no-skin-melanoma-lymph	DGCR8:TBX3:SIX3:NOTCH1:TERT:CTNNB1:NF2:NF1	GO:0072091  |  regulation of stem cell proliferation	NA	0.0183	NA
12	CDS	Pancan-no-skin-melanoma-lymph	RHOA:UBE2D1:PSMC5:EP300:PSMA2:CDKN1B:CPEB4:NFE2L2:DNMT3A:TEK:CDKN1A:VHL:MYC:TP53:SMAD4:AKT1:ATP1B1:NOTCH1:ATM:CHRNB2:TGFBR2:TERT:CITED2:TSC1:PTEN:POLR2A:NF1	GO:0070482  |  response to oxygen levels	NA	1.09e-08	NA
13	CDS	Pancan-no-skin-melanoma-lymph	RHOA:UBE2D1:PSMC5:EP300:PSMA2:CDKN1B:CPEB4:NFE2L2:DNMT3A:TEK:VHL:MYC:TP53:SMAD4:AKT1:ATP1B1:NOTCH1:ATM:CHRNB2:TGFBR2:TERT:CITED2:TSC1:PTEN:NF1	GO:0036293  |  response to decreased oxygen levels	NA	1.27e-07	NA
14	CDS	Pancan-no-skin-melanoma-lymph	RHOA:UBE2D1:PSMC5:EP300:PSMA2:CDKN1B:NFE2L2:DNMT3A:TEK:VHL:MYC:TP53:SMAD4:AKT1:ATP1B1:NOTCH1:ATM:CHRNB2:TGFBR2:TERT:CITED2:PTEN:NF1	GO:0001666  |  response to hypoxia	NA	2.57e-06	NA
15	CDS	Pancan-no-skin-melanoma-lymph	UBE2D1:PSMC5:EP300:PSMA2:CPEB4:NFE2L2:DNMT3A:VHL:MYC:TP53:AKT1:NOTCH1:TERT:CITED2:TSC1:PTEN:POLR2A	GO:0071453  |  cellular response to oxygen levels	NA	2.36e-05	NA
16	CDS	Pancan-no-skin-melanoma-lymph	UBE2D1:PSMC5:EP300:PSMA2:CPEB4:NFE2L2:DNMT3A:VHL:MYC:TP53:AKT1:NOTCH1:TERT:CITED2:TSC1:PTEN	GO:0036294  |  cellular response to decreased oxygen levels	NA	7.67e-05	NA
17	CDS	Pancan-no-skin-melanoma-lymph	NFE2L2:VHL:TP53:TERT:PTEN	GO:0071456  |  cellular response to hypoxia	NA	0.000331	NA
18	CDS	Pancan-no-skin-melanoma-lymph	TP63:EP300:JAG1:EYA1:FBXW7:CDKN1B:HES1:SOX9:FOXA1:MYC:ASCL1:NOTCH1:TGFBR2:GATA2:DLK1:NOTCH2NL:HNF1B	GO:0007219  |  Notch signaling pathway	NA	0.000724	NA
19	CDS	Pancan-no-skin-melanoma-lymph	CDH1:GATA3:CDKN1B:NFE2L2:SLC12A5:CDKN1A:TP53:EGFR:BRAF:TGFBR2:B2M:CTNNB1:PTEN:PTCH1	GO:0042493  |  response to drug	NA	1.06e-06	NA
20	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:MEF2C:NFE2L2:MYC:TP53:EGFR:BRAF:PPM1E	GO:0035690  |  cellular response to drug	NA	0.027	NA
21	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:MYH14:HOXA1:CPEB3:ARRDC3:EIF4G1:ID2:SLC12A5:FOXP2:KRAS:MEIS2:SIX3:TP53:MEIS1:EGFR:DRD3:BRAF:CHRNB2:SHANK1:ELAVL4:EN1:CARTPT:TSC1:PTEN:SPTBN2:NPAS4:JUN:SLITRK1:RELN:NF1:DMBX1:GRIN2B	GO:0007610  |  behavior	NA	0.0106	NA
22	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:MYH14:HOXA1:CPEB3:EIF4G1:SLC12A5:FOXP2:KRAS:MEIS2:EGFR:DRD3:BRAF:CHRNB2:SHANK1:ELAVL4:EN1:CARTPT:TSC1:PTEN:SPTBN2:NPAS4:JUN:SLITRK1:RELN:NF1:DMBX1:GRIN2B	GO:0044708  |  single-organism behavior	NA	0.00438	NA
23	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CASP8:MAP2K4:NUCKS1:BAX:MAP3K1:EP300:CASP2:GATA3:ERRFI1:CDKN1A:IRF1:SOX9:XPA:MYC:ASCL1:TP53:AKT1:INTS7:RHOB:PIK3R1:EGFR:TAF1:ATM:PTEN:HRAS:PTPN11:DDX3X	GO:0071214  |  cellular response to abiotic stimulus	NA	1.79e-08	NA
24	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:NUCKS1:MAP2K7:BAX:EP300:HOXA1:GATA3:ID2:DNMT3A:CDKN1A:KRAS:MEN1:MEIS2:XPA:MYC:TP53:AKT1:DTL:INTS7:PIK3R1:EGFR:TAF1:ATM:BRAF:CHRNB2:HRAS:JUN:NF1	GO:0009314  |  response to radiation	NA	4.24e-08	NA
25	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:NUCKS1:TP63:PTPRC:BAX:EYA1:GATA3:DNMT3A:CDKN1A:MEN1:MYC:TP53:INTS7:RHOB:ATM:HRAS	GO:0010212  |  response to ionizing radiation	NA	0.000841	NA
26	CDS	Pancan-no-skin-melanoma-lymph	BAX:GATA3:CDKN1A:MEN1:TP53:ATM:HRAS	GO:0010332  |  response to gamma radiation	NA	2.42e-05	NA
27	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:GATA3:CDKN1A:TP53:ATM	GO:0010165  |  response to X-ray	NA	0.00268	NA
28	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:MAP2K7:BAX:EP300:HOXA1:ID2:CDKN1A:KRAS:MEN1:MEIS2:XPA:MYC:TP53:AKT1:DTL:PIK3R1:EGFR:TAF1:BRAF:CHRNB2:NF1	GO:0009416  |  response to light stimulus	NA	1.09e-05	NA
29	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:MAP2K7:BAX:EP300:CDKN1A:MEN1:XPA:MYC:TP53:AKT1:DTL:PIK3R1:EGFR:TAF1	GO:0009411  |  response to UV	NA	2.33e-05	NA
30	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:BAX:EP300:CDKN1A:XPA:MYC:TP53:PIK3R1:TAF1	GO:0034644  |  cellular response to UV	NA	0.00312	NA
31	CDS	Pancan-no-skin-melanoma-lymph	HOXA1:KRAS:MEIS2:BRAF:CHRNB2:NF1	GO:0007632  |  visual behavior	NA	0.0308	NA
32	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:NUCKS1:BAX:EP300:GATA3:CDKN1A:XPA:MYC:TP53:INTS7:PIK3R1:TAF1:ATM:HRAS	GO:0071478  |  cellular response to radiation	NA	0.000536	NA
33	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:GATA3:CDKN1A:TP53:ATM:HRAS	GO:0071479  |  cellular response to ionizing radiation	NA	0.00346	NA
34	CDS	Pancan-no-skin-melanoma-lymph	CDKN1A:TP53:ATM:HRAS	GO:0071480  |  cellular response to gamma radiation	NA	0.0213	NA
35	CDS	Pancan-no-skin-melanoma-lymph	DGCR2:MEF2C:HOXA1:CPEB3:SLC12A5:FOXP2:KRAS:MEIS2:EGFR:DRD3:BRAF:CHRNB2:SHANK1:ELAVL4:EN1:PTEN:NPAS4:JUN:RELN:NF1:GRIN2B	GO:0050890  |  cognition	NA	0.00219	NA
36	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:CPEB3:SLC12A5:FOXP2:KRAS:MEIS2:EGFR:DRD3:BRAF:CHRNB2:SHANK1:ELAVL4:EN1:PTEN:NPAS4:JUN:RELN:NF1:GRIN2B	GO:0007611  |  learning or memory	NA	0.00411	NA
37	CDS	Pancan-no-skin-melanoma-lymph	SLC12A5:FOXP2:KRAS:MEIS2:DRD3:BRAF:CHRNB2:SHANK1:ELAVL4:EN1:NPAS4:JUN:RELN:NF1	GO:0007612  |  learning	NA	0.0047	NA
38	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TGFBR2	GO:0003214  |  cardiac left ventricle morphogenesis	NA	0.0109	NA
39	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:BAX:AKT1:PTPN1	GO:0032075  |  positive regulation of nuclease activity	NA	0.0395	NA
40	CDS	Pancan-no-skin-melanoma-lymph	XPO1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:IGF2BP3:ATM:U2AF1:SRSF2:EIF5A2:TSC1:HNRNPA3:SETD2	GO:0006403  |  RNA localization	NA	0.00558	NA
41	CDS	Pancan-no-skin-melanoma-lymph	XPO1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:IGF2BP3:ATM:U2AF1:SRSF2:EIF5A2:TSC1:HNRNPA3:SETD2	GO:0051236  |  establishment of RNA localization	NA	0.000933	NA
42	CDS	Pancan-no-skin-melanoma-lymph	XPO1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:IGF2BP3:U2AF1:SRSF2:EIF5A2:TSC1:HNRNPA3:SETD2	GO:0015931  |  nucleobase-containing compound transport	NA	0.0347	NA
43	CDS	Pancan-no-skin-melanoma-lymph	XPO1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:IGF2BP3:U2AF1:SRSF2:EIF5A2:TSC1:HNRNPA3:SETD2	GO:0050657  |  nucleic acid transport	NA	0.00532	NA
44	CDS	Pancan-no-skin-melanoma-lymph	XPO1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:IGF2BP3:U2AF1:SRSF2:EIF5A2:TSC1:HNRNPA3:SETD2	GO:0050658  |  RNA transport	NA	0.00532	NA
45	CDS	Pancan-no-skin-melanoma-lymph	XPO1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:IGF2BP3:U2AF1:SRSF2:EIF5A2:HNRNPA3:SETD2	GO:0051028  |  mRNA transport	NA	0.00257	NA
46	CDS	Pancan-no-skin-melanoma-lymph	RHOA:PSMC5:CHD8:AXIN1:SALL1:DKK4:PSMA2:GATA3:RNF43:BCL9:HDAC1:SOX4:SOX9:SMARCA4:APC:HNF1A:KLF4:MYC:SIX3:CLTC:KDM6A:NOTCH1:TCF7L2:TNIK:TERT:CTNNB1:CDH2:PTEN:JUP:CTDNEP1:MED12:LDB1:DDX3X:HNF1B	GO:0198738  |  cell-cell signaling by wnt	NA	4.85e-06	NA
47	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:PSMC5:CHD8:ZMYND8:AXIN1:SALL1:DKK4:PSMA2:GATA3:RNF43:BCL9:HDAC1:SOX4:SOX9:SMARCA4:APC:HNF1A:KLF4:MYC:SIX3:CLTC:AKT1:KDM6A:NOTCH1:TCF7L2:TNIK:CHRNB2:SHANK1:TERT:CTNNB1:CDH2:PTEN:JUP:NPAS4:CTDNEP1:MED12:RELN:LDB1:DDX3X:GRIN2B:HNF1B	GO:1905114  |  cell surface receptor signaling pathway involved in cell-cell signaling	NA	1.23e-07	NA
48	CDS	Pancan-no-skin-melanoma-lymph	RHOA:PSMC5:CHD8:AXIN1:SALL1:DKK4:PSMA2:GATA3:RNF43:BCL9:HDAC1:SOX4:SOX9:SMARCA4:APC:HNF1A:KLF4:MYC:SIX3:CLTC:KDM6A:NOTCH1:TCF7L2:TNIK:TERT:CTNNB1:CDH2:PTEN:JUP:CTDNEP1:MED12:LDB1:DDX3X:HNF1B	GO:0016055  |  Wnt signaling pathway	NA	4.59e-06	NA
49	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:AXIN1:PSMA2:GATA3:BCL9:HDAC1:SOX9:APC:KDM6A:NOTCH1:TCF7L2:CTNNB1:PTEN:JUP:CTDNEP1	GO:0060070  |  canonical Wnt signaling pathway	NA	0.00045	NA
50	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	GO:1904886  |  beta-catenin destruction complex disassembly	NA	0.0423	NA
51	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:CHD8:AXIN1:SALL1:DKK4:PSMA2:RNF43:HDAC1:SOX4:SOX9:SMARCA4:APC:HNF1A:SIX3:NOTCH1:TCF7L2:TERT:CDH2:JUP:CTDNEP1:MED12:HNF1B	GO:0030111  |  regulation of Wnt signaling pathway	NA	0.00597	NA
52	CDS	Pancan-no-skin-melanoma-lymph	BRAF:CHRNB2:COL1A2:TSC1:JUP:HRAS:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	GO:0051291  |  protein heterooligomerization	NA	0.0109	NA
53	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MTG2:DDX6:CNOT2:CPEB4:NFE2L2:RPL5:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:TOB1:AKT1:EGFR:ZFP36L2:EEF1A1:EIF4A2:EIF5A2:TSC1:RPL38:EIF1:SMAD2:RPS6KA3:POLR2A:HIST1H4C:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0034248  |  regulation of cellular amide metabolic process	NA	6.13e-07	NA
54	CDS	Pancan-no-skin-melanoma-lymph	CNOT2:CPEB4:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:TOB1:EGFR:ZFP36L2:TSC1:SMAD2:POLR2A:HIST1H4C:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0034249  |  negative regulation of cellular amide metabolic process	NA	0.000457	NA
55	CDS	Pancan-no-skin-melanoma-lymph	MTG2:DDX6:CNOT2:CPEB4:NFE2L2:RPL22:RPL5:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:CPM:IGF2BP3:IDH1:TOB1:AKT1:EGFR:ZFP36L2:EIF4A2:EIF5A2:TSC1:RPL38:EIF1:SMAD2:RPS6KA3:POLR2A:HIST1H4C:MRPL53:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0006518  |  peptide metabolic process	NA	0.00158	NA
56	CDS	Pancan-no-skin-melanoma-lymph	MTG2:DDX6:CNOT2:CPEB4:NFE2L2:RPL22:RPL5:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:TOB1:AKT1:EGFR:ZFP36L2:EIF4A2:EIF5A2:TSC1:RPL38:EIF1:SMAD2:RPS6KA3:ALOXE3:POLR2A:HIST1H4C:MRPL53:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0043604  |  amide biosynthetic process	NA	0.0011	NA
57	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MTG2:DDX6:CNOT2:CPEB4:NFE2L2:RPL22:RPL5:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:TOB1:AKT1:EGFR:ZFP36L2:EEF1A1:EIF4A2:EIF5A2:TSC1:RPL38:EIF1:SMAD2:RPS6KA3:POLR2A:HIST1H4C:MRPL53:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0043043  |  peptide biosynthetic process	NA	0.000539	NA
58	CDS	Pancan-no-skin-melanoma-lymph	XPO1:PSMC5:MTG2:PSMA2:DDX6:CNOT2:CPEB4:RPL5:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:ANP32A:TOB1:AKT1:SERBP1:EGFR:ZFP36L2:EIF4A2:EIF5A2:TERT:TSC1:RPL38:EIF1:SMAD2:RPS6KA3:POLR2A:RBM10:HIST1H4C:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0010608  |  posttranscriptional regulation of gene expression	NA	4.56e-09	NA
59	CDS	Pancan-no-skin-melanoma-lymph	PUM2:XPO1:PSMC5:PSMA2:CPEB3:EIF4G1:HNRNPR:IGF2BP3:ANP32A:AKT1:SERBP1:ZFP36L2:HNRNPU:YWHAB:RBM10:DXO	GO:0043487  |  regulation of RNA stability	NA	0.000276	NA
60	CDS	Pancan-no-skin-melanoma-lymph	PUM2:XPO1:PSMC5:PSMA2:CPEB3:EIF4G1:HNRNPR:IGF2BP3:ANP32A:AKT1:SERBP1:ZFP36L2:HNRNPU:YWHAB:RBM10	GO:0043488  |  regulation of mRNA stability	NA	0.000744	NA
61	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MTG2:DDX6:CNOT2:CPEB4:RPL22:RPL5:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:TOB1:AKT1:EGFR:ZFP36L2:EEF1A1:EIF4A2:EIF5A2:TSC1:RPL38:EIF1:SMAD2:RPS6KA3:POLR2A:HIST1H4C:MRPL53:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0006412  |  translation	NA	0.00091	NA
62	CDS	Pancan-no-skin-melanoma-lymph	MTG2:DDX6:CNOT2:CPEB4:RPL5:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:TOB1:AKT1:EGFR:ZFP36L2:EIF4A2:EIF5A2:TSC1:RPL38:EIF1:SMAD2:RPS6KA3:POLR2A:HIST1H4C:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0006417  |  regulation of translation	NA	1.13e-06	NA
63	CDS	Pancan-no-skin-melanoma-lymph	CNOT2:CPEB4:HNRNPA2B1:HNRNPR:DGCR8:H3F3B:IGF2BP3:TOB1:EGFR:ZFP36L2:TSC1:SMAD2:POLR2A:HIST1H4C:DDX3X:HIST1H4K:HIST1H4E:HIST1H3C	GO:0017148  |  negative regulation of translation	NA	0.000256	NA
64	CDS	Pancan-no-skin-melanoma-lymph	RHOA:NFE2L2:KLF4:AKT1:EPHA2:NOTCH1:EFNA1:NF1	GO:0043535  |  regulation of blood vessel endothelial cell migration	NA	0.00705	NA
65	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:NFE2L2:TP53	GO:0006984  |  ER-nucleus signaling pathway	NA	0.0168	NA
66	CDS	Pancan-no-skin-melanoma-lymph	CDC27:NDE1:XPO1:PDS5B:ATRX:CHMP4B:STAG2:CTCF:SMC3:FBXW7:SFPQ:USP9X:APC:RB1:ATM:TTN:CTNNB1:DDX3X	GO:0007059  |  chromosome segregation	NA	0.0383	NA
67	CDS	Pancan-no-skin-melanoma-lymph	SPI1:ATRX:CTCF:GATA3:DNMT3A:PIK3CA:APOBEC2:MTA2:ASZ1	GO:0044728  |  DNA methylation or demethylation	NA	0.0234	NA
68	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:BAX:JAG1:IL2:GDF5:HNF1A:IL21:EPHA2:EGFR:ELF3:CARTPT:TNFRSF11B:CTNNB1:NF1	GO:0048771  |  tissue remodeling	NA	0.0298	NA
69	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:BAX:PSMC5:CHMP4B:AXIN1:PSMA2:SUFU:TBC1D12:FBXW7:CDKN1B:NFE2L2:PIK3CA:RPL5:SOX9:HNRNPR:APC:OS9:IDH1:TOB1:AKT1:EGFR:CDKN2A:ATM:ZFP36L2:U2AF1:TSC1:PTEN:PTPN1:ATP6V1G2	GO:0009894  |  regulation of catabolic process	NA	4.44e-08	NA
70	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:BAX:PSMC5:AXIN1:PSMA2:FBXW7:CDKN1B:NFE2L2:SOX9:HNRNPR:APC:TOB1:AKT1:ZFP36L2:TSC1:PTEN:PTPN1	GO:0009896  |  positive regulation of catabolic process	NA	0.000337	NA
71	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:BAX:PSMC5:CHMP4B:AXIN1:PSMA2:SUFU:TBC1D12:FBXW7:NFE2L2:PIK3CA:RPL5:HNRNPR:IDH1:TOB1:AKT1:CDKN2A:ATM:ZFP36L2:U2AF1:TSC1:PTEN:PTPN1:ATP6V1G2	GO:0031329  |  regulation of cellular catabolic process	NA	3.22e-06	NA
72	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:BAX:PSMC5:AXIN1:PSMA2:FBXW7:NFE2L2:HNRNPR:TOB1:AKT1:ZFP36L2:TSC1:PTEN:PTPN1	GO:0031331  |  positive regulation of cellular catabolic process	NA	0.00656	NA
73	CDS	Pancan-no-skin-melanoma-lymph	CHMP4B:SUFU:PIK3CA:RPL5:OS9:TOB1:AKT1:EGFR:CDKN2A:TSC1	GO:0009895  |  negative regulation of catabolic process	NA	0.013	NA
74	CDS	Pancan-no-skin-melanoma-lymph	CASP8:KEAP1:AXIN1:RNF43:FBXW7:NFE2L2:RPL22:SPOP:RPL5:USP9X:HNRNPR:APC:OS9:TOB1:TP53:DTL:CDKN2A:ATM:ZFP36L2:EIF4A2:BAP1:CTNNB1:PTEN	GO:0044265  |  cellular macromolecule catabolic process	NA	1.85e-08	NA
75	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:AXIN1:RNF43:FBXW7:NFE2L2:SPOP:RPL5:USP9X:APC:OS9:TP53:DTL:CDKN2A:BAP1:CTNNB1:PTEN	GO:0043632  |  modification-dependent macromolecule catabolic process	NA	2.46e-06	NA
76	CDS	Pancan-no-skin-melanoma-lymph	CASP8:KEAP1:AXIN1:RNF43:FBXW7:CDKN1B:NFE2L2:SPOP:RPL5:USP9X:APC:OS9:TP53:DTL:EGFR:CDKN2A:ATM:BAP1:CTNNB1:PTEN	GO:0030163  |  protein catabolic process	NA	1.42e-07	NA
77	CDS	Pancan-no-skin-melanoma-lymph	CASP8:KEAP1:AXIN1:RNF43:FBXW7:NFE2L2:SPOP:RPL5:USP9X:APC:OS9:TP53:DTL:CDKN2A:BAP1:CTNNB1:PTEN	GO:0044257  |  cellular protein catabolic process	NA	3.04e-06	NA
78	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:PSMC5:AXIN1:PSMA2:SUFU:FBXW7:CDKN1B:NFE2L2:RPL5:SOX9:APC:OS9:AKT1:EGFR:CDKN2A:PTEN	GO:0042176  |  regulation of protein catabolic process	NA	0.000697	NA
79	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:PSMC5:AXIN1:PSMA2:SUFU:FBXW7:NFE2L2:RPL5:AKT1:CDKN2A:PTEN	GO:1903362  |  regulation of cellular protein catabolic process	NA	0.0202	NA
80	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDC27:ASB4:HSPA5:CBFB:UBE2D1:KEAP1:PSMC5:L3MBTL2:AXIN1:EYA1:PSMA2:SUFU:RNF43:FBXW7:ARRDC3:BIRC6:NFE2L2:BCL11A:SPOP:RPL5:USP9X:SOX4:LRRC41:RNF128:VHL:OS9:AKT1:RPL11:DTL:MARCH4:TAF1:CDKN2A:ASB17:HIST1H2BD:UBR1:SYVN1:RYBP:CTNNB1:PTEN:SUZ12:MED12:VHLL:DAXX:HLA-A:HIST1H2BG:HIST1H2BO	GO:0032446  |  protein modification by small protein conjugation	NA	1.97e-05	NA
81	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDC27:ASB4:HSPA5:CBFB:UBE2D1:KEAP1:PSMC5:AXIN1:PSMA2:SUFU:RNF43:FBXW7:ARRDC3:BIRC6:NFE2L2:SPOP:RPL5:USP9X:LRRC41:RNF128:VHL:OS9:AKT1:RPL11:DTL:MARCH4:TAF1:CDKN2A:ASB17:HIST1H2BD:UBR1:SYVN1:RYBP:PTEN:SUZ12:MED12:VHLL:DAXX:HLA-A:HIST1H2BG:HIST1H2BO	GO:0016567  |  protein ubiquitination	NA	7.02e-05	NA
82	CDS	Pancan-no-skin-melanoma-lymph	CASP8:KEAP1:AXIN1:RNF43:FBXW7:NFE2L2:SPOP:RPL5:USP9X:APC:OS9:TP53:DTL:CDKN2A:BAP1:CTNNB1:PTEN	GO:0051603  |  proteolysis involved in cellular protein catabolic process	NA	1.14e-06	NA
83	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:PSMC5:AXIN1:PSMA2:SUFU:FBXW7:NFE2L2:RPL5:AKT1:CDKN2A:PTEN	GO:1903050  |  regulation of proteolysis involved in cellular protein catabolic process	NA	0.00798	NA
84	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:NFE2L2:APC:TP53:CTNNB1	GO:0010498  |  proteasomal protein catabolic process	NA	0.0333	NA
85	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:AXIN1:RNF43:FBXW7:NFE2L2:SPOP:RPL5:USP9X:APC:OS9:TP53:DTL:CDKN2A:BAP1:CTNNB1:PTEN	GO:0019941  |  modification-dependent protein catabolic process	NA	2.07e-06	NA
86	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:AXIN1:RNF43:FBXW7:NFE2L2:SPOP:RPL5:USP9X:APC:OS9:TP53:DTL:CDKN2A:BAP1:CTNNB1:PTEN	GO:0006511  |  ubiquitin-dependent protein catabolic process	NA	1.73e-06	NA
87	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:NFE2L2:APC:TP53:CTNNB1	GO:0043161  |  proteasome-mediated ubiquitin-dependent protein catabolic process	NA	0.0233	NA
88	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:PSMC5:AXIN1:PSMA2:SUFU:RNF43:FBXW7:SPOP:RPL5:RNF128:OS9:RPL11:TAF1:CDKN2A:SYVN1:PTEN	GO:0042787  |  protein ubiquitination involved in ubiquitin-dependent protein catabolic process	NA	0.00113	NA
89	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:PSMC5:AXIN1:PSMA2:FBXW7:CDKN1B:NFE2L2:SOX9:APC:AKT1:PTEN	GO:0045732  |  positive regulation of protein catabolic process	NA	0.0471	NA
90	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:PSMC5:AXIN1:PSMA2:SUFU:FBXW7:RPL5:RPL11:TAF1:CDKN2A:PTEN	GO:2000058  |  regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	NA	0.00254	NA
91	CDS	Pancan-no-skin-melanoma-lymph	SUFU:RPL5:RPL11:TAF1:CDKN2A	GO:2000059  |  negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	NA	0.0125	NA
92	CDS	Pancan-no-skin-melanoma-lymph	CDH1:RHOA:ACTB:MEF2C:ZMYND8:CHD4:EIF4G1:EPHA7:CHRNB2:SHANK1:NFIA:TSC1:CTNNB1:IL1RAPL1:CDH2:PTEN:SPTBN2:NPAS4:SLITRK1:RELN:LRRTM3	GO:0050808  |  synapse organization	NA	0.00109	NA
93	CDS	Pancan-no-skin-melanoma-lymph	RHOA:AKT1:TSC1:PTEN	GO:0045792  |  negative regulation of cell size	NA	0.0376	NA
94	CDS	Pancan-no-skin-melanoma-lymph	RHOA:NDE1:MEF2C:FAT1:AXIN1:STMN2:WASL:PRKAR1A:CDKN1B:NCKAP1L:APC:SMAD4:PIK3R1:RASA1:CDKN2A:TTN:BRAF:ARHGAP35:SHANK1:DDR2:ARPC2:COL1A2:TSC1:SPTBN2:PPM1E:FIGN:NF2:NF1:ARPC1A:MARCKS	GO:0097435  |  supramolecular fiber organization	NA	0.0332	NA
95	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:ACTB:BAX:GATA3:NFE2L2:BCL9:HDAC1:PIK3CA:H3F3B:AKT1:PIK3R1:EGFR:NOTCH1:ZFP36L2:BRAF:ARHGAP35:TGFBR2:COL1A2:IRF2:PTEN:HRAS:NF1:HIST1H3C	GO:0009611  |  response to wounding	NA	3.94e-06	NA
96	CDS	Pancan-no-skin-melanoma-lymph	ACTB:GATA3:NFE2L2:BCL9:HDAC1:PIK3CA:H3F3B:AKT1:PIK3R1:EGFR:NOTCH1:ARHGAP35:TGFBR2:COL1A2:IRF2:PTEN:HRAS:NF1:HIST1H3C	GO:0042060  |  wound healing	NA	0.000152	NA
97	CDS	Pancan-no-skin-melanoma-lymph	MTG2:SRSF9:SF3B1:RPL22:RPL5:WDR74:CDKN2A:ATM:PTEN:DDX3X	GO:0022613  |  ribonucleoprotein complex biogenesis	NA	0.0164	NA
98	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:AXIN1:PTPN1:DAXX	GO:0007257  |  activation of JUN kinase activity	NA	0.0323	NA
99	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:ATRX:SMARCB1:CTCF:GATA3:PRDM13:MEN1:SMAD4:SETDB1:KDM6A:EEF1A1:KMT2D:CTNNB1:SUZ12:SETD2:HIST1H1C:NELFE	GO:0008213  |  protein alkylation	NA	1.2e-06	NA
100	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1905710  |  positive regulation of membrane permeability	NA	0.0267	NA
101	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:0035794  |  positive regulation of mitochondrial membrane permeability	NA	0.0232	NA
102	CDS	Pancan-no-skin-melanoma-lymph	GATA3:NFE2L2:DNMT3A:TEK:SPOP:SIX3:RB1:TCF7L2:BRAF:NEUROD1:TGFBR2:TERT:AKR1C3	GO:1904019  |  epithelial cell apoptotic process	NA	5.48e-06	NA
103	CDS	Pancan-no-skin-melanoma-lymph	GATA3:NFE2L2:TEK:SPOP:TCF7L2:BRAF:NEUROD1:TERT:AKR1C3	GO:1904035  |  regulation of epithelial cell apoptotic process	NA	0.00342	NA
104	CDS	Pancan-no-skin-melanoma-lymph	NFE2L2:BRAF:TERT	GO:0072577  |  endothelial cell apoptotic process	NA	0.046	NA
105	CDS	Pancan-no-skin-melanoma-lymph	NFE2L2:BRAF:TERT	GO:2000351  |  regulation of endothelial cell apoptotic process	NA	0.0309	NA
106	CDS	Pancan-no-skin-melanoma-lymph	CDC27:HSPA5:MAP2K4:RHOA:UBE2D1:MAP2K7:MEF2C:BAX:PSMC5:MAP3K1:AXIN1:PSMA2:PRKAR1A:FBXW7:PTGES3:CDKN1B:DUSP22:ARRDC3:ERRFI1:TEK:PIK3CA:RPL5:HNRNPA2B1:CDKN1A:KRAS:MEN1:APC:KLF4:MYC:RB1:TP53:AKT1:RPL11:JTB:PIK3R1:EGFR:CDKN2A:TNIK:TTN:EIF4A2:BRAF:DDR2:TGFBR2:RFC4:DUSP7:TSC1:CTNNB1:EFNA1:LDB2:YWHAG:PTEN:HRAS:PPM1E:PTPN11:NF2:HEXIM1:RELN:PTPN1:NF1:SERTAD1:LDB1:DAXX	GO:0051338  |  regulation of transferase activity	NA	2.61e-14	NA
107	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:AXIN1:PSMA2:FBXW7:ARRDC3:RPL5:CDKN2A:PTEN	GO:0051438  |  regulation of ubiquitin-protein transferase activity	NA	0.0196	NA
108	CDS	Pancan-no-skin-melanoma-lymph	ATRX:PSMC5:SMARCB1:CTCF:ARID1A:SOX9:SMARCA4:H3F3B:XPA:MYC:RB1:TAF1:HIST1H2BD:SETD2:HIST1H1C:ARID2:HIST1H4C:DAXX:HIST1H4K:HIST1H2BG:HIST1H2BO:HNF1B:HIST1H4E:HIST1H3C	GO:0071824  |  protein-DNA complex subunit organization	NA	6e-09	NA
109	CDS	Pancan-no-skin-melanoma-lymph	ACTB:MAP2K7:ATRX:BAX:CHMP4B:PTGES3:HNRNPA2B1:SOX9:KRAS:MYC:RB1:EGFR:ATM:NEUROD1:ALB:RFC4:TERT:TNFRSF11B:B2M:CTNNB1:LDB2:PTPN11:NF1:HIST1H4C:LDB1:HIST1H4K:HIST1H4E	GO:0060249  |  anatomical structure homeostasis	NA	1.01e-07	NA
110	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1902686  |  mitochondrial outer membrane permeabilization involved in programmed cell death	NA	0.0174	NA
111	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:GATA3:FBXW7:HES1:CDKN1A:OS9:TP53:SMAD4:PIK3R1:EGFR:BAP1:SETD2:NF1	GO:0090087  |  regulation of peptide transport	NA	0.00579	NA
112	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:KEAP1:BAX:LEPROTL1:SUFU:HES1:CDKN1A:GDF5:PEX1:TOB1:TP53:SMAD4:AKT1:EPHA2:ATP1B1:CALM2:PIK3R1:EGFR:BRAF:ALB:TSC1:CTNNB1:PTCH1:NF1	GO:1902580  |  single-organism cellular localization	NA	0.000203	NA
113	CDS	Pancan-no-skin-melanoma-lymph	JARID2:KMT2C:SPI1:ATRX:SMARCB1:CTCF:GATA3:PRDM13:DNMT3A:PIK3CA:MEN1:SMAD4:SETDB1:KDM6A:MTA2:ASZ1:EEF1A1:KMT2D:CTNNB1:KDM2A:SUZ12:SETD2:HIST1H1C:NELFE	GO:0032259  |  methylation	NA	1.69e-05	NA
114	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:ATRX:SMARCB1:CTCF:GATA3:PRDM13:DNMT3A:PIK3CA:MEN1:SMAD4:SETDB1:KDM6A:MTA2:ASZ1:KMT2D:CTNNB1:SUZ12:SETD2:NELFE	GO:0043414  |  macromolecule methylation	NA	6.27e-07	NA
115	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:ATRX:SMARCB1:CTCF:GATA3:PRDM13:MEN1:SMAD4:SETDB1:KDM6A:EEF1A1:KMT2D:CTNNB1:SUZ12:SETD2:HIST1H1C:NELFE	GO:0006479  |  protein methylation	NA	1.2e-06	NA
116	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:HNRNPA2B1:U2AF1:SRSF2:TSC1:SETD2	GO:0071166  |  ribonucleoprotein complex localization	NA	0.0333	NA
117	CDS	Pancan-no-skin-melanoma-lymph	RHOA:BAX:DYNLL1:PCIF1:ELL:PRKAR1A:YWHAE:IL2:CDKN1B:DUSP22:EIF4G1:ERRFI1:INHBA:NCKAP1L:CDKN1A:MEN1:APC:KLF4:MYC:RB1:SMAD4:AKT1:CDKN2A:DRD3:CDA:DUSP7:YWHAB:YWHAG:PTEN:PPM1E:JUN:NF2:HEXIM1:PTPN1:NF1:LRRTM3	GO:0010563  |  negative regulation of phosphorus metabolic process	NA	6.03e-05	NA
118	CDS	Pancan-no-skin-melanoma-lymph	RHOA:BAX:DYNLL1:PCIF1:ELL:PRKAR1A:YWHAE:IL2:CDKN1B:DUSP22:EIF4G1:ERRFI1:INHBA:NCKAP1L:CDKN1A:MEN1:APC:KLF4:MYC:RB1:SMAD4:AKT1:CDKN2A:DRD3:CDA:DUSP7:YWHAB:YWHAG:PTEN:PPM1E:JUN:NF2:HEXIM1:PTPN1:NF1:LRRTM3	GO:0045936  |  negative regulation of phosphate metabolic process	NA	5.76e-05	NA
119	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:LEPROTL1:SUFU:HES1:CDKN1A:GDF5:PEX1:TOB1:SMAD4:AKT1:ATP1B1:CALM2:PIK3R1:EGFR:BRAF:TSC1:CTNNB1:PTCH1:NF1	GO:1902582  |  single-organism intracellular transport	NA	0.00358	NA
120	CDS	Pancan-no-skin-melanoma-lymph	CDC27:JARID2:SPI1:UBE2D1:BAX:PSMC5:SMARCB1:PSMA2:SUFU:PRKAR1A:YWHAE:IL2:CDKN1B:DUSP22:EIF4G1:ERRFI1:RPL5:CDKN1A:MEN1:APC:KLF4:MYC:RB1:SMAD4:AKT1:RPL11:TAF1:CDKN2A:DUSP7:YWHAB:CTNNB1:YWHAG:PTEN:PPM1E:JUN:NF2:HEXIM1:PTPN1:NF1	GO:0031400  |  negative regulation of protein modification process	NA	3.94e-08	NA
121	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:HNRNPA2B1:TP53:TCF7L2:U2AF1:SRSF2:TSC1:SETD2	GO:0051168  |  nuclear export	NA	0.0133	NA
122	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:MAP2K4:BAX:CHMP4B:GATA3:FBXW7:PIK3CA:GDF5:KRAS:RB1:TP53:AKT1:RASA1:ATM:BRAF:EN1:TERT:TSC1:CTNNB1:HRAS:NF1:DAXX	GO:0070997  |  neuron death	NA	5.47e-12	NA
123	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:MAP2K4:BAX:GATA3:FBXW7:PIK3CA:GDF5:KRAS:RB1:TP53:RASA1:ATM:BRAF:EN1:TERT:CTNNB1:HRAS:NF1	GO:0051402  |  neuron apoptotic process	NA	2.53e-10	NA
124	CDS	Pancan-no-skin-melanoma-lymph	CDC27:RHOA:UBE2D1:NDE1:TP63:PDS5B:ATRX:BAX:PSMC5:DYNLL1:EP300:CHMP4B:EYA1:CASP2:EZH2:PSMA2:SMC3:YWHAE:PHOX2B:CDKN1B:CNOT2:HES1:EIF4G1:ID2:DNMT3A:INHBA:CDKN1A:SOX4:SMARCA4:FOXA1:MEN1:APC:ACVR1B:MYC:ASCL1:RB1:CLTC:TP53:AKT1:JTB:RASA1:EGFR:CDKN2A:ATM:DRD3:ZFP36L2:TTN:SRSF2:BRINP3:PBRM1:TERT:PRKCB:CTNNB1:YWHAG:PTEN:HRAS:CTDNEP1:PTPN11:PTCH1:DDX3X	GO:0000278  |  mitotic cell cycle	NA	2.92e-10	NA
125	CDS	Pancan-no-skin-melanoma-lymph	CDC27:CASP8:UBE2D1:PSMC5:PCIF1:ELL:PSMA2:PRKAR1A:YWHAE:CDKN1B:DUSP22:BIRC6:ERRFI1:RPL5:NCKAP1L:CDKN1A:HNRNPR:MEN1:APC:KLF4:CPEB2:PI15:RB1:TP53:AKT1:RPL11:CDKN2A:NOTCH1:DRD3:EIF4A2:DUSP7:TSC1:YWHAG:PTEN:HRAS:PPM1E:RPS6KA3:NF2:HEXIM1:PTPN1:NF1:LRRTM3:SPINK13:DDX3X:TXNIP	GO:0043086  |  negative regulation of catalytic activity	NA	0.000394	NA
126	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:PSMC5:PSMA2:PRKAR1A:CDKN1B:DUSP22:ERRFI1:RPL5:CDKN1A:MEN1:APC:RB1:TP53:AKT1:RPL11:CDKN2A:EIF4A2:DUSP7:YWHAG:PTEN:PPM1E:NF2:HEXIM1:PTPN1:NF1	GO:0051348  |  negative regulation of transferase activity	NA	1.1e-05	NA
127	CDS	Pancan-no-skin-melanoma-lymph	MAP2K7:ATRX:PTGES3:HNRNPA2B1:H3F3B:MYC:ATM:RFC4:TERT:CTNNB1:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	GO:0032200  |  telomere organization	NA	9.02e-05	NA
128	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:KEAP1:LEPROTL1:FBXW7:HES1:CDKN1A:APC:OS9:RB1:TP53:SMAD4:CALM2:PIK3R1:EGFR:BRAF:BAP1:TERT:CTNNB1:PTEN:SETD2:NF1	GO:0060341  |  regulation of cellular localization	NA	5.62e-09	NA
129	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:KEAP1:FBXW7:HES1:CDKN1A:OS9:TP53:SMAD4:CALM2:PIK3R1:EGFR:BRAF:BAP1:SETD2:NF1	GO:0032386  |  regulation of intracellular transport	NA	8.6e-07	NA
130	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:ARID1B:KMT2C:SPI1:NUCKS1:TP63:ACTB:BCORL1:ATRX:SMARCB1:EP300:L3MBTL2:CHD8:ZMYND8:SMARCA1:CTCF:SALL1:EYA1:ASF1B:EZH2:GATA3:CHD4:PRDM13:HDAC1:SFPQ:ARID1A:SUPT7L:DNMT3A:KANSL1:EPC1:SOX9:KDM5C:SMARCA4:FOXA1:H3F3B:MEN1:HNF1A:MYC:RB1:TP53:SMAD4:SETDB1:KDM6A:TAF1:CDKN2A:TAF5:ATM:MTA2:HIST1H2BD:RYBP:BAP1:PBRM1:PRKCB:KMT2D:CTNNB1:KDM2A:SUZ12:GATA2:HIST1H2AC:SETD2:HIST2H3D:HIST1H1C:ARID2:HIST1H2AI:HIST1H4C:BAZ1A:LDB1:DAXX:NELFE:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	GO:0006325  |  chromatin organization	NA	2.07e-26	NA
131	CDS	Pancan-no-skin-melanoma-lymph	ATRX:SMARCB1:CTCF:ARID1A:SOX9:SMARCA4:H3F3B:TP53:CDKN2A:MTA2:HIST1H2BD:HIST1H1C:ARID2:HIST1H4C:DAXX:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H3C	GO:0006333  |  chromatin assembly or disassembly	NA	2.43e-09	NA
132	CDS	Pancan-no-skin-melanoma-lymph	ARID1B:TP63:ACTB:ATRX:SMARCB1:CHD8:SMARCA1:GATA3:CHD4:HDAC1:ARID1A:SOX9:SMARCA4:FOXA1:HNF1A:MYC:RB1:CDKN2A:MTA2:PBRM1:CTNNB1:HIST1H4C:BAZ1A:DAXX:HIST1H4K:HIST1H4E	GO:0006338  |  chromatin remodeling	NA	6.07e-12	NA
133	CDS	Pancan-no-skin-melanoma-lymph	ACTB:SMARCB1:CHD8:SMARCA1:CHD4:HDAC1:ARID1A:SMARCA4:MTA2:HIST1H4C:HIST1H4K:HIST1H4E	GO:0043044  |  ATP-dependent chromatin remodeling	NA	8.1e-05	NA
134	CDS	Pancan-no-skin-melanoma-lymph	ATRX:SMARCB1:CTCF:ARID1A:SOX9:SMARCA4:H3F3B:HIST1H2BD:SETD2:HIST1H1C:ARID2:HIST1H4C:DAXX:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H3C	GO:0034728  |  nucleosome organization	NA	5.44e-08	NA
135	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:ARID1B:KMT2C:SPI1:BCORL1:ATRX:SMARCB1:EP300:L3MBTL2:CHD8:ZMYND8:SMARCA1:CTCF:SALL1:EYA1:ASF1B:EZH2:GATA3:CHD4:PRDM13:HDAC1:SFPQ:ARID1A:SUPT7L:DNMT3A:KANSL1:EPC1:KDM5C:SMARCA4:FOXA1:MEN1:HNF1A:RB1:TP53:SMAD4:SETDB1:KDM6A:TAF1:TAF5:ATM:MTA2:RYBP:BAP1:PBRM1:PRKCB:KMT2D:CTNNB1:KDM2A:SUZ12:GATA2:SETD2:HIST1H1C:ARID2:LDB1:DAXX:NELFE	GO:0016569  |  covalent chromatin modification	NA	1.59e-18	NA
136	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:KMT2C:SPI1:ATRX:SMARCB1:EP300:ZMYND8:CTCF:SALL1:EYA1:EZH2:GATA3:CHD4:PRDM13:HDAC1:SFPQ:SUPT7L:KANSL1:EPC1:KDM5C:MEN1:HNF1A:TP53:SMAD4:SETDB1:KDM6A:TAF1:TAF5:ATM:MTA2:RYBP:BAP1:PRKCB:KMT2D:CTNNB1:KDM2A:SUZ12:GATA2:SETD2:HIST1H1C:LDB1:NELFE	GO:0016570  |  histone modification	NA	2.25e-12	NA
137	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:ATRX:SMARCB1:CTCF:GATA3:PRDM13:MEN1:SMAD4:SETDB1:KDM6A:KMT2D:CTNNB1:SUZ12:SETD2:NELFE	GO:0016571  |  histone methylation	NA	4.18e-08	NA
138	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:NDE1:TP63:BAX:PSMC5:DYNLL1:EP300:CHMP4B:CASP2:EZH2:PSMA2:YWHAE:PHOX2B:FBXW7:CDKN1B:CNOT2:EIF4G1:ID2:INHBA:CDKN1A:SOX4:SMARCA4:MEN1:APC:ACVR1B:MYC:SIX3:RB1:TP53:AKT1:EGFR:TAF1:CDKN2A:ATM:ZFP36L2:TERT:YWHAG:PTEN:DDX3X	GO:0044770  |  cell cycle phase transition	NA	6.09e-07	NA
139	CDS	Pancan-no-skin-melanoma-lymph	BAX:FBXW7:CDKN1B:ID2:CDKN1A:SMARCA4:MEN1:ACVR1B:RB1:TP53:EGFR:CDKN2A:ATM:TERT:PTEN:DDX3X	GO:0044843  |  cell cycle G1/S phase transition	NA	2.93e-08	NA
140	CDS	Pancan-no-skin-melanoma-lymph	ATRX:SMARCA1:CTCF:CHD4:HNRNPA2B1:SOX9:H3F3B:XPA:TP53:CDKN2A:TTN:HIST1H2BD:HIST2H3D:HIST1H1C:HIST1H4C:DAXX:DDX3X:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H3C	GO:0071103  |  DNA conformation change	NA	5.6e-06	NA
141	CDS	Pancan-no-skin-melanoma-lymph	ATRX:CTCF:ASF1B:SOX9:H3F3B:TP53:CDKN2A:TTN:HIST1H2BD:HIST2H3D:HIST1H1C:HIST1H4C:DAXX:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H3C	GO:0006323  |  DNA packaging	NA	6.97e-05	NA
142	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:NUCKS1:PDS5B:ATRX:BAX:SMARCB1:EP300:SMC3:CDKN1B:CNOT2:SFPQ:CDKN1A:MEN1:APC:XPA:MYC:TP53:AKT1:EPHA2:DTL:INTS7:PIK3R1:EGFR:TAF1:ATM:RFC4:COPS2:KDM2A:PTPN11:POLR2A:SETD2:FIGN:HIST1H4C:HIST1H4K:HIST1H4E	GO:0006974  |  cellular response to DNA damage stimulus	NA	3.2e-05	NA
143	CDS	Pancan-no-skin-melanoma-lymph	TP63:BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:DTL:INTS7:ATM:TAOK1:PTPN11	GO:0000077  |  DNA damage checkpoint	NA	0.0334	NA
144	CDS	Pancan-no-skin-melanoma-lymph	TP63:BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0044783  |  G1 DNA damage checkpoint	NA	0.0148	NA
145	CDS	Pancan-no-skin-melanoma-lymph	TP63:ACTB:BAX:CHMP4B:PRKAR1A:ARRDC3:EIF4G1:PIK3CA:SOX9:KRAS:HNF1A:RB1:EGFR:NEUROD1:ALB:CARTPT:TNFRSF11B:B2M:CTNNB1:LDB2:NR1D2:ALOXE3:PTPN11:GATA2:NF1:LDB1	GO:0048871  |  multicellular organismal homeostasis	NA	0.000229	NA
146	CDS	Pancan-no-skin-melanoma-lymph	ACTB:BAX:CHMP4B:SOX9:KRAS:RB1:EGFR:NEUROD1:ALB:TNFRSF11B:B2M:CTNNB1:LDB2:PTPN11:NF1:LDB1	GO:0001894  |  tissue homeostasis	NA	0.000302	NA
147	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:KEAP1:LEPROTL1:GATA3:FBXW7:HES1:CDKN1A:APC:OS9:RB1:TP53:SMAD4:PIK3R1:EGFR:BAP1:TERT:CTNNB1:SETD2:PTCH1:NF1	GO:0032880  |  regulation of protein localization	NA	6.11e-07	NA
148	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:RHOA:TP63:KEAP1:XPO1:DYNLL1:GATA3:SUFU:YWHAE:IL2:FBXW7:HES1:CDKN1A:SOX4:YWHAH:HNF1A:OS9:TP53:SMAD4:AKT1:EPHA2:GOLPH3L:PIK3R1:EGFR:TCF7L2:DRD3:TTN:U2AF1:NEUROD1:IL17RC:BAP1:CARTPT:YWHAB:YWHAG:JUP:PTPN11:SETD2:IDH2:PTPN1:NF1:CACNA1E:UBL5:MARCKS	GO:0070201  |  regulation of establishment of protein localization	NA	0.000497	NA
149	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:GATA3:FBXW7:HES1:CDKN1A:OS9:TP53:SMAD4:PIK3R1:EGFR:BAP1:SETD2:NF1	GO:0051223  |  regulation of protein transport	NA	0.00372	NA
150	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:NFE2L2:CDKN2A:PTEN	GO:0010657  |  muscle cell apoptotic process	NA	0.00278	NA
151	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:NFE2L2:CDKN2A:PTEN	GO:0010660  |  regulation of muscle cell apoptotic process	NA	0.00199	NA
152	CDS	Pancan-no-skin-melanoma-lymph	CDC27:HSPA5:MAP2K4:RHOA:UBE2D1:MAP2K7:MEF2C:BAX:PSMC5:MAP3K1:AXIN1:PSMA2:PRKAR1A:FBXW7:PTGES3:CDKN1B:ARRDC3:TEK:PIK3CA:HNRNPA2B1:CDKN1A:KRAS:KLF4:MYC:AKT1:EGFR:BRAF:TGFBR2:RFC4:DUSP7:CTNNB1:EFNA1:PTEN:HRAS:PTPN11:RELN:PTPN1:DAXX	GO:0051347  |  positive regulation of transferase activity	NA	1.71e-08	NA
153	CDS	Pancan-no-skin-melanoma-lymph	CDH1:HSPA5:CASP8:KEAP1:XPO1:ATRX:BAX:DYNLL1:CHMP4B:CTCF:SUFU:FBXW7:HES1:RPL22:SUPT7L:RPL5:CDKN1A:SOX9:GDF5:PEX1:APC:OS9:RB1:TOB1:TP53:SMAD4:AKT1:CALM2:PIK3R1:EGFR:U2AF1:BAP1:TERT:CTNNB1:RPL38:JUP:CTDNEP1:NF1:NRAS:DDX3X	GO:0033365  |  protein localization to organelle	NA	1.74e-10	NA
154	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:FBXW7:HES1:YWHAH:TP53:AKT1:CALM2:U2AF1:BAP1:YWHAB:YWHAG:UBL5	GO:0070585  |  protein localization to mitochondrion	NA	0.026	NA
155	CDS	Pancan-no-skin-melanoma-lymph	CDH1:RHOA:KEAP1:XPO1:SUFU:HES1:SUPT7L:CDKN1A:SOX9:GDF5:NR5A1:XPA:SIX3:TOB1:SMAD4:AKT1:PIK3R1:EGFR:TERT:CTNNB1:JUP:CTDNEP1:JUN:NF2:AKR1C3:NF1	GO:0034504  |  protein localization to nucleus	NA	1.09e-06	NA
156	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:KEAP1:FBXW7:HES1:RPL22:RPL5:CDKN1A:TOB1:TP53:SMAD4:CALM2:PIK3R1:EGFR:BAP1:TERT:CTNNB1:NF1:NRAS	GO:0072594  |  establishment of protein localization to organelle	NA	6.27e-09	NA
157	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:FBXW7:HES1:YWHAH:TP53:AKT1:CALM2:U2AF1:BAP1:YWHAB:YWHAG:UBL5	GO:0072655  |  establishment of protein localization to mitochondrion	NA	0.0213	NA
158	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:SUFU:SRSF9:HES1:SRSF7:SRSF4:HNRNPA2B1:CDKN1A:GDF5:ANP32A:TOB1:TP53:SMAD4:AKT1:PIK3R1:EGFR:TCF7L2:U2AF1:SRSF2:TSC1:CTNNB1:SETD2:NF1	GO:0051169  |  nuclear transport	NA	4.95e-10	NA
159	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:HNRNPA2B1:ANP32A:TP53:PIK3R1:TCF7L2:U2AF1:SRSF2:TSC1:SETD2	GO:0006913  |  nucleocytoplasmic transport	NA	0.000516	NA
160	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:HNRNPA2B1:TP53:TCF7L2:U2AF1:SRSF2:TSC1:SETD2	GO:0006611  |  protein export from nucleus	NA	0.00587	NA
161	CDS	Pancan-no-skin-melanoma-lymph	CDC27:RHOA:UBE2D1:NDE1:TP63:PDS5B:ATRX:BAX:PSMC5:DYNLL1:EP300:CHMP4B:EYA1:CASP2:EZH2:PSMA2:SMC3:YWHAE:PHOX2B:CDKN1B:CNOT2:EIF4G1:ID2:INHBA:CDKN1A:SOX4:SMARCA4:APC:ACVR1B:MYC:RB1:CLTC:TP53:AKT1:RASA1:EGFR:CDKN2A:ATM:DRD3:ZFP36L2:TTN:TERT:PRKCB:YWHAG:PTEN:HRAS:CTDNEP1:DDX3X	GO:1903047  |  mitotic cell cycle process	NA	2.07e-06	NA
162	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:NDE1:TP63:BAX:PSMC5:DYNLL1:EP300:CHMP4B:CASP2:EZH2:PSMA2:YWHAE:PHOX2B:CDKN1B:CNOT2:EIF4G1:ID2:INHBA:CDKN1A:SOX4:SMARCA4:APC:ACVR1B:MYC:RB1:TP53:AKT1:EGFR:CDKN2A:ATM:ZFP36L2:TERT:YWHAG:PTEN:DDX3X	GO:0044772  |  mitotic cell cycle phase transition	NA	2.08e-05	NA
163	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:ID2:CDKN1A:SMARCA4:ACVR1B:RB1:TP53:EGFR:CDKN2A:ATM:TERT:PTEN:DDX3X	GO:0000082  |  G1/S transition of mitotic cell cycle	NA	1.8e-06	NA
164	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:TP63:BAX:DYNLL1:ZMYND8:CHMP4B:LIN7B:YWHAE:RPL22:RPL5:YWHAH:CLTC:TP53:AKT1:EPHA2:RPL11:ATP1B1:GOLPH3L:CALM2:PIK3R1:EGFR:TNIK:BRAF:FCER1G:YWHAB:YWHAG:CDH2:RPL38:JUP:PTCH1:RELN:RPL12	GO:0072657  |  protein localization to membrane	NA	0.000254	NA
165	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:BAX:DYNLL1:CHMP4B:RPL22:RPL5:TP53:AKT1:EPHA2:ATP1B1:CALM2:PIK3R1:EGFR:BRAF:RPL38:JUP:PTCH1	GO:0090150  |  establishment of protein localization to membrane	NA	0.000145	NA
166	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:EGFR:YWHAB:YWHAG	GO:0051205  |  protein insertion into membrane	NA	0.000441	NA
167	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:RHOA:TP63:BAX:DYNLL1:WASL:GATA3:YWHAE:IL2:FBXW7:IL4:HES1:NFE2L2:INHBA:NCKAP1L:SOX4:YWHAH:TP53:SMAD4:AKT1:ATP1B1:GOLPH3L:PIK3R1:EGFR:TCF7L2:DRD3:TTN:FCER1G:U2AF1:CHRNB2:CTSS:IL17RC:BAP1:CARTPT:TERT:HNRNPK:B2M:AP1G1:YWHAB:YWHAG:CDH2:JUP:PTPN11:GATA2:PTCH1:RELN:UBL5	GO:0051050  |  positive regulation of transport	NA	0.000372	NA
168	CDS	Pancan-no-skin-melanoma-lymph	SMARCB1:ARID1A:SMARCA4:MYC:ARID2	GO:0032986  |  protein-DNA complex disassembly	NA	0.0101	NA
169	CDS	Pancan-no-skin-melanoma-lymph	RHOA:UBE2D1:XPO1:ATRX:BAX:PSMC5:EP300:CHMP4B:STAG2:CTCF:PSMA2:SMC3:PRKAR1A:PHOX2B:FBXW7:CDKN1B:CNOT2:ID2:SFPQ:CDKN1A:SOX9:SMARCA4:MEN1:APC:SIX3:RB1:TP53:AKT1:EGFR:TAF1:CDKN2A:ATM:ZFP36L2:NEUROD1:TERT:CTNNB1:PTEN:DDX3X	GO:0010564  |  regulation of cell cycle process	NA	1.38e-10	NA
170	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:CDKN1B:CDKN1A:SMARCA4:MEN1:APC:RB1:TP53:EGFR:CDKN2A:ATM:ZFP36L2:TERT:PTEN:DDX3X	GO:1901987  |  regulation of cell cycle phase transition	NA	8.44e-09	NA
171	CDS	Pancan-no-skin-melanoma-lymph	BAX:FBXW7:CDKN1B:ID2:CDKN1A:SMARCA4:MEN1:RB1:TP53:EGFR:ATM:TERT:PTEN:DDX3X	GO:1902806  |  regulation of cell cycle G1/S phase transition	NA	1.09e-09	NA
172	CDS	Pancan-no-skin-melanoma-lymph	JARID2:SPI1:ACTB:EP300:CTCF:EIF4G1:SF3B1:HDAC1:ARID1A:DNMT3A:EPC1:HNRNPA2B1:DGCR8:H3F3B:SETDB1:EGFR:TERT:KMT2D:CTNNB1:EIF1:SMAD2:SUZ12:HIST1H2AC:POLR2A:HIST2H3D:POLR1D:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	GO:0040029  |  regulation of gene expression, epigenetic	NA	7.82e-11	NA
173	CDS	Pancan-no-skin-melanoma-lymph	JARID2:SPI1:HDAC1:ARID1A:DNMT3A:EPC1:H3F3B:SETDB1:KMT2D:SUZ12:HIST1H2AC:HIST2H3D:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	GO:0045814  |  negative regulation of gene expression, epigenetic	NA	1.92e-09	NA
174	CDS	Pancan-no-skin-melanoma-lymph	ATRX:PSMC5:ASF1B:SOX9:H3F3B:XPA:RB1:TAF1:HIST1H2BD:HIST2H3D:HIST1H1C:TCF4:HIST1H4C:DAXX:HIST1H4K:HIST1H2BG:HIST1H2BO:HNF1B:HIST1H4E:HIST1H3C	GO:0065004  |  protein-DNA complex assembly	NA	0.00011	NA
175	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:MAP2K4:BAX:CHMP4B:GATA3:FBXW7:PIK3CA:GDF5:KRAS:TP53:AKT1:RASA1:ATM:BRAF:EN1:TERT:TSC1:CTNNB1:HRAS:NF1:DAXX	GO:1901214  |  regulation of neuron death	NA	5.92e-12	NA
176	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:MAP2K4:BAX:GATA3:FBXW7:PIK3CA:GDF5:KRAS:TP53:RASA1:ATM:BRAF:EN1:TERT:CTNNB1:HRAS:NF1	GO:0043523  |  regulation of neuron apoptotic process	NA	4.74e-10	NA
177	CDS	Pancan-no-skin-melanoma-lymph	BAX:PSMC5:CHMP4B:PSMA2:CDKN1B:HES1:ID2:CDKN1A:SMARCA4:FOXA1:APC:RB1:TP53:AKT1:EGFR:CDKN2A:ATM:ZFP36L2:TERT:CTNNB1:PTEN:HRAS:PTCH1:DDX3X	GO:0007346  |  regulation of mitotic cell cycle	NA	9.01e-09	NA
178	CDS	Pancan-no-skin-melanoma-lymph	BAX:PSMC5:PSMA2:CDKN1B:ID2:CDKN1A:SMARCA4:APC:RB1:TP53:AKT1:EGFR:CDKN2A:ATM:ZFP36L2:TERT:PTEN:DDX3X	GO:1901990  |  regulation of mitotic cell cycle phase transition	NA	3.47e-07	NA
179	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:ID2:CDKN1A:SMARCA4:RB1:TP53:EGFR:ATM:TERT:PTEN:DDX3X	GO:2000045  |  regulation of G1/S transition of mitotic cell cycle	NA	1.27e-07	NA
180	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDC27:JARID2:SPI1:MAP2K7:ATRX:SMARCB1:CTCF:GATA3:SFPQ:HNRNPA2B1:APC:MYC:RB1:TP53:SMAD4:SETDB1:ATM:CTNNB1:NELFE	GO:0033044  |  regulation of chromosome organization	NA	0.000406	NA
181	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:SPI1:ATRX:SMARCB1:CTCF:GATA3:TP53:SMAD4:SETDB1:ATM:CTNNB1:NELFE	GO:1902275  |  regulation of chromatin organization	NA	0.00829	NA
182	CDS	Pancan-no-skin-melanoma-lymph	ATRX:BAX:PSMC5:EP300:STAG2:PSMA2:GATA3:SMC3:PRKAR1A:PHOX2B:FBXW7:CDKN1B:CNOT2:ID2:CDKN1A:SMARCA4:MEN1:APC:MYC:RB1:TP53:AKT1:DTL:INTS7:EGFR:CDKN2A:TCF7L2:ATM:ZFP36L2:NEUROD1:TSC1:CTNNB1:PTEN:HRAS:PTPN11:HEXIM1	GO:0045786  |  negative regulation of cell cycle	NA	4.08e-10	NA
183	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:CDKN1A:APC:RB1:TP53:DTL:ATM:HRAS	GO:0000075  |  cell cycle checkpoint	NA	0.00386	NA
184	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0072395  |  signal transduction involved in cell cycle checkpoint	NA	0.03	NA
185	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0072401  |  signal transduction involved in DNA integrity checkpoint	NA	0.0265	NA
186	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0072422  |  signal transduction involved in DNA damage checkpoint	NA	0.0265	NA
187	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:PHOX2B:CDKN1B:CNOT2:ID2:INHBA:CDKN1A:SOX4:IRF1:APC:MYC:RB1:TP53:CDKN2A:TCF7L2:ATM:BRINP3:NEUROD1:TSC1:HRAS	GO:0007050  |  cell cycle arrest	NA	7.6e-05	NA
188	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:PHOX2B:CDKN1B:CNOT2:ID2:CDKN1A:SOX4:TP53:ATM:NEUROD1	GO:0071156  |  regulation of cell cycle arrest	NA	0.00889	NA
189	CDS	Pancan-no-skin-melanoma-lymph	ATRX:BAX:PSMC5:EP300:STAG2:PSMA2:PRKAR1A:PHOX2B:FBXW7:CDKN1B:CNOT2:CDKN1A:SMARCA4:MEN1:APC:RB1:TP53:ATM:ZFP36L2:PTEN	GO:0010948  |  negative regulation of cell cycle process	NA	2.5e-06	NA
190	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:CDKN1A:SMARCA4:MEN1:APC:RB1:TP53:ATM:ZFP36L2:PTEN	GO:1901988  |  negative regulation of cell cycle phase transition	NA	1.82e-05	NA
191	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:CDKN1A:SMARCA4:MEN1:RB1:TP53:ATM:PTEN	GO:1902807  |  negative regulation of cell cycle G1/S phase transition	NA	5.5e-06	NA
192	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:1902400  |  intracellular signal transduction involved in G1 DNA damage checkpoint	NA	0.0157	NA
193	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:CDKN1A:SMARCA4:APC:RB1:TP53:EGFR:ATM:ZFP36L2:CTNNB1:PTEN:HRAS	GO:0045930  |  negative regulation of mitotic cell cycle	NA	2.79e-06	NA
194	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:CDKN1A:APC:RB1:TP53:ATM:HRAS	GO:0007093  |  mitotic cell cycle checkpoint	NA	0.00235	NA
195	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0072413  |  signal transduction involved in mitotic cell cycle checkpoint	NA	0.0205	NA
196	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:1902403  |  signal transduction involved in mitotic DNA integrity checkpoint	NA	0.0205	NA
197	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:1902402  |  signal transduction involved in mitotic DNA damage checkpoint	NA	0.0205	NA
198	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:CDKN1A:SMARCA4:APC:RB1:TP53:ATM:ZFP36L2:PTEN	GO:1901991  |  negative regulation of mitotic cell cycle phase transition	NA	0.000148	NA
199	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:CDKN1A:SMARCA4:RB1:TP53:ATM:PTEN	GO:2000134  |  negative regulation of G1/S transition of mitotic cell cycle	NA	8.04e-05	NA
200	CDS	Pancan-no-skin-melanoma-lymph	TP63:BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0044819  |  mitotic G1/S transition checkpoint	NA	0.013	NA
201	CDS	Pancan-no-skin-melanoma-lymph	TP63:BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0031571  |  mitotic G1 DNA damage checkpoint	NA	0.013	NA
202	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0072431  |  signal transduction involved in mitotic G1 DNA damage checkpoint	NA	0.0157	NA
203	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ATRX:BAX:EP300:PHOX2B:CDKN1B:CNOT2:HES1:ID2:SFPQ:CDKN1A:FOXA1:TBX3:RB1:TP53:AKT1:EGFR:ATM:TERT:CITED2:PTPN11:DDX3X	GO:0045787  |  positive regulation of cell cycle	NA	2.16e-05	NA
204	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ATRX:BAX:EP300:CASP2:PHOX2B:CDKN1B:CNOT2:EIF4G1:ID2:SFPQ:CDKN1A:SOX4:RB1:TP53:ATM:DRD3:TERT:DDX3X	GO:0090068  |  positive regulation of cell cycle process	NA	0.012	NA
205	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1B:ID2:CDKN1A:TP53:ATM	GO:0071158  |  positive regulation of cell cycle arrest	NA	0.0256	NA
206	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:AKT1:JTB:CDKN2A:YWHAB:YWHAG:JUN	GO:0008637  |  apoptotic mitochondrial changes	NA	0.01	NA
207	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TFAP2D:HSPA5:CASP8:MAP2K4:RHOA:TP63:MEF2C:BAX:PSMC5:CHD8:CHMP4B:EYA1:CASP2:GATA3:YWHAE:IL2:CDKN1B:BMP5:IL4:CPEB4:EIF4G1:BIRC6:NFE2L2:HDAC1:TEK:PIK3CA:NCKAP1L:CDKN1A:SOX4:SOX9:GDF5:KRAS:VHL:TBX3:KLF4:MYC:TFAP2A:ASCL1:TP53:SMAD4:AKT1:PIK3R1:RASA1:EGFR:NOTCH1:TCF7L2:BRAF:FCER1G:SYVN1:NEUROD1:EN1:ALB:TERT:CITED2:HNRNPK:VDAC2:TSC1:PRDX2:CTNNB1:EFNA1:PTEN:HRAS:RPS6KA3:JUN:PTPN1:DDX3X:TWIST2:HNF1B	GO:0060548  |  negative regulation of cell death	NA	2.38e-15	NA
208	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:MAP2K4:BAX:CHMP4B:PIK3CA:GDF5:KRAS:AKT1:RASA1:BRAF:EN1:TERT:TSC1:CTNNB1:HRAS	GO:1901215  |  negative regulation of neuron death	NA	3.69e-08	NA
209	CDS	Pancan-no-skin-melanoma-lymph	CASP8:MAP2K4:RHOA:TP63:MEF2C:BAX:DYNLL1:HOXA5:CASP2:YWHAE:FBXW7:CDKN1B:SFPQ:DNMT3A:SPOP:INHBA:CDKN1A:SOX4:YWHAH:APC:EPHA7:MYC:TFAP2A:ASCL1:TP53:AKT1:RHOB:CDKN2A:NOTCH1:ATM:NEUROD1:YWHAB:CTNNB1:YWHAG:PTEN:JUN:RBM10:AKR1C3:NF1:DAXX:DDX3X:TXNIP	GO:0010942  |  positive regulation of cell death	NA	1.44e-06	NA
210	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RHOA:BAX:CASP2:FBXW7:EPHA7:TFAP2A:ASCL1:TP53:ATM:CTNNB1:JUN:NF1:DAXX	GO:1901216  |  positive regulation of neuron death	NA	9.08e-07	NA
211	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:KEAP1:LEPROTL1:FBXW7:HES1:CDKN1A:APC:OS9:RB1:TP53:SMAD4:PIK3R1:EGFR:BAP1:TERT:CTNNB1:SETD2:NF1	GO:1903827  |  regulation of cellular protein localization	NA	4.3e-09	NA
212	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:DYNLL1:ZMYND8:YWHAE:YWHAH:CLTC:TP53:AKT1:EPHA2:PIK3R1:EGFR:YWHAB:YWHAG:CDH2	GO:1905475  |  regulation of protein localization to membrane	NA	0.00382	NA
213	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:DYNLL1:YWHAE:FBXW7:HES1:YWHAH:TP53:U2AF1:BAP1:YWHAB:YWHAG:UBL5	GO:1903747  |  regulation of establishment of protein localization to mitochondrion	NA	0.0225	NA
214	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:CDKN1A:SMAD4:PIK3R1:EGFR:TERT:NF1	GO:1900180  |  regulation of protein localization to nucleus	NA	0.00438	NA
215	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:FBXW7:HES1:CDKN1A:OS9:TP53:SMAD4:PIK3R1:EGFR:BAP1:SETD2:NF1	GO:0033157  |  regulation of intracellular protein transport	NA	7.63e-06	NA
216	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:GATA3:FBXW7:HES1:TP53:SMAD4:EPHA2:PIK3R1:EGFR:TCF7L2:U2AF1:BAP1	GO:1904951  |  positive regulation of establishment of protein localization	NA	0.0478	NA
217	CDS	Pancan-no-skin-melanoma-lymph	ATRX:CTCF:SOX9:H3F3B:TP53:CDKN2A:HIST1H2BD:HIST1H1C:HIST1H4C:DAXX:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H3C	GO:0031497  |  chromatin assembly	NA	1.37e-05	NA
218	CDS	Pancan-no-skin-melanoma-lymph	ATRX:ASF1B:SOX9:H3F3B:HIST1H2BD:HIST2H3D:HIST1H1C:HIST1H4C:DAXX:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H3C	GO:0006334  |  nucleosome assembly	NA	0.000936	NA
219	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TP63:ATRX:BAX:EP300:CASP2:CDKN1B:CNOT2:CHD4:HDAC1:CDKN1A:SOX4:TP53:AKT1:TAF1:TAF5:SSRP1:ATM:MTA2:RFC4:HNRNPK:HEXIM1	GO:0072331  |  signal transduction by p53 class mediator	NA	0.000526	NA
220	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TP63:ATRX:BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0030330  |  DNA damage response, signal transduction by p53 class mediator	NA	0.0203	NA
221	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:CASP2:CDKN1B:CNOT2:CDKN1A:SOX4:TP53:ATM	GO:0006977  |  DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	NA	0.0137	NA
222	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TP63:EP300:CHD4:HDAC1:TP53:AKT1:TAF1:TAF5:SSRP1:ATM:MTA2:RFC4:HNRNPK:HEXIM1	GO:1901796  |  regulation of signal transduction by p53 class mediator	NA	0.0232	NA
223	CDS	Pancan-no-skin-melanoma-lymph	CDC27:NDE1:XPO1:PDS5B:ATRX:CHMP4B:STAG2:CTCF:SMC3:FBXW7:SFPQ:APC:RB1:ATM:TTN:CTNNB1	GO:0000819  |  sister chromatid segregation	NA	0.00255	NA
224	CDS	Pancan-no-skin-melanoma-lymph	CDC27:ATRX:CTCF:SFPQ:APC:RB1:ATM:CTNNB1	GO:0033045  |  regulation of sister chromatid segregation	NA	0.0273	NA
225	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:CASP8:RHOA:TP63:MAP2K7:ATRX:BAX:DYNLL1:SMARCB1:STMN2:WASL:GATA3:YWHAE:FBXW7:CDKN1B:CNOT2:HES1:SFPQ:TEK:HNRNPA2B1:NCKAP1L:YWHAH:RB1:TP53:SMAD4:SETDB1:ATM:DRD3:BRAF:ARHGAP35:U2AF1:ARPC2:BAP1:TSC1:YWHAB:CTNNB1:YWHAG:HRAS:PPM1E:TMED9:NF2:UBL5:NELFE:ARPC1A	GO:0010638  |  positive regulation of organelle organization	NA	8.58e-09	NA
226	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:MAP2K7:ATRX:SMARCB1:GATA3:SFPQ:HNRNPA2B1:RB1:TP53:SMAD4:SETDB1:ATM:CTNNB1:NELFE	GO:2001252  |  positive regulation of chromosome organization	NA	3.73e-05	NA
227	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:SMARCB1:GATA3:TP53:SMAD4:SETDB1:ATM:CTNNB1:NELFE	GO:1905269  |  positive regulation of chromatin organization	NA	0.00376	NA
228	CDS	Pancan-no-skin-melanoma-lymph	NDE1:XPO1:PDS5B:ATRX:STAG2:CTCF:SMC3:FBXW7:SFPQ:RB1:CTNNB1	GO:0007062  |  sister chromatid cohesion	NA	0.00611	NA
229	CDS	Pancan-no-skin-melanoma-lymph	ATRX:CTCF:SFPQ:RB1:CTNNB1	GO:0007063  |  regulation of sister chromatid cohesion	NA	0.0137	NA
230	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TFAP2D:HSPA5:CASP8:MAP2K4:RHOA:TP63:MEF2C:BAX:PSMC5:CHD8:EYA1:CASP2:GATA3:YWHAE:IL2:CDKN1B:BMP5:IL4:CPEB4:BIRC6:NFE2L2:HDAC1:TEK:PIK3CA:NCKAP1L:CDKN1A:SOX9:GDF5:KRAS:VHL:TBX3:KLF4:MYC:TFAP2A:ASCL1:TP53:AKT1:PIK3R1:RASA1:EGFR:NOTCH1:TCF7L2:BRAF:FCER1G:SYVN1:NEUROD1:EN1:ALB:TERT:CITED2:HNRNPK:VDAC2:PRDX2:CTNNB1:EFNA1:PTEN:HRAS:RPS6KA3:JUN:PTPN1:DDX3X:TWIST2:HNF1B	GO:0043069  |  negative regulation of programmed cell death	NA	3.77e-14	NA
231	CDS	Pancan-no-skin-melanoma-lymph	CDH1:FBXW7:HES1:APC:TP53:SMAD4:BAP1:TERT	GO:1903829  |  positive regulation of cellular protein localization	NA	0.000173	NA
232	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:DYNLL1:YWHAE:FBXW7:HES1:YWHAH:TP53:U2AF1:BAP1:YWHAB:YWHAG:UBL5	GO:1903749  |  positive regulation of establishment of protein localization to mitochondrion	NA	0.00685	NA
233	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:DYNLL1:YWHAE:YWHAH:TP53:AKT1:EPHA2:PIK3R1:EGFR:YWHAB:YWHAG	GO:1905477  |  positive regulation of protein localization to membrane	NA	0.0167	NA
234	CDS	Pancan-no-skin-melanoma-lymph	CASP8:MAP2K4:FBXW7:SPOP:CDKN1A:APC:TP53:CDKN2A:NOTCH1:ATM:CTNNB1:PTEN:DDX3X	GO:0043068  |  positive regulation of programmed cell death	NA	3.36e-06	NA
235	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:BAX:FBXW7:HES1:TP53:SMAD4:PIK3R1:EGFR:TCF7L2:U2AF1:BAP1	GO:0032388  |  positive regulation of intracellular transport	NA	0.00209	NA
236	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:SUFU:HES1:CDKN1A:GDF5:PEX1:TOB1:SMAD4:AKT1:PIK3R1:EGFR:CTNNB1:NF1	GO:0017038  |  protein import	NA	0.000475	NA
237	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:CDKN1A:SMAD4:PIK3R1:EGFR:NF1	GO:1904589  |  regulation of protein import	NA	0.0114	NA
238	CDS	Pancan-no-skin-melanoma-lymph	ACTB:EP300:SF3B1:ARID1A:H3F3B:CTNNB1:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	GO:0045815  |  positive regulation of gene expression, epigenetic	NA	2e-05	NA
239	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:MAP2K4:SPI1:NUCKS1:MAP2K7:PDS5B:ATRX:BAX:SMARCB1:EP300:STAG2:SMARCA1:CTCF:GATA3:SMC3:IL2:FBXW7:PTGES3:HDAC1:SFPQ:DNMT3A:PIK3CA:HNRNPA2B1:APOBEC2:CDKN1A:PSMC3IP:MEN1:KLF4:XPA:MYC:TP53:AKT1:SETDB1:DTL:EGFR:CDKN2A:TCF7L2:ATM:MTA2:ASZ1:NFIA:S100A11:RFC4:TERT:COPS2:CTNNB1:KDM2A:HRAS:JUN:POLR2A:SETD2:FIGN:NF2:HIST1H4C:HIST1H4K:HIST1H4E	GO:0006259  |  DNA metabolic process	NA	1.12e-12	NA
240	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:MAP2K4:SPI1:NUCKS1:MAP2K7:ATRX:BAX:STAG2:GATA3:SMC3:IL2:FBXW7:PTGES3:PIK3CA:HNRNPA2B1:CDKN1A:MEN1:KLF4:MYC:TP53:AKT1:SETDB1:EGFR:CDKN2A:ATM:S100A11:RFC4:CTNNB1:HRAS:JUN:FIGN:NF2	GO:0051052  |  regulation of DNA metabolic process	NA	1.87e-10	NA
241	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:NUCKS1:PDS5B:ATRX:SMARCB1:EP300:SMC3:SFPQ:MEN1:XPA:TP53:DTL:EGFR:ATM:RFC4:COPS2:KDM2A:POLR2A:SETD2:FIGN:HIST1H4C:HIST1H4K:HIST1H4E	GO:0006281  |  DNA repair	NA	0.01	NA
242	CDS	Pancan-no-skin-melanoma-lymph	MAP2K7:ATRX:PTGES3:HNRNPA2B1:MYC:ATM:RFC4:TERT:CTNNB1:HIST1H4C:HIST1H4K:HIST1H4E	GO:0000723  |  telomere maintenance	NA	0.00198	NA
243	CDS	Pancan-no-skin-melanoma-lymph	HNRNPA2B1:CDKN1A:MEN1:TP53:DTL:ATM:TERT:CTNNB1	GO:0071897  |  DNA biosynthetic process	NA	0.000148	NA
244	CDS	Pancan-no-skin-melanoma-lymph	HNRNPA2B1:CDKN1A:MEN1:TP53:ATM:CTNNB1	GO:2000278  |  regulation of DNA biosynthetic process	NA	0.000334	NA
245	CDS	Pancan-no-skin-melanoma-lymph	MAP2K7:PTGES3:HNRNPA2B1:MEN1:KLF4:MYC:TP53:CTNNB1	GO:0051972  |  regulation of telomerase activity	NA	0.000886	NA
246	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:ATRX:BAX:EYA1:IL2:PTGES3:BMP5:IL4:HNRNPA2B1:KLF4:MYC:AKT1:SETDB1:EGFR:ATM:RFC4:CTNNB1:HRAS:JUN	GO:0051054  |  positive regulation of DNA metabolic process	NA	0.000131	NA
247	CDS	Pancan-no-skin-melanoma-lymph	MAP2K7:PTGES3:HNRNPA2B1:KLF4:MYC:ATM:RFC4:CTNNB1	GO:2000573  |  positive regulation of DNA biosynthetic process	NA	0.0135	NA
248	CDS	Pancan-no-skin-melanoma-lymph	MAP2K7:PTGES3:HNRNPA2B1:KLF4:MYC:CTNNB1	GO:0051973  |  positive regulation of telomerase activity	NA	0.0369	NA
249	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CASP8:TP63:BAX:DYNLL1:EP300:EYA1:CASP2:YWHAE:IL2:FBXW7:BMP5:IL4:BIRC6:NFE2L2:SFPQ:SPOP:INHBA:CDKN1A:YWHAH:ACVR1B:XPA:TP53:AKT1:EPHA2:PIK3R1:TCF7L2:ATM:SYVN1:TERT:TNFRSF11B:HNRNPK:VDAC2:YWHAB:CTNNB1:YWHAG:PTEN:HRAS:JUN:PTPN1:NF1:DAXX:DDX3X	GO:0097190  |  apoptotic signaling pathway	NA	3.6e-08	NA
250	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CASP8:TP63:BAX:DYNLL1:EYA1:CASP2:YWHAE:FBXW7:BMP5:IL4:BIRC6:NFE2L2:SFPQ:SPOP:INHBA:YWHAH:TP53:AKT1:TCF7L2:SYVN1:TERT:HNRNPK:VDAC2:YWHAB:CTNNB1:YWHAG:PTEN:PTPN1:NF1:DDX3X	GO:2001233  |  regulation of apoptotic signaling pathway	NA	2.64e-06	NA
251	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:BAX:EP300:FBXW7:NFE2L2:SFPQ:SPOP:CDKN1A:XPA:TP53:AKT1:EPHA2:PIK3R1:ATM:VDAC2:HRAS:PTPN1:DDX3X	GO:0097193  |  intrinsic apoptotic signaling pathway	NA	0.000289	NA
252	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TP63:BAX:EP300:CASP2:CDKN1A:XPA:TP53:EPHA2:PIK3R1:ATM:HNRNPK	GO:0008630  |  intrinsic apoptotic signaling pathway in response to DNA damage	NA	0.00588	NA
253	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:BAX:FBXW7:NFE2L2:SFPQ:SPOP:TP53:AKT1:VDAC2:PTPN1:DDX3X	GO:2001242  |  regulation of intrinsic apoptotic signaling pathway	NA	0.0154	NA
254	CDS	Pancan-no-skin-melanoma-lymph	JARID2:KMT2C:SPI1:ATRX:SMARCB1:EP300:L3MBTL2:CTCF:EYA1:EZH2:GATA3:SUPT7L:BCL11A:KANSL1:EPC1:SOX4:MEN1:HNF1A:SMAD4:SETDB1:KDM6A:TAF1:CDKN2A:TAF5:EIF5A2:KMT2D:CTNNB1:SUZ12:GATA2:SETD2:HIST1H1C:LDB1:NELFE	GO:0018205  |  peptidyl-lysine modification	NA	1.02e-07	NA
255	CDS	Pancan-no-skin-melanoma-lymph	SPI1:SMARCB1:EP300:CTCF:GATA3:SUPT7L:KANSL1:EPC1:SOX4:HNF1A:SMAD4:TAF1:TAF5:GATA2:LDB1	GO:0018394  |  peptidyl-lysine acetylation	NA	0.00958	NA
256	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:ATRX:SMARCB1:GATA3:MEN1:SMAD4:SETDB1:KDM6A:KMT2D:CTNNB1:SUZ12:SETD2:NELFE	GO:0018022  |  peptidyl-lysine methylation	NA	1.24e-06	NA
257	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:ATRX:SMARCB1:GATA3:MEN1:SMAD4:SETDB1:KDM6A:KMT2D:CTNNB1:SUZ12:SETD2:NELFE	GO:0034968  |  histone lysine methylation	NA	3.3e-07	NA
258	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:GATA3:SMAD4:KDM6A:KMT2D:CTNNB1	GO:0051568  |  histone H3-K4 methylation	NA	0.000125	NA
259	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TFAP2D:HSPA5:CASP8:MAP2K4:RHOA:TP63:MEF2C:BAX:CHD8:EYA1:CASP2:GATA3:YWHAE:IL2:CDKN1B:BMP5:IL4:CPEB4:BIRC6:NFE2L2:HDAC1:TEK:PIK3CA:NCKAP1L:CDKN1A:SOX9:GDF5:KRAS:VHL:TBX3:KLF4:MYC:TFAP2A:ASCL1:TP53:AKT1:PIK3R1:RASA1:EGFR:NOTCH1:TCF7L2:BRAF:FCER1G:SYVN1:NEUROD1:EN1:ALB:TERT:CITED2:HNRNPK:VDAC2:PRDX2:CTNNB1:EFNA1:PTEN:HRAS:RPS6KA3:JUN:PTPN1:DDX3X:TWIST2:HNF1B	GO:0043066  |  negative regulation of apoptotic process	NA	7.09e-14	NA
260	CDS	Pancan-no-skin-melanoma-lymph	GATA3:NFE2L2:TEK:TCF7L2:BRAF:NEUROD1:TERT	GO:1904036  |  negative regulation of epithelial cell apoptotic process	NA	0.00391	NA
261	CDS	Pancan-no-skin-melanoma-lymph	GATA3:NFE2L2:BRAF:TERT	GO:2000352  |  negative regulation of endothelial cell apoptotic process	NA	0.00596	NA
262	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:MAP2K4:RHOA:MEF2C:BAX:CPEB4:PIK3CA:GDF5:KRAS:RASA1:BRAF:EN1:TERT:HRAS:JUN	GO:0043524  |  negative regulation of neuron apoptotic process	NA	6.61e-06	NA
263	CDS	Pancan-no-skin-melanoma-lymph	CASP8:MAP2K4:RHOA:TP63:MEF2C:BAX:DYNLL1:HOXA5:CASP2:YWHAE:FBXW7:SFPQ:SPOP:INHBA:SOX4:YWHAH:APC:EPHA7:MYC:TFAP2A:ASCL1:TP53:AKT1:RHOB:CDKN2A:NOTCH1:ATM:NEUROD1:YWHAB:CTNNB1:YWHAG:PTEN:JUN:RBM10:AKR1C3:NF1:DDX3X:TXNIP	GO:0043065  |  positive regulation of apoptotic process	NA	2.35e-05	NA
264	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:CDKN2A:PTEN	GO:0010661  |  positive regulation of muscle cell apoptotic process	NA	0.00616	NA
265	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RHOA:BAX:CASP2:FBXW7:EPHA7:TFAP2A:ASCL1:TP53:ATM:CTNNB1:JUN:NF1	GO:0043525  |  positive regulation of neuron apoptotic process	NA	1.36e-07	NA
266	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:CASP2:YWHAE:FBXW7:SFPQ:SPOP:INHBA:YWHAH:TP53:YWHAB:YWHAG:PTEN:NF1	GO:2001235  |  positive regulation of apoptotic signaling pathway	NA	0.00917	NA
267	CDS	Pancan-no-skin-melanoma-lymph	SPI1:SMARCB1:EP300:CTCF:GATA3:SUPT7L:KANSL1:EPC1:HNF1A:SMAD4:TAF1:TAF5:GATA2:LDB1	GO:0006475  |  internal protein amino acid acetylation	NA	0.0452	NA
268	CDS	Pancan-no-skin-melanoma-lymph	SPI1:SMARCB1:EP300:CTCF:GATA3:SUPT7L:KANSL1:EPC1:HNF1A:SMAD4:TAF1:TAF5:GATA2:LDB1	GO:0018393  |  internal peptidyl-lysine acetylation	NA	0.0311	NA
269	CDS	Pancan-no-skin-melanoma-lymph	SPI1:SMARCB1:EP300:CTCF:GATA3:SUPT7L:KANSL1:EPC1:HNF1A:SMAD4:TAF1:TAF5:GATA2:LDB1	GO:0016573  |  histone acetylation	NA	0.0228	NA
270	CDS	Pancan-no-skin-melanoma-lymph	CNOT2:HDAC1:ARID1A:DNMT3A:HNRNPA2B1:DGCR8:H3F3B:SETDB1:EGFR:ASZ1:TERT:KMT2D:SMAD2:HIST1H2AC:POLR2A:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	GO:0016458  |  gene silencing	NA	1.82e-06	NA
271	CDS	Pancan-no-skin-melanoma-lymph	CNOT2:HNRNPA2B1:DGCR8:H3F3B:EGFR:ASZ1:TERT:SMAD2:POLR2A:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	GO:0031047  |  gene silencing by RNA	NA	0.0424	NA
272	CDS	Pancan-no-skin-melanoma-lymph	CASP8:BAX:ACVR1B:AKT1:PIK3R1:TCF7L2:TERT:PTEN:NF1:DAXX:DDX3X	GO:0097191  |  extrinsic apoptotic signaling pathway	NA	0.00251	NA
273	CDS	Pancan-no-skin-melanoma-lymph	CASP8:BAX:PIK3R1:PTEN:NF1:DAXX:DDX3X	GO:0008625  |  extrinsic apoptotic signaling pathway via death domain receptors	NA	0.00636	NA
274	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:MAP2K4:RHOA:MAP2K7:MEF2C:BAX:MAP3K1:AXIN1:PRKAR1A:FBXW7:CDKN1B:DUSP22:ERRFI1:TEK:PIK3CA:CDKN1A:KRAS:MEN1:APC:KLF4:RB1:AKT1:JTB:PIK3R1:EGFR:CDKN2A:TNIK:TTN:BRAF:DDR2:TGFBR2:DUSP7:TSC1:EFNA1:LDB2:YWHAG:PTEN:HRAS:PPM1E:PTPN11:NF2:HEXIM1:RELN:PTPN1:NF1:SERTAD1:LDB1:DAXX	GO:0043549  |  regulation of kinase activity	NA	1.58e-09	NA
275	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:MAP2K4:RHOA:MAP2K7:MEF2C:BAX:MAP3K1:AXIN1:PRKAR1A:FBXW7:CDKN1B:DUSP22:ERRFI1:PIK3CA:CDKN1A:KRAS:MEN1:APC:RB1:AKT1:JTB:EGFR:CDKN2A:TNIK:TTN:BRAF:DDR2:TGFBR2:DUSP7:TSC1:EFNA1:YWHAG:PTEN:HRAS:PPM1E:PTPN11:NF2:HEXIM1:RELN:PTPN1:NF1:SERTAD1:DAXX	GO:0045859  |  regulation of protein kinase activity	NA	9.09e-08	NA
276	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:MEN1:APC:AKT1:EGFR:CDKN2A:PTEN:HEXIM1:SERTAD1	GO:1904029  |  regulation of cyclin-dependent protein kinase activity	NA	1.05e-05	NA
277	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:MAP3K1:AXIN1:CDKN1B:CDKN1A:KRAS:MEN1:APC:EGFR:CDKN2A:BRAF:PTEN:HRAS:NF1:SERTAD1	GO:0071900  |  regulation of protein serine/threonine kinase activity	NA	2.17e-06	NA
278	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:MEN1:APC:AKT1:EGFR:CDKN2A:PTEN:HEXIM1:SERTAD1	GO:0000079  |  regulation of cyclin-dependent protein serine/threonine kinase activity	NA	7.34e-06	NA
279	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:FBXW7:HES1:RPL22:RPL5:CDKN1A:OS9:TOB1:SMAD4:PIK3R1:EGFR:BAP1:CTNNB1:PTCH1:NF1	GO:0006605  |  protein targeting	NA	2.57e-05	NA
280	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:HES1:CDKN1A:TOB1:SMAD4:PIK3R1:EGFR:CTNNB1:NF1	GO:0044744  |  protein targeting to nucleus	NA	0.000193	NA
281	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:HES1:CDKN1A:TOB1:SMAD4:PIK3R1:EGFR:CTNNB1:NF1	GO:0006606  |  protein import into nucleus	NA	0.000193	NA
282	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:FBXW7:HES1:CDKN1A:SMAD4:PIK3R1:EGFR:BAP1:NF1	GO:1903533  |  regulation of protein targeting	NA	0.00048	NA
283	CDS	Pancan-no-skin-melanoma-lymph	CDH1:KEAP1:CDKN1A:SMAD4:PIK3R1:EGFR:NF1	GO:0042306  |  regulation of protein import into nucleus	NA	0.0101	NA
284	CDS	Pancan-no-skin-melanoma-lymph	PUM2:EIF4G1:H3F3B:SETDB1:EGFR:TERT:POLR2A:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	GO:0060968  |  regulation of gene silencing	NA	0.0167	NA
285	CDS	Pancan-no-skin-melanoma-lymph	PUM2:EIF4G1:H3F3B:EGFR:TERT:POLR2A:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	GO:0060966  |  regulation of gene silencing by RNA	NA	0.0149	NA
286	CDS	Pancan-no-skin-melanoma-lymph	PUM2:EIF4G1:H3F3B:EGFR:TERT:POLR2A:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	GO:0060147  |  regulation of posttranscriptional gene silencing	NA	0.0149	NA
287	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP3K1:AXIN1:FBXW7:HES1:PIK3CA:ACVR2A:CDKN1A:KRAS:TP53:SMAD4:ATM:BRAF:TGFBR2:CTNNB1:PTEN	GO:0042327  |  positive regulation of phosphorylation	NA	1.56e-07	NA
288	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:MAP2K4:RHOA:MAP2K7:MEF2C:BAX:MAP3K1:AXIN1:PRKAR1A:FBXW7:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:AKT1:JTB:EGFR:TNIK:BRAF:DDR2:TGFBR2:DUSP7:EFNA1:HRAS:PTPN11:RELN:PTPN1:DAXX	GO:0033674  |  positive regulation of kinase activity	NA	0.000334	NA
289	CDS	Pancan-no-skin-melanoma-lymph	RHOA:BAX:DYNLL1:PRKAR1A:IL2:CDKN1B:DUSP22:EIF4G1:ERRFI1:CDKN1A:MEN1:APC:KLF4:MYC:RB1:SMAD4:AKT1:CDKN2A:DUSP7:YWHAG:PTEN:PPM1E:JUN:NF2:HEXIM1:PTPN1:NF1	GO:0042326  |  negative regulation of phosphorylation	NA	6.11e-05	NA
290	CDS	Pancan-no-skin-melanoma-lymph	PRKAR1A:CDKN1B:DUSP22:ERRFI1:CDKN1A:MEN1:APC:RB1:AKT1:CDKN2A:DUSP7:YWHAG:PTEN:PPM1E:NF2:HEXIM1:PTPN1:NF1	GO:0033673  |  negative regulation of kinase activity	NA	0.00306	NA
291	CDS	Pancan-no-skin-melanoma-lymph	BAX:PRKAR1A:IL2:CDKN1B:DUSP22:EIF4G1:ERRFI1:CDKN1A:MEN1:APC:KLF4:MYC:RB1:SMAD4:AKT1:CDKN2A:DUSP7:YWHAG:PTEN:PPM1E:JUN:NF2:HEXIM1:PTPN1:NF1	GO:0001933  |  negative regulation of protein phosphorylation	NA	0.00018	NA
292	CDS	Pancan-no-skin-melanoma-lymph	PRKAR1A:CDKN1B:DUSP22:ERRFI1:CDKN1A:MEN1:APC:RB1:AKT1:CDKN2A:DUSP7:YWHAG:PTEN:PPM1E:NF2:HEXIM1:PTPN1:NF1	GO:0006469  |  negative regulation of protein kinase activity	NA	0.0012	NA
293	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:MEN1:APC:CDKN2A:PTEN:NF1	GO:0071901  |  negative regulation of protein serine/threonine kinase activity	NA	0.00036	NA
294	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:MEN1:APC:CDKN2A:PTEN	GO:1904030  |  negative regulation of cyclin-dependent protein kinase activity	NA	3.09e-07	NA
295	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:MEN1:APC:CDKN2A:PTEN	GO:0045736  |  negative regulation of cyclin-dependent protein serine/threonine kinase activity	NA	2.35e-07	NA
296	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:CDKN2A:RBM10	GO:0034393  |  positive regulation of smooth muscle cell apoptotic process	NA	0.0342	NA
297	CDS	Pancan-no-skin-melanoma-lymph	CASP8:MAP2K4:MAP3K1:AXIN1:FBXW7:HES1:SPOP:PIK3CA:KRAS:TP53:NOTCH1:ATM:BRAF:CTNNB1:PTEN	GO:1902533  |  positive regulation of intracellular signal transduction	NA	5.52e-06	NA
298	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CASP8:RHOA:RASAL2:DUSP22:NFE2L2:ERRFI1:MEN1:VHL:KLF4:MYC:SMAD4:AKT1:EPHA2:RASA1:ATM:UBR1:ARHGAP35:SYVN1:NEUROD1:DUSP7:VDAC2:TSC1:PTEN:NF2:PTPN1:NF1:DDX3X	GO:1902532  |  negative regulation of intracellular signal transduction	NA	9.57e-05	NA
299	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1902108  |  regulation of mitochondrial membrane permeability involved in apoptotic process	NA	0.0306	NA
300	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1902110  |  positive regulation of mitochondrial membrane permeability involved in apoptotic process	NA	0.0174	NA
301	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:0097345  |  mitochondrial outer membrane permeabilization	NA	0.011	NA
302	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1901028  |  regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	NA	0.00277	NA
303	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1901030  |  positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	NA	0.000506	NA
304	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:HNRNPA2B1:U2AF1:SRSF2:TSC1:SETD2	GO:0071426  |  ribonucleoprotein complex export from nucleus	NA	0.0297	NA
305	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:0051204  |  protein insertion into mitochondrial membrane	NA	0.000183	NA
306	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:0001844  |  protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	NA	0.000104	NA
307	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1900739  |  regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	NA	0.000983	NA
308	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:DYNLL1:YWHAE:YWHAH:TP53:YWHAB:YWHAG	GO:1900740  |  positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	NA	0.000983	NA
309	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RASAL2:MAP2K7:MEF2C:PSMC5:MAP3K1:AXIN1:PSMA2:IL2:FBXW7:FGF6:DUSP22:ERRFI1:TEK:ACVR2A:SOX9:GDF5:KRAS:MEN1:ACVR1B:KLF4:MYC:SMAD4:AKT1:EPHA2:RASA1:EGFR:ZFP36L2:TNIK:BRAF:TGFBR2:DUSP7:YWHAB:CTNNB1:EFNA1:CDH2:PTEN:SPTBN2:HRAS:JUN:PTPN11:NF2:PTPN1:NF1:DAXX:NELFE:NRAS	GO:0023014  |  signal transduction by protein phosphorylation	NA	4.25e-08	NA
310	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RASAL2:MAP2K7:MEF2C:PSMC5:MAP3K1:AXIN1:PSMA2:IL2:FBXW7:FGF6:DUSP22:ERRFI1:TEK:SOX9:GDF5:KRAS:MEN1:KLF4:MYC:SMAD4:AKT1:EPHA2:RASA1:EGFR:ZFP36L2:TNIK:BRAF:DUSP7:YWHAB:CTNNB1:EFNA1:CDH2:PTEN:SPTBN2:HRAS:JUN:PTPN11:NF2:PTPN1:NF1:DAXX:NELFE:NRAS	GO:0000165  |  MAPK cascade	NA	4.61e-07	NA
311	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:TEK:SOX9:KLF4:MYC:SMAD4:EPHA2:EGFR:ZFP36L2:BRAF:PTEN:HRAS:JUN:PTPN11:PTPN1:NELFE	GO:0070371  |  ERK1 and ERK2 cascade	NA	0.00656	NA
312	CDS	Pancan-no-skin-melanoma-lymph	XPO1:YWHAE:SOX4:TP53:TCF7L2:PTPN11:SETD2	GO:0046825  |  regulation of protein export from nucleus	NA	0.0266	NA
313	CDS	Pancan-no-skin-melanoma-lymph	CDH1:FBXW7:HES1:TP53:SMAD4:BAP1	GO:0090316  |  positive regulation of intracellular protein transport	NA	0.00546	NA
314	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:NUCKS1:ATRX:STAG2:SMC3:FBXW7:EGFR:S100A11:RFC4:HRAS:JUN:NF2	GO:0006275  |  regulation of DNA replication	NA	0.00191	NA
315	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:SPI1:ATRX:SMARCB1:CTCF:GATA3:TP53:SMAD4:ATM:CTNNB1:NELFE	GO:0031056  |  regulation of histone modification	NA	0.00729	NA
316	CDS	Pancan-no-skin-melanoma-lymph	ATRX:SMARCB1:CTCF:GATA3:SMAD4:CTNNB1:NELFE	GO:0031060  |  regulation of histone methylation	NA	0.0123	NA
317	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP3K1:AXIN1:FBXW7:HES1:PIK3CA:ACVR2A:CDKN1A:KRAS:TP53:SMAD4:ATM:BRAF:TGFBR2:CTNNB1:PTEN	GO:0001934  |  positive regulation of protein phosphorylation	NA	7.77e-08	NA
318	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:BAX:MAP3K1:AXIN1:FBXW7:CDKN1B:PIK3CA:CDKN1A:KRAS:EGFR:BRAF:TGFBR2:HRAS	GO:0045860  |  positive regulation of protein kinase activity	NA	0.000176	NA
319	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RHOA:MAP2K7:MEF2C:MAP3K1:AXIN1:CDKN1B:KRAS:AKT1:EGFR:TNIK:BRAF:DUSP7:EFNA1:HRAS:PTPN11:PTPN1:DAXX	GO:0071902  |  positive regulation of protein serine/threonine kinase activity	NA	0.0419	NA
320	CDS	Pancan-no-skin-melanoma-lymph	TP53:SMAD4:CTNNB1	GO:0031058  |  positive regulation of histone modification	NA	0.0129	NA
321	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:MEF2C:MAP3K1:AXIN1:EZH2:FBXW7:BMP5:DUSP22:ERRFI1:TEK:INHBA:GDF5:KRAS:MEN1:EPHA7:KLF4:MYC:SMAD4:AKT1:EPHA2:EGFR:TNIK:BRAF:TAOK1:DUSP7:CARTPT:CTNNB1:EFNA1:CDH2:PTEN:HRAS:JUN:PTPN11:NF2:PTPN1:NF1:DAXX:NELFE	GO:0043408  |  regulation of MAPK cascade	NA	0.000144	NA
322	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP3K1:FBXW7:KRAS:BRAF:CTNNB1:PTEN	GO:0043410  |  positive regulation of MAPK cascade	NA	0.0172	NA
323	CDS	Pancan-no-skin-melanoma-lymph	DUSP22:ERRFI1:MEN1:KLF4:MYC:SMAD4:AKT1:DUSP7:PTEN:NF2:PTPN1:NF1	GO:0043409  |  negative regulation of MAPK cascade	NA	0.0367	NA
324	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:ARID1A:DNMT3A:H3F3B:SETDB1:KMT2D:HIST1H2AC:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	GO:0006342  |  chromatin silencing	NA	1.21e-06	NA
325	CDS	Pancan-no-skin-melanoma-lymph	JARID2:DBP:EZH2:FBXW7:HES1:PIK3CA:SOX9:KRAS:HNF1A:SRSF1:EGFR:NOTCH1:CITED2:JUN:NF1:HNF1B	GO:0061008  |  hepaticobiliary system development	NA	0.000246	NA
326	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:SOX9:ACVR1B:SMAD4:EGFR:NOTCH1:TERT:CTNNB1:NF1:LDB1	GO:0042303  |  molting cycle	NA	0.000117	NA
327	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:SOX9:ACVR1B:SMAD4:EGFR:NOTCH1:TERT:CTNNB1:NF1:LDB1	GO:0042633  |  hair cycle	NA	0.000117	NA
328	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RHOA:MEF2C:ATRX:SALL4:SALL1:GATA3:PRKAR1A:IL2:CDKN1B:EIF4G1:BCL9:BCL11A:EPC1:PIK3CA:SLC12A5:TP53TG5:USP9X:CDKN1A:NRN1:SOX9:GDF5:SMARCA4:FOXP2:H3F3B:ACVR1B:XPA:RB1:TP53:SMAD4:AKT1:EGFR:KDM6A:CDKN2A:NOTCH1:ATM:CDA:DDR2:EN1:TGFBR2:BAP1:KMT2D:CLIC4:PTEN:SPTBN2:SMAD2:RPS6KA3:SLITRK1:PTPN11:MED12:PTCH1:ARID2:SERTAD1:DMBX1:DDX3X:HNF1B	GO:0040007  |  growth	NA	6.97e-11	NA
329	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:CDKN1B:BCL11A:USP9X:CDKN1A:SMARCA4:H3F3B:RB1:TP53:SMAD4:EGFR:CDKN2A:TGFBR2:BAP1:KMT2D:SERTAD1:DDX3X	GO:0016049  |  cell growth	NA	2.07e-07	NA
330	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:PRKAR1A:CDKN1B:ID2:KLF4:AKT1:EGFR:NOTCH1:TCF7L2:TGFBR2:TERT:CTNNB1:PTEN:JUN:ARID2	GO:0033002  |  muscle cell proliferation	NA	0.000224	NA
331	CDS	Pancan-no-skin-melanoma-lymph	NOTCH1:TGFBR2:PTEN:ARID2	GO:0014855  |  striated muscle cell proliferation	NA	0.0258	NA
332	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:ID2:AKT1:EGFR:TCF7L2:TGFBR2:TERT:CTNNB1	GO:0048659  |  smooth muscle cell proliferation	NA	0.0164	NA
333	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:ID2:AKT1:EGFR:TCF7L2:TGFBR2:TERT:CTNNB1	GO:0048660  |  regulation of smooth muscle cell proliferation	NA	0.0138	NA
334	CDS	Pancan-no-skin-melanoma-lymph	HES1:CDKN1A:CDKN2A:ATM:TGFBR2:CTNNB1	GO:0070663  |  regulation of leukocyte proliferation	NA	0.02	NA
335	CDS	Pancan-no-skin-melanoma-lymph	HES1:CDKN1A:CDKN2A:ATM:TGFBR2:CTNNB1	GO:0032944  |  regulation of mononuclear cell proliferation	NA	0.0164	NA
336	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CDH10:RHOA:ACTB:FAT1:GATA3:PRKAR1A:IL2:DUSP22:HES1:TEK:PIK3CA:IRF1:SOX9:FOXA1:KLF4:AKT1:PIK3R1:EGFR:CDKN2A:BRAF:TGFBR2:CITED2:CTNNB1:EFNA1:CDH2:JUP:PTPN11:NF2	GO:0098602  |  single organism cell adhesion	NA	0.00365	NA
337	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:JAG1:EYA1:STMN2:HOXA2:EZH2:GATA3:CPEB3:PHOX2B:IL2:DDX6:BMP5:HES1:EIF4G1:ID2:NFE2L2:PRRX1:BCL11A:SOX9:GDF5:YWHAH:FOXA1:CASZ1:EPHA7:KLF4:SIX3:ASCL1:SMAD4:AKT1:MEIS1:NOTCH1:DRD3:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:BRINP3:NEUROD1:ARPC2:TERT:TSC1:B2M:CTNNB1:EFNA1:IL1RAPL1:YWHAG:CDH2:PTEN:NR2F1:SLITRK1:GATA2:IDH2:NF2:RELN:TCF4:NF1	GO:0060284  |  regulation of cell development	NA	1.15e-13	NA
338	CDS	Pancan-no-skin-melanoma-lymph	ASB4:RHOA:MEF2C:BAX:PSMC5:EYA1:DKK4:MYH14:HOXA5:PSMA2:GATA3:FBXW7:IL4:HES1:NFE2L2:BCL11A:TEK:SOX9:YWHAH:FOXP2:EPHA7:KLF4:MYC:TFAP2A:CLTC:SMAD4:EPHA2:RHOB:RASA1:NOTCH1:TNIK:BRAF:ARHGAP35:CHRNB2:ARPC2:TGFBR2:TERT:CITED2:TNFRSF11B:PRKCB:CTNNB1:EFNA1:IL1RAPL1:PTEN:SLITRK1:MED12:RELN:TCF4:NF1:HNF1B	GO:0022603  |  regulation of anatomical structure morphogenesis	NA	7e-05	NA
339	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:SOX9:ACVR1B:SMAD4:EGFR:NOTCH1:CTNNB1:NF1:LDB1	GO:0022404  |  molting cycle process	NA	0.000227	NA
340	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:SOX9:ACVR1B:SMAD4:EGFR:NOTCH1:CTNNB1:NF1:LDB1	GO:0022405  |  hair cycle process	NA	0.000227	NA
341	CDS	Pancan-no-skin-melanoma-lymph	MEN1:PIK3R1:CDKN2A:NOTCH1:BRAF:CTNNB1:PTEN:NF1	GO:0031589  |  cell-substrate adhesion	NA	0.0167	NA
342	CDS	Pancan-no-skin-melanoma-lymph	SPI1:MAP2K7:ATRX:BAX:SMARCB1:HOXA5:IL2:ARRDC3:EIF4G1:ACVR2A:HNRNPA2B1:INHBA:NCKAP1L:SMARCA4:ACVR1B:MYC:EGFR:ATM:DRD3:HNRNPU:FCER1G:NEUROD1:CARTPT:TNFRSF11B:B2M:CTNNB1:NR1D2:GATA2:NF1:LDB1	GO:0032844  |  regulation of homeostatic process	NA	0.000766	NA
343	CDS	Pancan-no-skin-melanoma-lymph	MAP2K7:BAX:ACVR2A:HNRNPA2B1:SMARCA4:EGFR:ATM:CTNNB1	GO:0032846  |  positive regulation of homeostatic process	NA	0.0167	NA
344	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:RHOA:TP63:JAG1:AXIN1:DKK4:STMN2:HOXA2:HOXA5:EZH2:GATA3:SUFU:PHOX2B:IL2:FBXW7:DDX6:CDKN1B:BMP5:IL4:HES1:ID2:NFE2L2:BCL11A:TEK:INHBA:IRF1:SOX9:GDF5:YWHAH:FOXA1:KRAS:MEN1:MEIS2:TBX3:EPHA7:KLF4:NR5A1:MYC:SIX3:ASCL1:TOB1:SMAD4:EPHA2:MEIS1:PIK3R1:EGFR:CDKN2A:NOTCH1:DRD3:ZFP36L2:TGFBR2:CARTPT:TERT:TNFRSF11B:TSC1:B2M:CTNNB1:EFNA1:PTEN:NR2F1:SUZ12:GATA2:IDH2:PTCH1:TCF4:NF1:HIST1H4C:LDB1:TWIST2:HIST1H4K:HNF1B:HIST1H4E	GO:0051093  |  negative regulation of developmental process	NA	2.63e-18	NA
345	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:ATRX:BAX:SALL4:SALL1:PRRX1:HDAC1:SOX4:SOX9:GDF5:HNF1A:TBX3:TFAP2A:SMAD4:NOTCH1:MBNL1:EN1:SP8:CTNNB1:PTCH1:HOXA10	GO:0048736  |  appendage development	NA	1.44e-07	NA
346	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:ATRX:BAX:SALL4:SALL1:PRRX1:HDAC1:SOX4:SOX9:GDF5:HNF1A:TBX3:TFAP2A:SMAD4:NOTCH1:MBNL1:EN1:SP8:CTNNB1:PTCH1:HOXA10	GO:0060173  |  limb development	NA	1.44e-07	NA
347	CDS	Pancan-no-skin-melanoma-lymph	DLX6:MEF2C:BAX:GATA3:FBXW7:CDKN1B:HES1:ID2:TEK:ACVR2A:SOX9:GDF5:FOXP2:MEN1:MYC:RB1:AKT1:EPHA2:EGFR:NOTCH1:CTNNB1:PTEN:HRAS:JUN:PTCH1:NF1:HNF1B	GO:0050673  |  epithelial cell proliferation	NA	8.46e-09	NA
348	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:ATRX:BAX:SALL4:SALL1:PRRX1:HDAC1:SOX4:SOX9:GDF5:HNF1A:TBX3:TFAP2A:SMAD4:NOTCH1:MBNL1:EN1:SP8:CTNNB1:PTCH1:HOXA10	GO:0035107  |  appendage morphogenesis	NA	5.78e-09	NA
349	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:ATRX:BAX:SALL4:SALL1:PRRX1:HDAC1:SOX4:SOX9:GDF5:HNF1A:TBX3:TFAP2A:SMAD4:NOTCH1:MBNL1:EN1:SP8:CTNNB1:PTCH1:HOXA10	GO:0035108  |  limb morphogenesis	NA	5.78e-09	NA
350	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:HOXA1:HOXA2:PRRX1:TFAP2A:TGFBR2:CTNNB1:SMAD2:SETD2:MED12	GO:1904888  |  cranial skeletal system development	NA	0.00264	NA
351	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:JAG1:HES1:HDAC1:SOX9:ACVR1B:SMAD4:EPHA2:EGFR:NOTCH1:ELF3:CTNNB1:CLIC4:JUP:PTCH1:NF1:LDB1	GO:0008544  |  epidermis development	NA	0.00474	NA
352	CDS	Pancan-no-skin-melanoma-lymph	TP63:KEAP1:DKK4:EZH2:HES1:ERRFI1:INHBA:SMAD4:NOTCH1:NAB2:CTNNB1:PTCH1	GO:0045682  |  regulation of epidermis development	NA	0.000152	NA
353	CDS	Pancan-no-skin-melanoma-lymph	TP63:DKK4:EZH2:HES1:INHBA:NOTCH1	GO:0045683  |  negative regulation of epidermis development	NA	0.00399	NA
354	CDS	Pancan-no-skin-melanoma-lymph	TP63:AXIN1:EYA1:PRKAR1A:ACVR2A:INHBA:HNF1A:TBX3:KLF4:SMAD4:EPHA2:KDM6A:CITED2:RPL38:SMAD2:CTDNEP1:SETD2:NF2	GO:0007498  |  mesoderm development	NA	2.54e-06	NA
355	CDS	Pancan-no-skin-melanoma-lymph	CASP8:GATA3:CDKN1B:HES1:ARID1A:ACVR2A:FOXA1:MEN1:IDH1:SMAD4:EGFR:NOTCH1:ATM:KMT2D:CTNNB1:PTEN:SETD2	GO:0003006  |  developmental process involved in reproduction	NA	3.81e-07	NA
356	CDS	Pancan-no-skin-melanoma-lymph	CSDE1:TP63:ATRX:BAX:SALL1:CASP2:GATA3:BMP5:ACVR2A:INHBA:SOX9:TBX3:ACVR1B:NR5A1:IDH1:SMAD4:ATM:CITED2:CTNNB1:PTPN11:AKR1C3:HOXA10	GO:0007548  |  sex differentiation	NA	6e-04	NA
357	CDS	Pancan-no-skin-melanoma-lymph	CSDE1:ATRX:BAX:GATA3:ACVR2A:SOX9:TBX3:NR5A1:SMAD4:CITED2:CTNNB1:AKR1C3:HOXA10	GO:0046661  |  male sex differentiation	NA	0.00505	NA
358	CDS	Pancan-no-skin-melanoma-lymph	CSDE1:ATRX:BAX:SALL1:GATA3:ACVR2A:SOX9:ACVR1B:NR5A1:IDH1:SMAD4:ATM:CITED2:AKR1C3:HOXA10	GO:0045137  |  development of primary sexual characteristics	NA	0.0189	NA
359	CDS	Pancan-no-skin-melanoma-lymph	CSDE1:ATRX:BAX:GATA3:ACVR2A:SOX9:NR5A1:SMAD4:CITED2:AKR1C3:HOXA10	GO:0046546  |  development of primary male sexual characteristics	NA	0.0409	NA
360	CDS	Pancan-no-skin-melanoma-lymph	RHOA:CBFB:TP63:MEF2C:JAG1:HOXA2:SUFU:BMP5:TEK:ACVR2A:SOX9:GDF5:MEN1:TFAP2A:TOB1:CLTC:AKT1:EPHA2:EGFR:NOTCH1:HNRNPU:DDR2:NAB2:CTNNB1:RPL38:PTCH1:NF1:TWIST2	GO:0001503  |  ossification	NA	9.58e-05	NA
361	CDS	Pancan-no-skin-melanoma-lymph	CBFB:JAG1:HOXA2:SUFU:ACVR2A:MEN1:TOB1:AKT1:EPHA2:NOTCH1:CTNNB1:PTCH1:NF1	GO:0001649  |  osteoblast differentiation	NA	4.39e-05	NA
362	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RHOA:MEF2C:EP300:MYH14:PRKAR1A:PHOX2B:BCL9:ARID1A:SOX9:FOXP2:TBX3:RB1:SMAD4:NOTCH1:TGFBR2:TSC1:COPS2:CTNNB1:PTEN:ZBTB18:ARID2:NF1	GO:0060537  |  muscle tissue development	NA	2.45e-05	NA
363	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TGFBR2:CTNNB1:PTEN	GO:1901861  |  regulation of muscle tissue development	NA	0.0266	NA
364	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:ARID1A:RB1:SMAD4:NOTCH1:TGFBR2:CTNNB1:PTEN:ZBTB18:ARID2	GO:0014706  |  striated muscle tissue development	NA	1.88e-05	NA
365	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:BCL11A:PIK3CA:CDKN1A:SMARCA4:H3F3B:RB1:TP53:SMAD4:EGFR:CDKN2A:NOTCH1:TGFBR2:BAP1:PTEN:PTCH1:SERTAD1:DDX3X	GO:0040008  |  regulation of growth	NA	1.3e-06	NA
366	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:BCL11A:CDKN1A:SMARCA4:TP53:SMAD4:CDKN2A:TGFBR2:PTEN:PTCH1:SERTAD1:DDX3X	GO:0045926  |  negative regulation of growth	NA	1.82e-06	NA
367	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:BCL11A:CDKN1A:SMARCA4:H3F3B:ACVR1B:RB1:TP53:SMAD4:EGFR:CDKN2A:BAP1:RPS6KA3:SERTAD1:DDX3X	GO:0001558  |  regulation of cell growth	NA	4.9e-05	NA
368	CDS	Pancan-no-skin-melanoma-lymph	SPI1:MEF2C:BAX:HOXA5:EZH2:GATA3:HOXB6:IL2:ACVR2A:INHBA:NCKAP1L:SOX9:KRAS:ACVR1B:RB1:AKT1:FCER1G:BAP1:B2M:CDH2:PTPN11:GATA2:LDB1	GO:0048872  |  homeostasis of number of cells	NA	1.17e-05	NA
369	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:DLX6:TFAP2D:CDH1:HSPA5:RHOA:NDE1:ACTB:MEF2C:ATRX:BAX:DYNLL1:CHD8:SMARCA1:AXIN1:SALL1:HOXA2:CASP2:EZH2:YWHAE:PHOX2B:BMP5:HES1:ARID1A:INHBA:YWHAH:FOXP2:H3F3B:KRAS:MEN1:TBX3:EPHA7:SIX3:ASCL1:EGFR:TAF1:NOTCH1:ATM:BRAF:ARHGAP35:CHRNB2:NEUROD1:EN1:TGFBR2:NEUROD6:TSC1:CTNNB1:CDH2:PTEN:SPTBN2:PTPN11:GATA2:SETD2:PCDH9:PTCH1:NF2:RELN:NF1:DMBX1:LDB1:HNF1B	GO:0060322  |  head development	NA	3.7e-15	NA
370	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MEF2C:ATRX:SALL4:SALL1:GATA3:PRKAR1A:BCL9:BCL11A:PIK3CA:SLC12A5:USP9X:NRN1:SOX9:GDF5:XPA:SMAD4:AKT1:KDM6A:NOTCH1:ATM:DDR2:EN1:TGFBR2:KMT2D:CLIC4:PTEN:SPTBN2:SMAD2:SLITRK1:PTPN11:MED12:PTCH1:ARID2:DMBX1:HNF1B	GO:0048589  |  developmental growth	NA	1.55e-06	NA
371	CDS	Pancan-no-skin-melanoma-lymph	ATRX:HOXA5:PIK3CA:SLC12A5:GDF5:XPA:KDM6A:ATM:DRD3:EN1:CLIC4:SPTBN2:SLITRK1:PTPN11:PTCH1	GO:0035264  |  multicellular organism growth	NA	0.00301	NA
372	CDS	Pancan-no-skin-melanoma-lymph	CDH1:GATA3:HES1:PIK3CA:FOXA1:MEN1:PIK3R1:CDKN2A:NOTCH1:BRAF:TGFBR2:CTNNB1:PTEN:NF1	GO:0030155  |  regulation of cell adhesion	NA	5.05e-05	NA
373	CDS	Pancan-no-skin-melanoma-lymph	MEN1:PIK3R1:CDKN2A:NOTCH1:BRAF:PTEN:NF1	GO:0010810  |  regulation of cell-substrate adhesion	NA	0.00503	NA
374	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CDH10:RHOA:ACTB:FAT1:GATA3:PRKAR1A:IL2:DUSP22:HES1:PIK3CA:IRF1:SOX9:FOXA1:KLF4:AKT1:PIK3R1:EGFR:CDKN2A:BRAF:TGFBR2:CITED2:CTNNB1:CDH2:JUP:PTPN11:NF2	GO:0016337  |  single organismal cell-cell adhesion	NA	0.00651	NA
375	CDS	Pancan-no-skin-melanoma-lymph	CDH1:GATA3:HES1:PIK3CA:FOXA1:PIK3R1:CDKN2A:BRAF:TGFBR2:CTNNB1	GO:0022407  |  regulation of cell-cell adhesion	NA	0.00165	NA
376	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:PIK3R1:CDKN2A:BRAF:TGFBR2:CTNNB1	GO:1903037  |  regulation of leukocyte cell-cell adhesion	NA	0.0289	NA
377	CDS	Pancan-no-skin-melanoma-lymph	HOXA5:WASL:PRKAR1A:IL2:BMP5:DUSP22:IL4:HES1:NFE2L2:INHBA:IRF1:SOX9:BPIFB1:MEIS2:MYC:MEIS1:PIK3R1:CDKN2A:NOTCH1:ATM:FCER1G:CARTPT:CTNNB1:GATA2:NF1:HIST1H4C:LDB1:HLA-A:HIST1H4K:HIST1H4E	GO:0002683  |  negative regulation of immune system process	NA	2.24e-05	NA
378	CDS	Pancan-no-skin-melanoma-lymph	SPI1:BAX:HOXA5:GATA3:HOXB6:ACVR2A:INHBA:NCKAP1L:ACVR1B:RB1:FCER1G:BAP1:B2M:GATA2:LDB1	GO:0002262  |  myeloid cell homeostasis	NA	0.000925	NA
379	CDS	Pancan-no-skin-melanoma-lymph	SPI1:HOXA5:GATA3:HOXB6:ACVR2A:INHBA:NCKAP1L:ACVR1B:RB1:B2M:GATA2:LDB1	GO:0034101  |  erythrocyte homeostasis	NA	0.0174	NA
380	CDS	Pancan-no-skin-melanoma-lymph	CASP8:CBFB:GATA3:HES1:RPL22:PIK3CA:CDKN1A:PIK3R1:CDKN2A:ATM:ZFP36L2:BRAF:TGFBR2:B2M:CTNNB1	GO:0046649  |  lymphocyte activation	NA	8.69e-06	NA
381	CDS	Pancan-no-skin-melanoma-lymph	CASP8:GATA3:HES1:RPL22:PIK3CA:PIK3R1:CDKN2A:ZFP36L2:BRAF:TGFBR2:B2M:CTNNB1	GO:0042110  |  T cell activation	NA	5.99e-05	NA
382	CDS	Pancan-no-skin-melanoma-lymph	RHOA:TP63:MEF2C:PSMC5:SALL4:JAG1:AXIN1:SALL1:EYA1:HOXA5:PSMA2:GATA3:SUFU:PRKAR1A:BMP5:HES1:ARID1A:INHBA:SOX4:SOX9:FOXA1:KRAS:HNF1A:TBX3:EPHA7:KLF4:MYC:TFAP2A:SIX3:CLTC:SMAD4:EPHA2:RHOB:EGFR:KDM6A:NOTCH1:TTN:ARHGAP35:TGFBR2:TSC1:CTNNB1:CLIC4:PTEN:SMAD2:SETD2:MED12:PTCH1:NF2:HNF1B	GO:0048729  |  tissue morphogenesis	NA	1.22e-10	NA
383	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:EYA1:PRKAR1A:INHBA:HNF1A:TBX3:KLF4:EPHA2:KDM6A:SMAD2:SETD2:NF2	GO:0048332  |  mesoderm morphogenesis	NA	0.000262	NA
384	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:CDKN1A:PIK3R1:CDKN2A:ATM:ZFP36L2:BRAF:TGFBR2:CTNNB1	GO:0050865  |  regulation of cell activation	NA	0.00342	NA
385	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:CDKN1A:PIK3R1:CDKN2A:ATM:ZFP36L2:BRAF:TGFBR2:CTNNB1	GO:0002694  |  regulation of leukocyte activation	NA	0.00181	NA
386	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:CDKN1A:PIK3R1:CDKN2A:ATM:ZFP36L2:BRAF:TGFBR2:CTNNB1	GO:0051249  |  regulation of lymphocyte activation	NA	0.000527	NA
387	CDS	Pancan-no-skin-melanoma-lymph	HES1:CDKN1A:CDKN2A:ATM:TGFBR2:CTNNB1	GO:0050670  |  regulation of lymphocyte proliferation	NA	0.0159	NA
388	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:PIK3R1:CDKN2A:BRAF:TGFBR2:CTNNB1	GO:0050863  |  regulation of T cell activation	NA	0.0186	NA
389	CDS	Pancan-no-skin-melanoma-lymph	DLX6:RCN1:CASP8:TP63:KEAP1:MEF2C:BAX:SMARCB1:EP300:CHD8:SALL4:AXIN1:SALL1:EYA1:ELL:HOXA1:HOXA2:HOXA5:GATA3:SUFU:HOXB6:PRKAR1A:CNOT2:BMP5:HES1:ID2:BIRC6:NFE2L2:PRRX1:HDAC1:ARID1A:DNMT3A:HOXB5:ACVR2A:INHBA:SOX4:SOX9:GDF5:FOXA1:RAI2:HNF1A:TBX3:ACVR1B:SRSF1:KLF4:TFAP2A:SIX3:SMAD4:AKT1:EPHA2:RASA1:EGFR:KDM6A:NOTCH1:ATM:MBNL1:ARHGAP35:NEUROD1:EN1:ELF3:TGFBR2:CITED2:SP8:TSC1:CTNNB1:EFNA1:TANC2:RPL38:STOX2:SMAD2:GATA2:SETD2:MED12:PTCH1:NF2:ARID2:NF1:HOXC4:LDB1:HOXA10:HNF1B	GO:0009790  |  embryo development	NA	4.06e-21	NA
390	CDS	Pancan-no-skin-melanoma-lymph	RCN1:CASP8:KEAP1:MEF2C:SMARCB1:EP300:CHD8:SALL4:AXIN1:EYA1:ELL:HOXA1:HOXA2:HOXA5:GATA3:SUFU:HOXB6:CNOT2:BMP5:HES1:BIRC6:PRRX1:ARID1A:HOXB5:ACVR2A:SOX4:FOXA1:HNF1A:TBX3:ACVR1B:SRSF1:TFAP2A:SMAD4:AKT1:EPHA2:EGFR:KDM6A:NOTCH1:ATM:MBNL1:ARHGAP35:EN1:ELF3:TGFBR2:TSC1:CTNNB1:TANC2:SMAD2:GATA2:SETD2:MED12:PTCH1:NF1:HNF1B	GO:0009792  |  embryo development ending in birth or egg hatching	NA	4.61e-15	NA
391	CDS	Pancan-no-skin-melanoma-lymph	RCN1:CASP8:KEAP1:MEF2C:SMARCB1:EP300:CHD8:SALL4:AXIN1:EYA1:ELL:HOXA1:HOXA2:HOXA5:GATA3:SUFU:HOXB6:CNOT2:BMP5:HES1:BIRC6:PRRX1:ARID1A:HOXB5:ACVR2A:SOX4:FOXA1:HNF1A:TBX3:ACVR1B:SRSF1:TFAP2A:SMAD4:AKT1:EPHA2:EGFR:KDM6A:NOTCH1:ATM:MBNL1:ARHGAP35:EN1:ELF3:TGFBR2:TSC1:CTNNB1:TANC2:SMAD2:GATA2:SETD2:MED12:PTCH1:NF1:HNF1B	GO:0043009  |  chordate embryonic development	NA	3.39e-15	NA
392	CDS	Pancan-no-skin-melanoma-lymph	RCN1:CASP8:KEAP1:SMARCB1:CHD8:SALL4:ELL:GATA3:CNOT2:BMP5:HES1:BIRC6:HNF1A:TBX3:ACVR1B:SRSF1:SMAD4:AKT1:EGFR:KDM6A:NOTCH1:MBNL1:ELF3:TGFBR2:CTNNB1:TANC2:SMAD2:GATA2:SETD2:PTCH1:HNF1B	GO:0001701  |  in utero embryonic development	NA	8.21e-08	NA
393	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:MEF2C:BAX:SALL4:AXIN1:SALL1:EYA1:HOXA1:HOXA2:HOXA5:GATA3:SUFU:HOXB6:PRKAR1A:BMP5:HES1:ID2:PRRX1:HDAC1:ARID1A:HOXB5:ACVR2A:INHBA:SOX4:SOX9:GDF5:HNF1A:TBX3:KLF4:TFAP2A:SIX3:SMAD4:EPHA2:KDM6A:NOTCH1:MBNL1:ARHGAP35:NEUROD1:EN1:TGFBR2:SP8:TSC1:CTNNB1:EFNA1:RPL38:SMAD2:GATA2:SETD2:MED12:PTCH1:NF2:HOXC4:LDB1:HOXA10:HNF1B	GO:0048598  |  embryonic morphogenesis	NA	2.16e-16	NA
394	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:BAX:SALL4:SALL1:PRRX1:HDAC1:GDF5:HNF1A:TBX3:TFAP2A:SMAD4:NOTCH1:MBNL1:EN1:SP8:CTNNB1:PTCH1:HOXA10	GO:0035113  |  embryonic appendage morphogenesis	NA	1.89e-07	NA
395	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:BAX:SALL4:SALL1:PRRX1:HDAC1:GDF5:HNF1A:TBX3:TFAP2A:SMAD4:NOTCH1:MBNL1:EN1:SP8:CTNNB1:PTCH1:HOXA10	GO:0030326  |  embryonic limb morphogenesis	NA	1.89e-07	NA
396	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:ARID1A:ACVR2A:SMAD4:KDM6A:TGFBR2:CTNNB1	GO:0007369  |  gastrulation	NA	0.000341	NA
397	CDS	Pancan-no-skin-melanoma-lymph	ACVR2A:SMAD4:CTNNB1	GO:0001702  |  gastrulation with mouth forming second	NA	0.038	NA
398	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:EYA1:PRKAR1A:ARID1A:INHBA:HNF1A:KLF4:EPHA2:KDM6A:CTNNB1:SMAD2:NF2:HNF1B	GO:0001704  |  formation of primary germ layer	NA	0.0103	NA
399	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:EYA1:PRKAR1A:INHBA:HNF1A:KLF4:EPHA2:KDM6A:SMAD2:NF2	GO:0001707  |  mesoderm formation	NA	0.0137	NA
400	CDS	Pancan-no-skin-melanoma-lymph	BAX:HDAC1:SMAD4:NOTCH1:CTNNB1	GO:0042733  |  embryonic digit morphogenesis	NA	0.029	NA
401	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:KDM6A:NOTCH1:ATM:PTCH1	GO:0061053  |  somite development	NA	0.0271	NA
402	CDS	Pancan-no-skin-melanoma-lymph	HES1:NFE2L2:FOXA1:SMAD4:NOTCH1:ZFP36L2:SETD2	GO:0048863  |  stem cell differentiation	NA	0.00067	NA
403	CDS	Pancan-no-skin-melanoma-lymph	JAG1:HES1:NFE2L2:SOX9:NOTCH1:ZFP36L2	GO:2000736  |  regulation of stem cell differentiation	NA	0.00335	NA
404	CDS	Pancan-no-skin-melanoma-lymph	JAG1:HOXA2:SUFU:ACVR2A:SOX9:MEN1:TOB1:NOTCH1:CTNNB1:PTCH1	GO:0030278  |  regulation of ossification	NA	0.0125	NA
405	CDS	Pancan-no-skin-melanoma-lymph	HOXA2:SUFU:SOX9:MEN1:TOB1:NOTCH1:PTCH1	GO:0030279  |  negative regulation of ossification	NA	0.00844	NA
406	CDS	Pancan-no-skin-melanoma-lymph	JAG1:HOXA2:SUFU:ACVR2A:MEN1:TOB1:NOTCH1:CTNNB1:PTCH1	GO:0045667  |  regulation of osteoblast differentiation	NA	0.000937	NA
407	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:ATRX:EP300:CHD8:SALL4:JAG1:SALL1:EYA1:HOXA1:HOXA5:GATA3:SUFU:PTGES3:BMP5:HES1:ID2:ERRFI1:ARID1A:CDKN1A:SOX4:SOX9:FOXP2:FOXA1:KRAS:TBX3:EPHA7:MYC:ASCL1:RB1:SMAD4:EPHA2:RHOB:EGFR:KDM6A:NOTCH1:ARHGAP35:NFIA:EN1:TGFBR2:CITED2:TSC1:CTNNB1:CLIC4:SMAD2:SETD2:MED12:PTCH1:NF1:HNF1B	GO:0035295  |  tube development	NA	5.81e-14	NA
408	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:SALL4:SALL1:EYA1:HOXA1:HOXA5:GATA3:SUFU:BMP5:HES1:ID2:ARID1A:SOX4:SOX9:FOXA1:KRAS:TBX3:EPHA7:MYC:SMAD4:EPHA2:RHOB:EGFR:KDM6A:NOTCH1:ARHGAP35:TGFBR2:TSC1:CTNNB1:CLIC4:SMAD2:SETD2:MED12:PTCH1:HNF1B	GO:0035239  |  tube morphogenesis	NA	1.11e-11	NA
409	CDS	Pancan-no-skin-melanoma-lymph	HOXA1:GATA3:SUFU:ARID1A:SOX9:KDM6A:NOTCH1:ARHGAP35:TSC1:CTNNB1:SETD2:PTCH1:HNF1B	GO:0035148  |  tube formation	NA	1.3e-06	NA
410	CDS	Pancan-no-skin-melanoma-lymph	SUFU:ARID1A:KDM6A:ARHGAP35:TSC1:SETD2:PTCH1	GO:0060606  |  tube closure	NA	0.014	NA
411	CDS	Pancan-no-skin-melanoma-lymph	TP63:SALL1:EYA1:HOXA5:BCL11A:SOX9:FOXA1:KRAS:TBX3:EPHA7:MYC:SMAD4:EPHA2:NOTCH1:TGFBR2:CTNNB1:CLIC4:SETD2:PTCH1:HNF1B	GO:0001763  |  morphogenesis of a branching structure	NA	4.98e-05	NA
412	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:EP300:AXIN1:HOXA2:SUFU:HOXB6:HES1:HOXB5:ACVR2A:FOXA1:TBX3:SIX3:SMAD4:KDM6A:NOTCH1:ATM:NEUROD1:EN1:TGFBR2:CITED2:SP8:CTNNB1:SMAD2:MED12:PTCH1:RELN:CCDC151:HOXC4:LDB1:HOXA10:HNF1B	GO:0007389  |  pattern specification process	NA	3.52e-09	NA
413	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:AXIN1:SUFU:ACVR2A:TBX3:NOTCH1:TGFBR2:CITED2:CTNNB1:SMAD2:CCDC151	GO:0009799  |  specification of symmetry	NA	0.00689	NA
414	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:AXIN1:SUFU:ACVR2A:TBX3:NOTCH1:TGFBR2:CITED2:CTNNB1:SMAD2:CCDC151	GO:0009855  |  determination of bilateral symmetry	NA	0.00636	NA
415	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:AXIN1:SUFU:ACVR2A:TBX3:NOTCH1:TGFBR2:CITED2:SMAD2:CCDC151	GO:0007368  |  determination of left/right symmetry	NA	0.024	NA
416	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:EP300:AXIN1:HOXA2:SUFU:HOXB6:HES1:HOXB5:ACVR2A:FOXA1:TBX3:SIX3:SMAD4:KDM6A:NOTCH1:ATM:NEUROD1:EN1:CITED2:SP8:CTNNB1:SMAD2:MED12:PTCH1:RELN:HOXC4:LDB1:HOXA10:HNF1B	GO:0003002  |  regionalization	NA	2.5e-10	NA
417	CDS	Pancan-no-skin-melanoma-lymph	HOXA2:SUFU:FOXA1:EN1:SP8:CTNNB1:SMAD2:PTCH1	GO:0009953  |  dorsal/ventral pattern formation	NA	0.00371	NA
418	CDS	Pancan-no-skin-melanoma-lymph	EP300:AXIN1:HOXA2:HOXB6:HES1:HOXB5:ACVR2A:TBX3:SIX3:SMAD4:KDM6A:NOTCH1:ATM:NEUROD1:EN1:CTNNB1:SMAD2:MED12:HOXC4:LDB1:HOXA10:HNF1B	GO:0009952  |  anterior/posterior pattern specification	NA	4.52e-09	NA
419	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:KDM6A:NOTCH1:ATM	GO:0001756  |  somitogenesis	NA	0.0444	NA
420	CDS	Pancan-no-skin-melanoma-lymph	TBX3:SIX3:SMAD4:KDM6A:NOTCH1:CITED2:CTNNB1:SMAD2:PTCH1:LDB1	GO:0009798  |  axis specification	NA	0.0017	NA
421	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:KDM6A:CTNNB1:SMAD2:PTCH1	GO:0000578  |  embryonic axis specification	NA	0.0158	NA
422	CDS	Pancan-no-skin-melanoma-lymph	EP300:AXIN1:EYA1:HOXA5:PHOX2B:PTGES3:HES1:ERRFI1:SOX9:FOXP2:FOXA1:KRAS:ASCL1:EGFR:NOTCH1:TGFBR2:CTNNB1:SMAD2	GO:0060541  |  respiratory system development	NA	0.000469	NA
423	CDS	Pancan-no-skin-melanoma-lymph	DLX6:MEF2C:BAX:GATA3:FBXW7:CDKN1B:HES1:TEK:SOX9:GDF5:FOXP2:MEN1:MYC:RB1:AKT1:EGFR:NOTCH1:CTNNB1:PTEN:HRAS:JUN:PTCH1:NF1	GO:0050678  |  regulation of epithelial cell proliferation	NA	2.57e-07	NA
424	CDS	Pancan-no-skin-melanoma-lymph	HES1:ID2:CDKN1A:RB1:EGFR:NOTCH1:TGFBR2:CTNNB1:SMAD2:HNF1B	GO:0055123  |  digestive system development	NA	0.000961	NA
425	CDS	Pancan-no-skin-melanoma-lymph	HES1:ID2:CDKN1A:RB1:EGFR:NOTCH1:TGFBR2:CTNNB1:SMAD2:HNF1B	GO:0048565  |  digestive tract development	NA	0.000443	NA
426	CDS	Pancan-no-skin-melanoma-lymph	ID2:EGFR:NOTCH1:CTNNB1:SMAD2:HNF1B	GO:0048546  |  digestive tract morphogenesis	NA	0.0125	NA
427	CDS	Pancan-no-skin-melanoma-lymph	ASB4:MAP2K4:SPI1:RHOA:MEF2C:BAX:EP300:SALL4:JAG1:SALL1:EYA1:HOXA1:HOXA5:GATA3:SUFU:PRKAR1A:FBXW7:FGF6:BMP5:HES1:SNX17:NFE2L2:ERRFI1:ARID1A:TEK:EPC1:PIK3CA:SOX4:SOX9:TBX3:KLF4:SMAD4:AKT1:EPHA2:RHOB:MEIS1:RASA1:EGFR:KDM6A:NOTCH1:TCF7L2:ATM:TTN:TGFBR2:TERT:CITED2:COL1A2:TSC1:PRKCB:CTNNB1:EFNA1:CLIC4:CDH2:PTEN:SMAD2:JUN:PTPN11:SETD2:MED12:PTCH1:HEXIM1:ARID2:TCF4:NF1	GO:0072359  |  circulatory system development	NA	7.17e-13	NA
428	CDS	Pancan-no-skin-melanoma-lymph	TP63:MEF2C:BAX:JAG1:SALL1:EYA1:GATA3:CDKN1B:HES1:TEK:SOX4:SOX9:FOXA1:EPHA7:MYC:TFAP2A:SMAD4:NOTCH1:NFIA:TSC1:CTNNB1:PTEN:SMAD2:GATA2:PTCH1:NF1:HNF1B	GO:0001655  |  urogenital system development	NA	1.48e-05	NA
429	CDS	Pancan-no-skin-melanoma-lymph	DLX6:RHOA:MEF2C:EP300:AXIN1:EYA1:HOXA1:HOXA2:HOXA5:SUFU:HOXB6:FGF6:BMP5:PRRX1:HOXB5:TEK:ACVR2A:SOX4:SOX9:GDF5:HAPLN2:TBX3:TFAP2A:EPHA2:MEIS1:EN1:TGFBR2:COL1A2:TNFRSF11B:NAB2:CTNNB1:RPL38:SMAD2:RPS6KA3:PTPN11:SETD2:MED12:HOXC4:HOXA10	GO:0001501  |  skeletal system development	NA	5.02e-09	NA
430	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:AXIN1:EYA1:HOXA1:HOXA2:HOXA5:HOXB6:PRRX1:HOXB5:ACVR2A:TFAP2A:TGFBR2:CTNNB1:SMAD2:SETD2:MED12	GO:0048706  |  embryonic skeletal system development	NA	2.67e-05	NA
431	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:TERT:CTNNB1	GO:0042634  |  regulation of hair cycle	NA	0.000432	NA
432	CDS	Pancan-no-skin-melanoma-lymph	TP63:PRRX1:SOX9:FOXP2:MYC:TGFBR2:CTNNB1	GO:0010464  |  regulation of mesenchymal cell proliferation	NA	0.0419	NA
433	CDS	Pancan-no-skin-melanoma-lymph	RHOA:TP63:MEF2C:PSMC5:SALL4:JAG1:SALL1:EYA1:HOXA5:PSMA2:GATA3:SUFU:BMP5:HES1:ARID1A:SOX4:SOX9:FOXA1:KRAS:TBX3:EPHA7:KLF4:MYC:TFAP2A:CLTC:SMAD4:EPHA2:RHOB:EGFR:KDM6A:NOTCH1:ARHGAP35:TGFBR2:TSC1:CTNNB1:CLIC4:PTEN:SETD2:MED12:PTCH1:HNF1B	GO:0002009  |  morphogenesis of an epithelium	NA	1.41e-08	NA
434	CDS	Pancan-no-skin-melanoma-lymph	SOX9:FOXA1:KRAS:SMAD4:EPHA2:NOTCH1:TGFBR2:CTNNB1:CLIC4:PTCH1:HNF1B	GO:0061138  |  morphogenesis of a branching epithelium	NA	0.00216	NA
435	CDS	Pancan-no-skin-melanoma-lymph	TP63:SALL4:GATA3:SUFU:BMP5:ARID1A:SOX4:SOX9:TFAP2A:KDM6A:ARHGAP35:TSC1:CTNNB1:SETD2:MED12:PTCH1:HNF1B	GO:0016331  |  morphogenesis of embryonic epithelium	NA	0.000177	NA
436	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:SALL4:SALL1:EYA1:HOXA5:GATA3:SUFU:BMP5:HES1:ARID1A:SOX4:SOX9:FOXA1:KRAS:TBX3:EPHA7:MYC:SMAD4:EPHA2:RHOB:KDM6A:NOTCH1:ARHGAP35:TGFBR2:TSC1:CTNNB1:CLIC4:SETD2:MED12:PTCH1:HNF1B	GO:0060562  |  epithelial tube morphogenesis	NA	4.92e-10	NA
437	CDS	Pancan-no-skin-melanoma-lymph	SALL1:EYA1:HOXA5:SOX9:FOXA1:KRAS:TBX3:MYC:SMAD4:EPHA2:NOTCH1:TGFBR2:CTNNB1:CLIC4:PTCH1:HNF1B	GO:0048754  |  branching morphogenesis of an epithelial tube	NA	0.00016	NA
438	CDS	Pancan-no-skin-melanoma-lymph	GATA3:SUFU:ARID1A:SOX9:KDM6A:ARHGAP35:TSC1:CTNNB1:SETD2:PTCH1:HNF1B	GO:0072175  |  epithelial tube formation	NA	6.07e-05	NA
439	CDS	Pancan-no-skin-melanoma-lymph	GATA3:SUFU:ARID1A:SOX9:KDM6A:ARHGAP35:TSC1:CTNNB1:SETD2:PTCH1:HNF1B	GO:0001838  |  embryonic epithelial tube formation	NA	3.17e-05	NA
440	CDS	Pancan-no-skin-melanoma-lymph	CASP8:GATA3:CDKN1B:HES1:ARID1A:ACVR2A:FOXA1:MEN1:IDH1:SMAD4:EGFR:NOTCH1:ATM:CTNNB1:PTEN:SETD2	GO:0061458  |  reproductive system development	NA	9.88e-09	NA
441	CDS	Pancan-no-skin-melanoma-lymph	CASP8:GATA3:CDKN1B:HES1:ARID1A:ACVR2A:FOXA1:MEN1:IDH1:SMAD4:EGFR:NOTCH1:ATM:CTNNB1:PTEN:SETD2	GO:0048608  |  reproductive structure development	NA	8.58e-09	NA
442	CDS	Pancan-no-skin-melanoma-lymph	ASB4:SPI1:RHOA:MEF2C:BAX:JAG1:EYA1:HOXA1:HOXA5:SUFU:FBXW7:FGF6:HES1:SNX17:NFE2L2:PRRX1:ERRFI1:ARID1A:TEK:EPC1:PIK3CA:SOX4:TBX3:KLF4:AKT1:EPHA2:RHOB:MEIS1:RASA1:KDM6A:NOTCH1:TCF7L2:TGFBR2:TERT:COL1A2:PRKCB:CTNNB1:EFNA1:CLIC4:CDH2:PTEN:JUN:SETD2:ARID2:TCF4:NF1	GO:0072358  |  cardiovascular system development	NA	3.25e-09	NA
443	CDS	Pancan-no-skin-melanoma-lymph	GATA3:FBXW7:CDKN1B:HES1:CDKN1A:MEN1:VHL:APC:RB1:TOB1:TP53:SMAD4:CDKN2A:NOTCH1:ATM:TGFBR2:BAP1:PBRM1:TERT:CTNNB1:PTEN:PTCH1:ARID2:NF1	GO:0008285  |  negative regulation of cell proliferation	NA	7.36e-16	NA
444	CDS	Pancan-no-skin-melanoma-lymph	GATA3:FBXW7:CDKN1B:MEN1:RB1:PTEN:PTCH1:NF1	GO:0050680  |  negative regulation of epithelial cell proliferation	NA	1.46e-05	NA
445	CDS	Pancan-no-skin-melanoma-lymph	JAG1:SUFU:PTGES3:ARRDC3:HDAC1:SOX9:ACVR1B:SMAD4:EPHA2:EGFR:NOTCH1:COL1A2:CTNNB1:CLIC4:JUP:NF1:LDB1	GO:0043588  |  skin development	NA	0.00118	NA
446	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:SOX9:ACVR1B:SMAD4:EGFR:NOTCH1:CTNNB1:NF1:LDB1	GO:0098773  |  skin epidermis development	NA	0.000482	NA
447	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:SOX9:ACVR1B:SMAD4:EGFR:NOTCH1:CTNNB1:NF1:LDB1	GO:0001942  |  hair follicle development	NA	0.000186	NA
448	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:MEF2C:EYA1:IL2:FGF6:CDKN1B:BMP5:IL4:HES1:EIF4G1:ID2:BIRC6:PRRX1:HDAC1:TEK:NCKAP1L:CDKN1A:SOX4:SOX9:FOXP2:KRAS:TBX3:MYC:IL21:ASCL1:SMAD4:AKT1:EGFR:TAF1:NOTCH1:DRD3:CHRNB2:DDR2:TGFBR2:EIF5A2:TERT:KMT2D:CTNNB1:CNBP:PTEN:HRAS:JUN:SUZ12:AKR1C3:NF1:SERTAD1	GO:0008284  |  positive regulation of cell proliferation	NA	5.83e-05	NA
449	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TEK:SOX9:FOXP2:MYC:AKT1:EGFR:NOTCH1:CTNNB1:HRAS:JUN:NF1	GO:0050679  |  positive regulation of epithelial cell proliferation	NA	0.012	NA
450	CDS	Pancan-no-skin-melanoma-lymph	TP63:PRRX1:SOX9:FOXP2:MYC:TGFBR2:CTNNB1	GO:0002053  |  positive regulation of mesenchymal cell proliferation	NA	0.00695	NA
451	CDS	Pancan-no-skin-melanoma-lymph	CASP8:CBFB:GATA3:HES1:NFE2L2:RPL22:ACVR2A:RB1:PIK3R1:CDKN2A:NOTCH1:ATM:ZFP36L2:BRAF:TGFBR2:B2M:CTNNB1:NF1	GO:0002520  |  immune system development	NA	1.99e-07	NA
452	CDS	Pancan-no-skin-melanoma-lymph	CDH1:BAX:GATA3:FBXW7:CDKN1B:HES1:ID2:PIK3CA:FOXA1:KRAS:SMAD4:EPHA2:EGFR:NOTCH1:ATM:BRAF:ARHGAP35:ELF3:TGFBR2:CTNNB1:PTEN:PTCH1:NF1	GO:0048732  |  gland development	NA	4.47e-13	NA
453	CDS	Pancan-no-skin-melanoma-lymph	BAX:GATA3:ID2:SOX9:AKT1:EPHA2:ARHGAP35:ELF3:TGFBR2:PTCH1	GO:0030879  |  mammary gland development	NA	0.00102	NA
454	CDS	Pancan-no-skin-melanoma-lymph	JARID2:DBP:EZH2:FBXW7:HES1:PIK3CA:SOX9:KRAS:HNF1A:SRSF1:EGFR:NOTCH1:CITED2:JUN:NF1:HNF1B	GO:0001889  |  liver development	NA	0.00018	NA
455	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:FOXA1:NOTCH1:CTNNB1:PTEN	GO:0030850  |  prostate gland development	NA	0.000823	NA
456	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:SOX9:NOTCH1:CTNNB1	GO:0060767  |  epithelial cell proliferation involved in prostate gland development	NA	0.00506	NA
457	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:TFAP2D:CDH1:HSPA5:RHOA:NDE1:ACTB:MEF2C:ATRX:BAX:DYNLL1:CHD8:SMARCA1:AXIN1:SALL1:HOXA2:CASP2:EZH2:SUFU:YWHAE:PHOX2B:BMP5:HES1:ARID1A:INHBA:SOX4:SOX9:YWHAH:FOXP2:H3F3B:HAPLN2:KRAS:MEN1:TBX3:EPHA7:ACVR1B:SRSF1:TFAP2A:SIX3:ASCL1:SH3GL3:AKT1:EGFR:TAF1:NOTCH1:ATM:DRD3:ARHGAP35:CHRNB2:NEUROD1:EN1:TGFBR2:NEUROD6:TSC1:CTNNB1:CDH2:PTEN:SPTBN2:RPS6KA3:PTPN11:GATA2:SETD2:PCDH9:MED12:PTCH1:NF2:RELN:NF1:DMBX1:LDB1:HNF1B	GO:0007417  |  central nervous system development	NA	5.46e-17	NA
458	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:TFAP2D:CDH1:HSPA5:RHOA:NDE1:ACTB:MEF2C:ATRX:BAX:DYNLL1:CHD8:SMARCA1:AXIN1:SALL1:HOXA2:CASP2:EZH2:YWHAE:PHOX2B:BMP5:HES1:ARID1A:INHBA:YWHAH:FOXP2:H3F3B:KRAS:MEN1:TBX3:EPHA7:SIX3:ASCL1:EGFR:TAF1:NOTCH1:ATM:ARHGAP35:CHRNB2:NEUROD1:EN1:TGFBR2:NEUROD6:TSC1:CTNNB1:CDH2:PTEN:SPTBN2:PTPN11:GATA2:SETD2:PCDH9:PTCH1:NF2:RELN:NF1:DMBX1:LDB1:HNF1B	GO:0007420  |  brain development	NA	6.4e-15	NA
459	CDS	Pancan-no-skin-melanoma-lymph	DLX6:RCN1:BAX:JAG1:AXIN1:SALL1:EYA1:HOXA1:HOXA2:CASP2:GATA3:PHOX2B:CDKN1B:IL4:HES1:PRRX1:HDAC1:ARID1A:INHBA:SOX9:SMARCA4:FOXP2:MEIS2:KLF4:TFAP2A:SIX3:ASCL1:EPHA2:MEIS1:EGFR:NOTCH1:ARHGAP35:NEUROD1:TGFBR2:CTNNB1:CLIC4:RPL38:JUN:PTPN11:NF2:NF1	GO:0007423  |  sensory organ development	NA	3.05e-09	NA
460	CDS	Pancan-no-skin-melanoma-lymph	DLX6:JAG1:SALL1:EYA1:HOXA1:HOXA2:GATA3:PHOX2B:CDKN1B:HES1:PRRX1:SOX9:TFAP2A:NOTCH1:NEUROD1:RPL38:PTPN11:GATA2	GO:0043583  |  ear development	NA	0.00502	NA
461	CDS	Pancan-no-skin-melanoma-lymph	RCN1:BAX:JAG1:AXIN1:CASP2:GATA3:CDKN1B:IL4:HDAC1:ARID1A:INHBA:SOX9:SMARCA4:FOXP2:MEIS2:KLF4:TFAP2A:SIX3:EPHA2:MEIS1:EGFR:ARHGAP35:NEUROD1:TGFBR2:CTNNB1:CLIC4:JUN:NF2:NF1	GO:0001654  |  eye development	NA	1.34e-06	NA
462	CDS	Pancan-no-skin-melanoma-lymph	RCN1:BAX:JAG1:CASP2:GATA3:CDKN1B:IL4:HDAC1:ARID1A:INHBA:SOX9:SMARCA4:FOXP2:KLF4:TFAP2A:SIX3:EPHA2:MEIS1:EGFR:ARHGAP35:NEUROD1:TGFBR2:CTNNB1:CLIC4:JUN:NF2:NF1	GO:0043010  |  camera-type eye development	NA	9.18e-07	NA
463	CDS	Pancan-no-skin-melanoma-lymph	CDH1:MEN1:PIK3R1:CDKN2A:NOTCH1:PTEN:NF1	GO:0007162  |  negative regulation of cell adhesion	NA	0.0262	NA
464	CDS	Pancan-no-skin-melanoma-lymph	MEN1:PIK3R1:CDKN2A:NOTCH1:PTEN:NF1	GO:0010812  |  negative regulation of cell-substrate adhesion	NA	4.62e-05	NA
465	CDS	Pancan-no-skin-melanoma-lymph	TP63:MEF2C:BAX:JAG1:SALL1:EYA1:GATA3:HES1:TEK:SOX4:SOX9:EPHA7:MYC:TFAP2A:SMAD4:NOTCH1:NFIA:TSC1:CTNNB1:SMAD2:PTCH1:NF1:HNF1B	GO:0072001  |  renal system development	NA	0.000293	NA
466	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MEF2C:EP300:SALL4:JAG1:SALL1:GATA3:SUFU:PRKAR1A:HES1:ARID1A:TEK:SOX9:TBX3:SMAD4:EGFR:KDM6A:NOTCH1:ATM:TTN:TGFBR2:CITED2:TSC1:CTNNB1:EFNA1:PTEN:SMAD2:JUN:PTPN11:SETD2:MED12:PTCH1:HEXIM1:ARID2:NF1	GO:0007507  |  heart development	NA	1.23e-08	NA
467	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:NOTCH1:TGFBR2:PTEN:ARID2	GO:0060419  |  heart growth	NA	0.00314	NA
468	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:GATA3:SOX4:SOX9:SMAD4:NOTCH1:TGFBR2:EFNA1	GO:0003170  |  heart valve development	NA	0.000217	NA
469	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:SALL4:JAG1:SALL1:GATA3:SUFU:BMP5:HES1:SNX17:ARID1A:TEK:SOX4:TBX3:SMAD4:NOTCH1:TGFBR2:CITED2	GO:0003205  |  cardiac chamber development	NA	7.52e-05	NA
470	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:SALL4:JAG1:SALL1:GATA3:SUFU:HES1:TBX3:SMAD4:NOTCH1:TGFBR2:CITED2	GO:0003231  |  cardiac ventricle development	NA	0.00229	NA
471	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:ARID1A:SMAD4:NOTCH1:TGFBR2:PTEN:ARID2	GO:0048738  |  cardiac muscle tissue development	NA	0.000648	NA
472	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:NOTCH1:TGFBR2:PTEN:ARID2	GO:0055017  |  cardiac muscle tissue growth	NA	0.00202	NA
473	CDS	Pancan-no-skin-melanoma-lymph	NOTCH1:TGFBR2:PTEN:ARID2	GO:0060038  |  cardiac muscle cell proliferation	NA	0.0112	NA
474	CDS	Pancan-no-skin-melanoma-lymph	DLX6:RHOA:DGCR2:TP63:MEF2C:BAX:PSMC5:EP300:JAG1:AXIN1:SALL1:EYA1:HOXA1:HOXA2:HOXA5:PSMA2:GATA3:SUFU:HOXB6:FBXW7:FGF6:BMP5:HES1:ID2:PRRX1:ERRFI1:HDAC1:ARID1A:HOXB5:TEK:INHBA:SOX4:SOX9:FOXP2:FOXA1:KRAS:HNF1A:TBX3:MYC:TFAP2A:SIX3:CLTC:SMAD4:EPHA2:MEIS1:EGFR:KDM6A:NOTCH1:TTN:BRAF:NEUROD1:ELF3:TGFBR2:CITED2:COL1A2:TNFRSF11B:NAB2:CTNNB1:EFNA1:CDH2:PTEN:RPL38:HRAS:SMAD2:JUN:GATA2:SETD2:MED12:PTCH1:NF2:ARID2:NF1:HOXC4:HNF1B	GO:0009887  |  animal organ morphogenesis	NA	5.49e-16	NA
475	CDS	Pancan-no-skin-melanoma-lymph	DLX6:BAX:JAG1:AXIN1:SALL1:EYA1:HOXA1:HOXA2:GATA3:PRRX1:HDAC1:ARID1A:SOX9:TFAP2A:SIX3:EPHA2:MEIS1:CTNNB1:RPL38:GATA2:NF1	GO:0090596  |  sensory organ morphogenesis	NA	0.00126	NA
476	CDS	Pancan-no-skin-melanoma-lymph	BAX:FBXW7:FOXA1:EPHA2:EGFR:NOTCH1:ELF3:TGFBR2:PTCH1	GO:0022612  |  gland morphogenesis	NA	7.15e-05	NA
477	CDS	Pancan-no-skin-melanoma-lymph	BAX:EPHA2:ELF3:TGFBR2:PTCH1	GO:0060443  |  mammary gland morphogenesis	NA	0.0167	NA
478	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:AXIN1:EYA1:HOXA1:HOXA2:HOXA5:HOXB6:FGF6:PRRX1:HOXB5:TEK:SOX9:TFAP2A:TGFBR2:NAB2:CTNNB1:SMAD2:SETD2:MED12	GO:0048705  |  skeletal system morphogenesis	NA	0.000593	NA
479	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:EYA1:GATA3:SUFU:BMP5:HES1:TEK:SOX4:SOX9:TBX3:SMAD4:KDM6A:NOTCH1:TTN:TGFBR2:CITED2:CTNNB1:EFNA1:JUN:PTCH1:ARID2	GO:0003007  |  heart morphogenesis	NA	1.36e-05	NA
480	CDS	Pancan-no-skin-melanoma-lymph	HES1:SMAD4:NOTCH1:CTNNB1	GO:0061323  |  cell proliferation involved in heart morphogenesis	NA	0.000185	NA
481	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:CTNNB1	GO:0003263  |  cardioblast proliferation	NA	0.00361	NA
482	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:GATA3:BMP5:HES1:TEK:SOX4:TBX3:SMAD4:NOTCH1:TGFBR2:CITED2	GO:0003206  |  cardiac chamber morphogenesis	NA	0.019	NA
483	CDS	Pancan-no-skin-melanoma-lymph	RHOA:BAX:PSMC5:PSMA2:GATA3:FBXW7:HES1:SOX9:FOXP2:MYC:SMAD4:NOTCH1:TGFBR2:CITED2:TNFRSF11B:CTNNB1:MED12:HNF1B	GO:2000027  |  regulation of organ morphogenesis	NA	0.000116	NA
484	CDS	Pancan-no-skin-melanoma-lymph	HES1:SMAD4:NOTCH1:TGFBR2:CTNNB1	GO:2000826  |  regulation of heart morphogenesis	NA	2.78e-05	NA
485	CDS	Pancan-no-skin-melanoma-lymph	HES1:SMAD4:NOTCH1:CTNNB1	GO:2000136  |  regulation of cell proliferation involved in heart morphogenesis	NA	0.000144	NA
486	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:CTNNB1	GO:0003264  |  regulation of cardioblast proliferation	NA	0.00361	NA
487	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:CTNNB1	GO:0003266  |  regulation of secondary heart field cardioblast proliferation	NA	0.00253	NA
488	CDS	Pancan-no-skin-melanoma-lymph	ASB4:SPI1:RHOA:MEF2C:BAX:JAG1:EYA1:HOXA1:HOXA5:SUFU:FBXW7:FGF6:HES1:SNX17:NFE2L2:PRRX1:ERRFI1:ARID1A:TEK:EPC1:PIK3CA:SOX4:TBX3:KLF4:AKT1:EPHA2:RHOB:MEIS1:RASA1:NOTCH1:TCF7L2:TGFBR2:TERT:COL1A2:PRKCB:CTNNB1:EFNA1:CLIC4:CDH2:PTEN:JUN:SETD2:ARID2:TCF4:NF1	GO:0001944  |  vasculature development	NA	7.3e-09	NA
489	CDS	Pancan-no-skin-melanoma-lymph	ASB4:SPI1:RHOA:MEF2C:BAX:JAG1:EYA1:HOXA1:HOXA5:SUFU:FGF6:HES1:SNX17:NFE2L2:PRRX1:ARID1A:TEK:PIK3CA:SOX4:TBX3:KLF4:AKT1:EPHA2:RHOB:MEIS1:RASA1:NOTCH1:TCF7L2:TGFBR2:TERT:COL1A2:PRKCB:CTNNB1:EFNA1:CLIC4:CDH2:PTEN:JUN:SETD2:ARID2:TCF4:NF1	GO:0001568  |  blood vessel development	NA	9.94e-08	NA
490	CDS	Pancan-no-skin-melanoma-lymph	JAG1:EYA1:HOXA1:SUFU:HES1:SNX17:PRRX1:SOX4:NOTCH1:ARID2:NF1	GO:0060840  |  artery development	NA	0.00375	NA
491	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:DYNLL1:ZMYND8:STMN2:WASL:EZH2:GATA3:CPEB3:IL2:BMP5:NFE2L2:PRRX1:BCL11A:YWHAH:APC:EPHA7:KLF4:AKT1:EPHA2:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:ARPC2:TSC1:B2M:EFNA1:IL1RAPL1:PTEN:HRAS:NR2F1:SLITRK1:RELN:CCDC151	GO:0031344  |  regulation of cell projection organization	NA	1.19e-06	NA
492	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:DYNLL1:ZMYND8:STMN2:WASL:EZH2:GATA3:CPEB3:IL2:BMP5:NFE2L2:PRRX1:BCL11A:YWHAH:APC:EPHA7:KLF4:AKT1:EPHA2:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:ARPC2:TSC1:B2M:EFNA1:IL1RAPL1:PTEN:HRAS:NR2F1:SLITRK1:RELN:CCDC151	GO:0120035  |  regulation of plasma membrane bounded cell projection organization	NA	7.09e-07	NA
493	CDS	Pancan-no-skin-melanoma-lymph	DLX6:TP63:KEAP1:MEF2C:ATRX:HNRNPH3:JAG1:SALL1:EYA1:HOXA5:EZH2:GATA3:CDKN1B:BMP5:HES1:ID2:ERRFI1:HDAC1:HOXB5:CDKN1A:SOX4:SOX9:FOXA1:HAPLN2:MEN1:TBX3:KLF4:SIX3:ASCL1:SMAD4:AKT1:EPHA2:NOTCH1:NEUROD1:ELF3:CTNNB1:CLIC4:CDH2:JUP:JUN:PTCH1:NF2:AKR1C3:TXNIP:HNF1B	GO:0030855  |  epithelial cell differentiation	NA	5.04e-06	NA
494	CDS	Pancan-no-skin-melanoma-lymph	TP63:JAG1:HOXA5:BMP5:HES1:CDKN1A:SOX4:FOXA1:MEN1:ASCL1:NOTCH1:NEUROD1:CDH2	GO:0002065  |  columnar/cuboidal epithelial cell differentiation	NA	0.00243	NA
495	CDS	Pancan-no-skin-melanoma-lymph	TP63:HOXA5:BMP5:HES1:FOXA1:MEN1:ASCL1:NOTCH1:NEUROD1	GO:0002067  |  glandular epithelial cell differentiation	NA	0.00277	NA
496	CDS	Pancan-no-skin-melanoma-lymph	FOXA1:NOTCH1:CTNNB1	GO:0060742  |  epithelial cell differentiation involved in prostate gland development	NA	0.0112	NA
497	CDS	Pancan-no-skin-melanoma-lymph	EP300:EYA1:HOXA5:PTGES3:HES1:ERRFI1:SOX9:FOXP2:FOXA1:KRAS:ASCL1:EGFR:NOTCH1:TGFBR2:CTNNB1:SMAD2	GO:0030323  |  respiratory tube development	NA	0.00239	NA
498	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:HOXA5:EZH2:PHOX2B:BMP5:HES1:SOX9:FOXA1:HNF1A:MYC:SMAD4:NOTCH1:TCF7L2:TGFBR2:CITED2:CTNNB1:EFNA1:PTEN:SMAD2:HNRNPAB	GO:0060485  |  mesenchyme development	NA	0.00052	NA
499	CDS	Pancan-no-skin-melanoma-lymph	BMP5:SOX9:HNF1A:MYC:SMAD4:NOTCH1:TGFBR2:SMAD2	GO:0072132  |  mesenchyme morphogenesis	NA	0.0241	NA
500	CDS	Pancan-no-skin-melanoma-lymph	DLX6:CASP8:MEF2C:AXIN1:SALL1:EYA1:HOXA1:HOXA2:HOXA5:GATA3:SUFU:HOXB6:BMP5:HES1:ID2:BIRC6:PRRX1:ARID1A:HOXB5:SOX9:TBX3:TFAP2A:SIX3:AKT1:EPHA2:EGFR:KDM6A:NOTCH1:NEUROD1:EN1:TGFBR2:CITED2:CTNNB1:EFNA1:RPL38:SMAD2:SETD2:MED12:PTCH1:ARID2:HOXC4:HNF1B	GO:0048568  |  embryonic organ development	NA	3.75e-13	NA
501	CDS	Pancan-no-skin-melanoma-lymph	DLX6:MEF2C:AXIN1:SALL1:EYA1:HOXA1:HOXA2:HOXA5:GATA3:SUFU:HOXB6:HES1:ID2:PRRX1:ARID1A:HOXB5:SOX9:TBX3:TFAP2A:SIX3:EPHA2:KDM6A:NOTCH1:NEUROD1:TGFBR2:CTNNB1:EFNA1:RPL38:SMAD2:SETD2:MED12:HOXC4:HNF1B	GO:0048562  |  embryonic organ morphogenesis	NA	1.23e-11	NA
502	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:AXIN1:EYA1:HOXA1:HOXA2:HOXA5:HOXB6:PRRX1:HOXB5:TFAP2A:TGFBR2:CTNNB1:SMAD2:SETD2:MED12	GO:0048704  |  embryonic skeletal system morphogenesis	NA	3.77e-06	NA
503	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:HOXA1:HOXA2:PRRX1:TFAP2A:TGFBR2:SMAD2:SETD2:MED12	GO:0048701  |  embryonic cranial skeleton morphogenesis	NA	0.00148	NA
504	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:BAX:JAG1:SALL1:EYA1:GATA3:HES1:TEK:SOX4:SOX9:EPHA7:MYC:TFAP2A:SMAD4:NOTCH1:TSC1:CTNNB1:SMAD2:PTCH1:NF1:HNF1B	GO:0001822  |  kidney development	NA	0.00061	NA
505	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:SOX9:SMAD4:CTNNB1:SMAD2:PTCH1:HNF1B	GO:0001823  |  mesonephros development	NA	0.0083	NA
506	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:SMAD4:CTNNB1:PTCH1:NF1	GO:0001656  |  metanephros development	NA	0.00135	NA
507	CDS	Pancan-no-skin-melanoma-lymph	SALL1:EYA1:GATA3:HES1:SOX4:SOX9:MYC:SMAD4:CTNNB1:PTCH1:HNF1B	GO:0060993  |  kidney morphogenesis	NA	0.00855	NA
508	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:EP300:MYH14:PHOX2B:BCL9:FOXP2:RB1:NOTCH1:COPS2:CTNNB1:ZBTB18:NF1	GO:0060538  |  skeletal muscle organ development	NA	0.00449	NA
509	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:EP300:MYH14:PHOX2B:BCL9:FOXP2:RB1:NOTCH1:COPS2:CTNNB1:ZBTB18:NF1	GO:0007519  |  skeletal muscle tissue development	NA	0.00279	NA
510	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:USP9X:KRAS:VHL:RB1:SMAD4:PIK3R1:NOTCH1:BRAF:ARHGAP35:CTNNB1:PTEN:NRAS	GO:0000902  |  cell morphogenesis	NA	0.000544	NA
511	CDS	Pancan-no-skin-melanoma-lymph	JARID2:CASP8:SPI1:RHOA:CBFB:MEF2C:BAX:EP300:JAG1:HOXA5:GATA3:IL2:IL4:HES1:NFE2L2:RPL22:TEK:ACVR2A:INHBA:NCKAP1L:SOX4:IRF1:MEIS2:ACVR1B:KLF4:MYC:RB1:EPHA2:MEIS1:PIK3R1:CDKN2A:NOTCH1:ATM:ZFP36L2:BRAF:FCER1G:TGFBR2:CARTPT:CITED2:TSC1:B2M:CTNNB1:THEMIS:JUN:PTPN11:GATA2:NF1:HIST1H4C:LDB1:HIST1H4K:HIST1H4E	GO:0048534  |  hematopoietic or lymphoid organ development	NA	5.24e-08	NA
512	CDS	Pancan-no-skin-melanoma-lymph	CASP8:CBFB:GATA3:HES1:NFE2L2:RPL22:ACVR2A:RB1:PIK3R1:CDKN2A:NOTCH1:ATM:ZFP36L2:BRAF:TGFBR2:B2M:CTNNB1:NF1	GO:0030097  |  hemopoiesis	NA	3.63e-08	NA
513	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:ATM:BRAF:CTNNB1	GO:0048538  |  thymus development	NA	0.00103	NA
514	CDS	Pancan-no-skin-melanoma-lymph	BAX:GATA3:BCL11A:PIK3CA:USP9X:KRAS:SMAD4:PIK3R1:EGFR:NOTCH1:BRAF:ARHGAP35:PTEN:HRAS:NRAS	GO:0032990  |  cell part morphogenesis	NA	0.000723	NA
515	CDS	Pancan-no-skin-melanoma-lymph	GATA3:BCL11A:PIK3CA:USP9X:KRAS:SMAD4:PIK3R1:EGFR:NOTCH1:BRAF:ARHGAP35:PTEN:HRAS:NRAS	GO:0048858  |  cell projection morphogenesis	NA	0.00299	NA
516	CDS	Pancan-no-skin-melanoma-lymph	GATA3:BCL11A:PIK3CA:USP9X:KRAS:SMAD4:PIK3R1:EGFR:NOTCH1:BRAF:ARHGAP35:PTEN:HRAS:NRAS	GO:0120039  |  plasma membrane bounded cell projection morphogenesis	NA	0.00276	NA
517	CDS	Pancan-no-skin-melanoma-lymph	EP300:EYA1:HOXA5:PTGES3:HES1:ERRFI1:SOX9:FOXP2:FOXA1:KRAS:ASCL1:EGFR:NOTCH1:TGFBR2:CTNNB1:SMAD2	GO:0030324  |  lung development	NA	0.00176	NA
518	CDS	Pancan-no-skin-melanoma-lymph	FOXA1:KRAS:TGFBR2:CTNNB1	GO:0060425  |  lung morphogenesis	NA	0.0339	NA
519	CDS	Pancan-no-skin-melanoma-lymph	EYA1:HOXA5:ERRFI1:SOX9:FOXP2:FOXA1:ASCL1	GO:0060428  |  lung epithelium development	NA	0.0348	NA
520	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:SALL1:EYA1:GATA3:HES1:TEK:SOX9:MYC:SMAD4:NOTCH1:CTNNB1:PTCH1:HNF1B	GO:0072006  |  nephron development	NA	0.00188	NA
521	CDS	Pancan-no-skin-melanoma-lymph	SALL4:JAG1:SALL1:GATA3:SUFU:BMP5:HES1:SNX17:SOX4:TBX3:SMAD4:NOTCH1:TGFBR2:CITED2	GO:0003279  |  cardiac septum development	NA	2.78e-05	NA
522	CDS	Pancan-no-skin-melanoma-lymph	SALL4:SALL1:GATA3:SUFU:HES1:SOX4:TBX3:SMAD4:NOTCH1:TGFBR2:CITED2	GO:0003281  |  ventricular septum development	NA	0.00014	NA
523	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:TGFBR2:CTNNB1	GO:0048645  |  animal organ formation	NA	0.0276	NA
524	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:INHBA:TFAP2A:EGFR:JUN	GO:0061029  |  eyelid development in camera-type eye	NA	0.0157	NA
525	CDS	Pancan-no-skin-melanoma-lymph	ASB4:SPI1:RHOA:BAX:JAG1:EYA1:HOXA1:HOXA5:FGF6:HES1:NFE2L2:PRRX1:TEK:PIK3CA:SOX4:KLF4:EPHA2:RHOB:MEIS1:RASA1:NOTCH1:TGFBR2:TERT:PRKCB:CTNNB1:EFNA1:CLIC4:CDH2:PTEN:JUN:SETD2:ARID2:TCF4:NF1	GO:0048514  |  blood vessel morphogenesis	NA	3.76e-05	NA
526	CDS	Pancan-no-skin-melanoma-lymph	JAG1:EYA1:HOXA1:HES1:PRRX1:SOX4:NOTCH1:ARID2:NF1	GO:0048844  |  artery morphogenesis	NA	0.0152	NA
527	CDS	Pancan-no-skin-melanoma-lymph	NOTCH1:SETD2:ARID2	GO:0060977  |  coronary vasculature morphogenesis	NA	0.00857	NA
528	CDS	Pancan-no-skin-melanoma-lymph	BAX:GATA3:ID2:AKT1:EPHA2:PTCH1	GO:0061180  |  mammary gland epithelium development	NA	0.0463	NA
529	CDS	Pancan-no-skin-melanoma-lymph	BAX:GATA3:ID2:EPHA2	GO:0033598  |  mammary gland epithelial cell proliferation	NA	0.0489	NA
530	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:RHOA:NDE1:MEF2C:ATRX:BAX:AXIN1:SALL1:EZH2:YWHAE:HES1:ARID1A:INHBA:FOXP2:KRAS:TBX3:SIX3:ASCL1:EGFR:NOTCH1:ARHGAP35:CHRNB2:NEUROD1:NEUROD6:TSC1:CTNNB1:CDH2:PTEN:GATA2:SETD2:PCDH9:NF2:RELN:NF1	GO:0030900  |  forebrain development	NA	5.87e-09	NA
531	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:GATA3:SOX4:SOX9:SMAD4:NOTCH1:TGFBR2:EFNA1	GO:0003179  |  heart valve morphogenesis	NA	7.78e-05	NA
532	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:HSPA5:RHOA:ACTB:DYNLL1:YWHAE:HES1:YWHAH:TAF1:EN1:CTNNB1	GO:0030901  |  midbrain development	NA	0.0138	NA
533	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:HOXA2:EZH2:PHOX2B:BMP5:HES1:FOXP2:ASCL1:NEUROD1:EN1:CTNNB1:SPTBN2:PTPN11:GATA2:LDB1:HNF1B	GO:0030902  |  hindbrain development	NA	0.000839	NA
534	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:NOTCH1:CTNNB1:PTCH1:HNF1B	GO:0061326  |  renal tubule development	NA	0.000152	NA
535	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:CTNNB1:PTCH1:HNF1B	GO:0061333  |  renal tubule morphogenesis	NA	0.00105	NA
536	CDS	Pancan-no-skin-melanoma-lymph	RHOA:EZH2:PHOX2B:HES1:SOX4:SOX9:KRAS:SRSF1:ASCL1:AKT1:EGFR:NOTCH1:DRD3:TERT:NAB2:CTNNB1:CDH2:PTEN:PTPN11:IDH2:MED12:NF2:RELN:NF1	GO:0042063  |  gliogenesis	NA	6.21e-06	NA
537	CDS	Pancan-no-skin-melanoma-lymph	RHOA:PHOX2B:HES1:SOX4:SOX9:KRAS:SRSF1:ASCL1:AKT1:EGFR:NOTCH1:DRD3:NAB2:CTNNB1:CDH2:PTEN:PTPN11:MED12:RELN:NF1	GO:0010001  |  glial cell differentiation	NA	9.18e-06	NA
538	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:CTNNB1:PTEN:NF1	GO:0048709  |  oligodendrocyte differentiation	NA	0.0179	NA
539	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:CTNNB1:NF1	GO:0048713  |  regulation of oligodendrocyte differentiation	NA	0.00604	NA
540	CDS	Pancan-no-skin-melanoma-lymph	HES1:KRAS:EGFR:NOTCH1:NF1	GO:0048708  |  astrocyte differentiation	NA	0.0103	NA
541	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:USP9X:KRAS:RB1:SMAD4:PIK3R1:NOTCH1:BRAF:ARHGAP35:CTNNB1:PTEN:NRAS	GO:0000904  |  cell morphogenesis involved in differentiation	NA	5.77e-05	NA
542	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:DYNLL1:ZMYND8:STMN2:WASL:EZH2:CPEB3:IL2:BMP5:NFE2L2:APC:BRAF:ARHGAP35:SHANK1:ARPC2:IL1RAPL1:HRAS:SLITRK1:RELN	GO:0031346  |  positive regulation of cell projection organization	NA	0.0489	NA
543	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:SALL1:EYA1:GATA3:HES1:SOX9:EPHA7:MYC:SMAD4:NOTCH1:CTNNB1:SMAD2:PTCH1:HNF1B	GO:0072073  |  kidney epithelium development	NA	0.000493	NA
544	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:NOTCH1:CTNNB1:PTCH1:HNF1B	GO:0072009  |  nephron epithelium development	NA	0.00071	NA
545	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:NOTCH1:CTNNB1:PTCH1:HNF1B	GO:0072080  |  nephron tubule development	NA	0.000102	NA
546	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:SOX9:SMAD4:CTNNB1:SMAD2:PTCH1:HNF1B	GO:0072163  |  mesonephric epithelium development	NA	0.00613	NA
547	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:SOX9:SMAD4:CTNNB1:SMAD2:PTCH1:HNF1B	GO:0072164  |  mesonephric tubule development	NA	0.00613	NA
548	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:SOX9:SMAD4:CTNNB1:SMAD2:PTCH1:HNF1B	GO:0001657  |  ureteric bud development	NA	0.00567	NA
549	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:JAG1:EYA1:STMN2:HOXA2:EZH2:GATA3:CPEB3:SUFU:PHOX2B:IL2:DDX6:BMP5:HES1:EIF4G1:ID2:NFE2L2:PRRX1:BCL11A:SOX9:GDF5:YWHAH:FOXA1:CASZ1:EPHA7:KLF4:SIX3:ASCL1:AKT1:MEIS1:NOTCH1:DRD3:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:BRINP3:NEUROD1:TERT:TSC1:B2M:CTNNB1:EFNA1:IL1RAPL1:YWHAG:CDH2:PTEN:NR2F1:SLITRK1:GATA2:IDH2:NF2:RELN:TCF4:NF1:LRRTM3	GO:0051960  |  regulation of nervous system development	NA	2.34e-14	NA
550	CDS	Pancan-no-skin-melanoma-lymph	RHOA:JAG1:STMN2:HOXA2:SUFU:PHOX2B:DDX6:HES1:ID2:BCL11A:SOX9:YWHAH:EPHA7:SIX3:ASCL1:MEIS1:NOTCH1:DRD3:TERT:TSC1:B2M:CTNNB1:EFNA1:PTEN:NR2F1:IDH2:NF1	GO:0051961  |  negative regulation of nervous system development	NA	5.17e-08	NA
551	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:STMN2:EZH2:CPEB3:PHOX2B:IL2:BMP5:HES1:EIF4G1:NFE2L2:GDF5:FOXA1:ASCL1:NOTCH1:BRAF:ARHGAP35:SHANK1:BRINP3:NEUROD1:CTNNB1:IL1RAPL1:PTEN:SLITRK1:GATA2:RELN:TCF4:LRRTM3	GO:0051962  |  positive regulation of nervous system development	NA	0.000376	NA
552	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:RHOA:NDE1:MEF2C:BAX:SALL1:EZH2:YWHAE:HES1:INHBA:FOXP2:SIX3:ASCL1:EGFR:NEUROD1:NEUROD6:TSC1:CTNNB1:CDH2:PTEN:NF2:RELN:NF1	GO:0021537  |  telencephalon development	NA	2.42e-05	NA
553	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:HES1:TBX3:SMAD4:TGFBR2:CITED2:CTNNB1:JUN	GO:0003151  |  outflow tract morphogenesis	NA	0.00261	NA
554	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:BAX:EZH2:YWHAE:TBX3:NEUROD1:NEUROD6:TSC1:PTEN:NF2:RELN:NF1	GO:0021761  |  limbic system development	NA	0.0148	NA
555	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TGFBR2	GO:0003181  |  atrioventricular valve morphogenesis	NA	0.0394	NA
556	CDS	Pancan-no-skin-melanoma-lymph	HES1:FOXA1:SMAD4:NOTCH1:TGFBR2:CTNNB1:PTEN	GO:0048762  |  mesenchymal cell differentiation	NA	0.00175	NA
557	CDS	Pancan-no-skin-melanoma-lymph	FOXA1:SMAD4:NOTCH1:TGFBR2:CTNNB1:PTEN	GO:0001837  |  epithelial to mesenchymal transition	NA	0.00334	NA
558	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:RHOA:TP63:JAG1:AXIN1:STMN2:HOXA2:HOXA5:EZH2:GATA3:SUFU:PHOX2B:IL2:DDX6:BMP5:IL4:HES1:ID2:NFE2L2:BCL11A:INHBA:IRF1:SOX9:GDF5:YWHAH:FOXA1:KRAS:MEN1:MEIS2:TBX3:EPHA7:MYC:SIX3:ASCL1:TOB1:SMAD4:MEIS1:PIK3R1:EGFR:CDKN2A:NOTCH1:DRD3:ZFP36L2:CARTPT:TERT:TSC1:B2M:CTNNB1:EFNA1:PTEN:NR2F1:SUZ12:GATA2:IDH2:PTCH1:NF1:HIST1H4C:LDB1:TWIST2:HIST1H4K:HIST1H4E	GO:0045596  |  negative regulation of cell differentiation	NA	7.53e-18	NA
559	CDS	Pancan-no-skin-melanoma-lymph	HES1:NFE2L2:NOTCH1:ZFP36L2	GO:2000737  |  negative regulation of stem cell differentiation	NA	0.000185	NA
560	CDS	Pancan-no-skin-melanoma-lymph	RHOA:JAG1:STMN2:HOXA2:PHOX2B:DDX6:HES1:ID2:BCL11A:SOX9:YWHAH:EPHA7:SIX3:ASCL1:SMAD4:MEIS1:NOTCH1:DRD3:TERT:TSC1:B2M:CTNNB1:EFNA1:PTEN:NR2F1:IDH2:NF1	GO:0010721  |  negative regulation of cell development	NA	2.65e-07	NA
561	CDS	Pancan-no-skin-melanoma-lymph	HOXA2:SUFU:MEN1:TOB1:NOTCH1:PTCH1	GO:0045668  |  negative regulation of osteoblast differentiation	NA	0.0029	NA
562	CDS	Pancan-no-skin-melanoma-lymph	SUFU:HES1:ARID1A:FOXA1:EPHA2:KDM6A:NOTCH1:ARHGAP35:EN1:TSC1:SETD2:PTCH1:NF1	GO:0021915  |  neural tube development	NA	6.11e-07	NA
563	CDS	Pancan-no-skin-melanoma-lymph	SUFU:HES1:FOXA1:EN1:PTCH1	GO:0021532  |  neural tube patterning	NA	0.0274	NA
564	CDS	Pancan-no-skin-melanoma-lymph	SALL4:SUFU:BMP5:ARID1A:SOX4:KDM6A:ARHGAP35:TSC1:SETD2:MED12:PTCH1	GO:0001841  |  neural tube formation	NA	0.0345	NA
565	CDS	Pancan-no-skin-melanoma-lymph	SUFU:ARID1A:KDM6A:ARHGAP35:TSC1:SETD2:PTCH1	GO:0014020  |  primary neural tube formation	NA	0.0215	NA
566	CDS	Pancan-no-skin-melanoma-lymph	SUFU:ARID1A:KDM6A:ARHGAP35:TSC1:SETD2:PTCH1	GO:0001843  |  neural tube closure	NA	0.013	NA
567	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:RHOA:NDE1:MEF2C:BAX:YWHAE:FOXP2:ASCL1:EGFR:NEUROD1:NEUROD6:TSC1:CTNNB1:CDH2:PTEN:NF2:RELN:NF1	GO:0021543  |  pallium development	NA	1.03e-05	NA
568	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:RHOA:NDE1:BAX:YWHAE:FOXP2:ASCL1:EGFR:TSC1:CTNNB1:CDH2:RELN:NF1	GO:0021987  |  cerebral cortex development	NA	0.000628	NA
569	CDS	Pancan-no-skin-melanoma-lymph	PIK3R1:RASA1:CDKN2A:PTEN:NF1	GO:0001953  |  negative regulation of cell-matrix adhesion	NA	0.00481	NA
570	CDS	Pancan-no-skin-melanoma-lymph	CASP8:CDKN1B:HES1:ARID1A:MEN1:EGFR:SETD2	GO:0001890  |  placenta development	NA	0.00387	NA
571	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:ASB4:HSPA5:CASP8:RHOA:TP63:MEF2C:ZMYND8:JAG1:STMN2:HOXA5:EZH2:GATA3:CPEB3:PHOX2B:IL2:BMP5:IL4:HES1:EIF4G1:NFE2L2:ACVR2A:INHBA:NCKAP1L:SOX9:GDF5:FOXA1:VHL:ACVR1B:ASCL1:RB1:SMAD4:AKT1:NOTCH1:TCF7L2:BRAF:ARHGAP35:SHANK1:BRINP3:DDR2:NEUROD1:ARPC2:TGFBR2:TERT:CTNNB1:IL1RAPL1:CDH2:PTEN:SMAD2:RPS6KA3:JUN:SLITRK1:GATA2:PTCH1:NF2:RELN:TCF4	GO:0045597  |  positive regulation of cell differentiation	NA	2.8e-09	NA
572	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:HES1:ARID1A:SMAD4:EGFR:NOTCH1	GO:0035051  |  cardiocyte differentiation	NA	0.0293	NA
573	CDS	Pancan-no-skin-melanoma-lymph	NFE2L2:PIK3CA:TERT:CTNNB1:PTEN:SETD2	GO:0001525  |  angiogenesis	NA	0.0067	NA
574	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:SUFU:HES1:TBX3:NOTCH1:TGFBR2:CITED2:CTNNB1	GO:0035050  |  embryonic heart tube development	NA	0.0442	NA
575	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:NOTCH1:CTNNB1:PTCH1	GO:0061005  |  cell differentiation involved in kidney development	NA	0.00283	NA
576	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TGFBR2:CTNNB1:PTEN	GO:0048634  |  regulation of muscle organ development	NA	0.0298	NA
577	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TGFBR2:CTNNB1:PTEN	GO:0016202  |  regulation of striated muscle tissue development	NA	0.0246	NA
578	CDS	Pancan-no-skin-melanoma-lymph	SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:CTNNB1:PTCH1:HNF1B	GO:0072028  |  nephron morphogenesis	NA	0.00886	NA
579	CDS	Pancan-no-skin-melanoma-lymph	SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:CTNNB1:PTCH1:HNF1B	GO:0072088  |  nephron epithelium morphogenesis	NA	0.00694	NA
580	CDS	Pancan-no-skin-melanoma-lymph	SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:CTNNB1:PTCH1:HNF1B	GO:0072078  |  nephron tubule morphogenesis	NA	0.00539	NA
581	CDS	Pancan-no-skin-melanoma-lymph	SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:CTNNB1:PTCH1:HNF1B	GO:0072171  |  mesonephric tubule morphogenesis	NA	0.00179	NA
582	CDS	Pancan-no-skin-melanoma-lymph	SALL1:EYA1:GATA3:HES1:SOX9:MYC:SMAD4:CTNNB1:PTCH1:HNF1B	GO:0060675  |  ureteric bud morphogenesis	NA	0.00154	NA
583	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:BCL11A:CDKN1A:SMARCA4:TP53:SMAD4:CDKN2A:SERTAD1:DDX3X	GO:0030308  |  negative regulation of cell growth	NA	0.000159	NA
584	CDS	Pancan-no-skin-melanoma-lymph	JAG1:BMP5:HES1:SOX4:TBX3:SMAD4:NOTCH1:TGFBR2:CITED2	GO:0060411  |  cardiac septum morphogenesis	NA	0.0141	NA
585	CDS	Pancan-no-skin-melanoma-lymph	HES1:SMAD4:NOTCH1:TGFBR2	GO:0060412  |  ventricular septum morphogenesis	NA	0.00346	NA
586	CDS	Pancan-no-skin-melanoma-lymph	CASP8:SPI1:CBFB:MEF2C:EP300:JAG1:HOXA5:GATA3:IL4:ACVR2A:INHBA:NCKAP1L:MEIS2:ACVR1B:MYC:RB1:EPHA2:MEIS1:PIK3R1:TGFBR2:CARTPT:B2M:CTNNB1:JUN:PTPN11:GATA2:NF1:HIST1H4C:LDB1:HIST1H4K:HIST1H4E	GO:0030099  |  myeloid cell differentiation	NA	1.9e-07	NA
587	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:EP300:MEIS1:PTPN11:GATA2:HIST1H4C:HIST1H4K:HIST1H4E	GO:0030219  |  megakaryocyte differentiation	NA	0.0371	NA
588	CDS	Pancan-no-skin-melanoma-lymph	SPI1:HOXA5:GATA3:ACVR2A:INHBA:NCKAP1L:ACVR1B:RB1:B2M:GATA2:LDB1	GO:0030218  |  erythrocyte differentiation	NA	0.042	NA
589	CDS	Pancan-no-skin-melanoma-lymph	CASP8:CBFB:GATA3:RPL22:RB1:PIK3R1:CDKN2A:ATM:ZFP36L2:BRAF:TGFBR2:B2M:CTNNB1:NF1	GO:0002521  |  leukocyte differentiation	NA	7.75e-07	NA
590	CDS	Pancan-no-skin-melanoma-lymph	CASP8:GATA3:RB1:PIK3R1:TGFBR2:CTNNB1:NF1	GO:0002573  |  myeloid leukocyte differentiation	NA	0.00728	NA
591	CDS	Pancan-no-skin-melanoma-lymph	CBFB:GATA3:RPL22:PIK3R1:CDKN2A:ATM:ZFP36L2:BRAF:TGFBR2:B2M:CTNNB1	GO:0030098  |  lymphocyte differentiation	NA	1.85e-05	NA
592	CDS	Pancan-no-skin-melanoma-lymph	GATA3:RPL22:CDKN2A:ZFP36L2:BRAF:TGFBR2:B2M:CTNNB1	GO:0030217  |  T cell differentiation	NA	0.00168	NA
593	CDS	Pancan-no-skin-melanoma-lymph	GATA3:CDKN2A:ZFP36L2:B2M:CTNNB1	GO:0033077  |  T cell differentiation in thymus	NA	0.00894	NA
594	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:SALL1:SUFU:PHOX2B:HES1:INHBA:SOX4:ASCL1:ARHGAP35:CHRNB2:CTNNB1:PTEN:GATA2:PTCH1:LDB1	GO:0021953  |  central nervous system neuron differentiation	NA	0.0391	NA
595	CDS	Pancan-no-skin-melanoma-lymph	EYA1:HOXA5:SOX9:FOXA1:ASCL1:CTNNB1	GO:0060479  |  lung cell differentiation	NA	0.0325	NA
596	CDS	Pancan-no-skin-melanoma-lymph	EPHA2:RASA1:NOTCH1:TGFBR2:CTNNB1:SETD2	GO:0001570  |  vasculogenesis	NA	0.024	NA
597	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:STMN2:EZH2:CPEB3:PHOX2B:IL2:BMP5:HES1:EIF4G1:NFE2L2:GDF5:FOXA1:ASCL1:NOTCH1:BRAF:ARHGAP35:SHANK1:BRINP3:NEUROD1:ARPC2:CTNNB1:IL1RAPL1:PTEN:SLITRK1:GATA2:RELN:TCF4	GO:0010720  |  positive regulation of cell development	NA	0.000433	NA
598	CDS	Pancan-no-skin-melanoma-lymph	CASP8:SPI1:RHOA:MEF2C:JAG1:HOXA5:GATA3:IL2:IL4:HES1:NFE2L2:ACVR2A:INHBA:NCKAP1L:IRF1:MEIS2:ACVR1B:MYC:RB1:MEIS1:PIK3R1:CDKN2A:NOTCH1:ZFP36L2:BRAF:TGFBR2:CARTPT:B2M:CTNNB1:JUN:GATA2:NF1:HIST1H4C:LDB1:HIST1H4K:HIST1H4E	GO:1903706  |  regulation of hemopoiesis	NA	4.24e-11	NA
599	CDS	Pancan-no-skin-melanoma-lymph	CASP8:GATA3:RB1:PIK3R1:CDKN2A:ZFP36L2:BRAF:TGFBR2:CTNNB1:NF1	GO:1902105  |  regulation of leukocyte differentiation	NA	2.02e-05	NA
600	CDS	Pancan-no-skin-melanoma-lymph	CASP8:RHOA:JAG1:HOXA5:GATA3:IL2:IL4:ACVR2A:INHBA:NCKAP1L:ACVR1B:RB1:TGFBR2:JUN:GATA2	GO:1903708  |  positive regulation of hemopoiesis	NA	0.0276	NA
601	CDS	Pancan-no-skin-melanoma-lymph	HES1:NFE2L2:NOTCH1	GO:1901532  |  regulation of hematopoietic progenitor cell differentiation	NA	0.0203	NA
602	CDS	Pancan-no-skin-melanoma-lymph	CSDE1:ATRX:BAX:GATA3:ACVR2A:SOX9:NR5A1:SMAD4:CITED2:AKR1C3:HOXA10	GO:0008584  |  male gonad development	NA	0.0409	NA
603	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:GATA3:CDKN1B:HES1:NOTCH1:CTNNB1:PTCH1	GO:0030856  |  regulation of epithelial cell differentiation	NA	0.000827	NA
604	CDS	Pancan-no-skin-melanoma-lymph	TP63:JAG1:EZH2:HES1:SOX9:TBX3:NOTCH1:CTNNB1	GO:0030857  |  negative regulation of epithelial cell differentiation	NA	0.00654	NA
605	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:HSPA5:ARID1B:RHOA:MEF2C:ZMYND8:STMN2:HOXA2:WASL:EZH2:GATA3:CPEB3:PHOX2B:IL2:BMP5:HES1:NFE2L2:PRRX1:BCL11A:PIK3CA:SLC12A5:USP9X:NRN1:YWHAH:KRAS:EPHA7:KLF4:RB1:SMAD4:AKT1:PIK3R1:EGFR:NOTCH1:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:ELAVL4:TSC1:B2M:EFNA1:IL1RAPL1:PTEN:SPTBN2:HRAS:NR2F1:JUN:SLITRK1:PTPN11:RELN:NRAS	GO:0031175  |  neuron projection development	NA	5.18e-08	NA
606	CDS	Pancan-no-skin-melanoma-lymph	GATA3:PIK3CA:USP9X:KRAS:SMAD4:PIK3R1:NOTCH1:BRAF:ARHGAP35:PTEN:NRAS	GO:0061564  |  axon development	NA	0.000833	NA
607	CDS	Pancan-no-skin-melanoma-lymph	GATA3:BCL11A:PIK3CA:USP9X:KRAS:SMAD4:PIK3R1:EGFR:NOTCH1:BRAF:ARHGAP35:PTEN:HRAS:NRAS	GO:0048812  |  neuron projection morphogenesis	NA	0.00217	NA
608	CDS	Pancan-no-skin-melanoma-lymph	GATA3:PIK3CA:KRAS:SMAD4:PIK3R1:ARHGAP35:NRAS	GO:0097485  |  neuron projection guidance	NA	0.0268	NA
609	CDS	Pancan-no-skin-melanoma-lymph	ARID1B:RHOA:MEF2C:ZMYND8:WASL:EZH2:CPEB3:IL2:BMP5:BCL11A:SLC12A5:YWHAH:TNIK:CHRNB2:SHANK1:ELAVL4:EFNA1:IL1RAPL1:PTEN:RELN	GO:0016358  |  dendrite development	NA	0.000124	NA
610	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:PIK3CA:USP9X:KRAS:RB1:SMAD4:PIK3R1:NOTCH1:BRAF:ARHGAP35:PTEN:NRAS	GO:0048667  |  cell morphogenesis involved in neuron differentiation	NA	3.77e-05	NA
611	CDS	Pancan-no-skin-melanoma-lymph	GATA3:PIK3CA:USP9X:KRAS:SMAD4:PIK3R1:NOTCH1:BRAF:ARHGAP35:PTEN:NRAS	GO:0007409  |  axonogenesis	NA	0.000374	NA
612	CDS	Pancan-no-skin-melanoma-lymph	GATA3:PIK3CA:KRAS:SMAD4:PIK3R1:ARHGAP35:NRAS	GO:0007411  |  axon guidance	NA	0.0253	NA
613	CDS	Pancan-no-skin-melanoma-lymph	FOXA1:SMAD4:NOTCH1:TGFBR2:CTNNB1:PTEN	GO:0010717  |  regulation of epithelial to mesenchymal transition	NA	0.000159	NA
614	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TCF7L2:TGFBR2:CTNNB1:SMAD2	GO:0010718  |  positive regulation of epithelial to mesenchymal transition	NA	0.00171	NA
615	CDS	Pancan-no-skin-melanoma-lymph	HOXA5:IL2:IL4:HES1:NFE2L2:INHBA:IRF1:MEIS2:MYC:MEIS1:PIK3R1:CDKN2A:NOTCH1:CARTPT:CTNNB1:GATA2:NF1:HIST1H4C:LDB1:HIST1H4K:HIST1H4E	GO:1903707  |  negative regulation of hemopoiesis	NA	1.72e-08	NA
616	CDS	Pancan-no-skin-melanoma-lymph	IL2:IL4:INHBA:IRF1:MYC:PIK3R1:CDKN2A:CARTPT:CTNNB1:GATA2:NF1	GO:1902106  |  negative regulation of leukocyte differentiation	NA	0.0162	NA
617	CDS	Pancan-no-skin-melanoma-lymph	HES1:NFE2L2:NOTCH1	GO:1901533  |  negative regulation of hematopoietic progenitor cell differentiation	NA	0.00106	NA
618	CDS	Pancan-no-skin-melanoma-lymph	ARID1B:MEF2C:ZMYND8:WASL:CPEB3:IL2:SLC12A5:SHANK1:EFNA1:PTEN:RELN	GO:0060996  |  dendritic spine development	NA	0.00684	NA
619	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:JAG1:EYA1:STMN2:HOXA2:EZH2:GATA3:CPEB3:PHOX2B:IL2:DDX6:BMP5:HES1:EIF4G1:ID2:NFE2L2:PRRX1:BCL11A:SOX9:GDF5:YWHAH:FOXA1:CASZ1:EPHA7:KLF4:SIX3:ASCL1:AKT1:MEIS1:NOTCH1:DRD3:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:BRINP3:NEUROD1:TERT:TSC1:B2M:CTNNB1:EFNA1:IL1RAPL1:YWHAG:CDH2:PTEN:NR2F1:SLITRK1:GATA2:IDH2:NF2:RELN:TCF4:NF1	GO:0050767  |  regulation of neurogenesis	NA	1.31e-15	NA
620	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:JAG1:EYA1:STMN2:HOXA2:EZH2:GATA3:CPEB3:PHOX2B:IL2:DDX6:BMP5:HES1:EIF4G1:ID2:NFE2L2:PRRX1:BCL11A:SOX9:GDF5:YWHAH:FOXA1:CASZ1:EPHA7:KLF4:SIX3:ASCL1:AKT1:MEIS1:NOTCH1:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:BRINP3:NEUROD1:TSC1:B2M:EFNA1:IL1RAPL1:YWHAG:PTEN:NR2F1:SLITRK1:GATA2:RELN:TCF4	GO:0045664  |  regulation of neuron differentiation	NA	6.59e-15	NA
621	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:STMN2:EZH2:GATA3:CPEB3:IL2:BMP5:NFE2L2:PRRX1:BCL11A:YWHAH:EPHA7:KLF4:AKT1:TNIK:CHODL:BRAF:ARHGAP35:CHRNB2:SHANK1:TSC1:B2M:EFNA1:IL1RAPL1:PTEN:NR2F1:SLITRK1:RELN	GO:0010975  |  regulation of neuron projection development	NA	3.97e-06	NA
622	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:ZMYND8:EZH2:CPEB3:IL2:BMP5:BCL11A:YWHAH:TNIK:CHRNB2:SHANK1:EFNA1:IL1RAPL1:PTEN:RELN	GO:0050773  |  regulation of dendrite development	NA	0.000117	NA
623	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:TERT:CTNNB1:NF1	GO:0014013  |  regulation of gliogenesis	NA	0.0387	NA
624	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:STMN2:EZH2:CPEB3:PHOX2B:IL2:BMP5:HES1:EIF4G1:NFE2L2:GDF5:FOXA1:ASCL1:NOTCH1:BRAF:ARHGAP35:SHANK1:BRINP3:NEUROD1:CTNNB1:IL1RAPL1:PTEN:SLITRK1:GATA2:RELN:TCF4	GO:0050769  |  positive regulation of neurogenesis	NA	5.63e-05	NA
625	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:RHOA:MEF2C:ZMYND8:STMN2:EZH2:CPEB3:PHOX2B:IL2:BMP5:EIF4G1:NFE2L2:GDF5:FOXA1:ASCL1:BRAF:ARHGAP35:SHANK1:BRINP3:NEUROD1:IL1RAPL1:PTEN:SLITRK1:GATA2:RELN:TCF4	GO:0045666  |  positive regulation of neuron differentiation	NA	3.08e-05	NA
626	CDS	Pancan-no-skin-melanoma-lymph	RHOA:JAG1:STMN2:HOXA2:PHOX2B:DDX6:HES1:ID2:BCL11A:SOX9:YWHAH:EPHA7:SIX3:ASCL1:MEIS1:NOTCH1:DRD3:TERT:TSC1:B2M:CTNNB1:EFNA1:PTEN:NR2F1:IDH2:NF1	GO:0050768  |  negative regulation of neurogenesis	NA	5.2e-08	NA
627	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:TERT:CTNNB1:NF1	GO:0014014  |  negative regulation of gliogenesis	NA	0.000318	NA
628	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:CTNNB1:NF1	GO:0045686  |  negative regulation of glial cell differentiation	NA	0.00155	NA
629	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:CTNNB1:NF1	GO:0048715  |  negative regulation of oligodendrocyte differentiation	NA	5.58e-05	NA
630	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:TERT	GO:0060253  |  negative regulation of glial cell proliferation	NA	0.0109	NA
631	CDS	Pancan-no-skin-melanoma-lymph	RHOA:JAG1:STMN2:HOXA2:PHOX2B:DDX6:HES1:ID2:BCL11A:SOX9:YWHAH:EPHA7:SIX3:ASCL1:MEIS1:NOTCH1:TSC1:B2M:EFNA1:PTEN:NR2F1	GO:0045665  |  negative regulation of neuron differentiation	NA	2.78e-06	NA
632	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:IL2:IL4:NCKAP1L:CDKN1A:IL21:CDKN2A:ATM:CHRNB2	GO:0030888  |  regulation of B cell proliferation	NA	0.0124	NA
633	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:IL2:IL4:NCKAP1L:CDKN1A:IL21:CHRNB2	GO:0030890  |  positive regulation of B cell proliferation	NA	0.0492	NA
634	CDS	Pancan-no-skin-melanoma-lymph	CASP8:SPI1:MEF2C:JAG1:HOXA5:IL4:ACVR2A:INHBA:NCKAP1L:MEIS2:ACVR1B:MYC:RB1:MEIS1:PIK3R1:CARTPT:B2M:CTNNB1:JUN:GATA2:NF1:HIST1H4C:LDB1:HIST1H4K:HIST1H4E	GO:0045637  |  regulation of myeloid cell differentiation	NA	5.45e-09	NA
635	CDS	Pancan-no-skin-melanoma-lymph	SPI1:HOXA5:ACVR2A:INHBA:NCKAP1L:ACVR1B:B2M:GATA2:LDB1	GO:0045646  |  regulation of erythrocyte differentiation	NA	0.000568	NA
636	CDS	Pancan-no-skin-melanoma-lymph	HOXA5:IL4:INHBA:MEIS2:MYC:MEIS1:PIK3R1:CARTPT:CTNNB1:GATA2:NF1:HIST1H4C:LDB1:HIST1H4K:HIST1H4E	GO:0045638  |  negative regulation of myeloid cell differentiation	NA	2.98e-06	NA
637	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:NOTCH1:CTNNB1	GO:0060768  |  regulation of epithelial cell proliferation involved in prostate gland development	NA	0.00967	NA
638	CDS	Pancan-no-skin-melanoma-lymph	IL4:INHBA:MYC:PIK3R1:CARTPT:CTNNB1:GATA2:NF1	GO:0002762  |  negative regulation of myeloid leukocyte differentiation	NA	0.0225	NA
639	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RHOA:MEF2C:SMARCB1:CDKN1B:PIK3CA:SOX4:SMARCA4:MEN1:HNF1A:TCF7L2:NEUROD1:TGFBR2:PRKCB:PTEN:SMAD2:TXNIP:HNF1B	GO:0009743  |  response to carbohydrate	NA	0.00918	NA
640	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:SMARCB1:CDKN1B:PIK3CA:SMARCA4:MEN1:TCF7L2:NEUROD1:TGFBR2:PTEN:SMAD2:HNF1B	GO:0034284  |  response to monosaccharide	NA	0.0229	NA
641	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:SMARCB1:CDKN1B:PIK3CA:SMARCA4:MEN1:TCF7L2:NEUROD1:TGFBR2:PTEN:SMAD2:HNF1B	GO:0009746  |  response to hexose	NA	0.0163	NA
642	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:SMARCB1:CDKN1B:PIK3CA:SMARCA4:MEN1:TCF7L2:NEUROD1:TGFBR2:PTEN:SMAD2:HNF1B	GO:0009749  |  response to glucose	NA	0.0122	NA
643	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:MAP2K4:RHOA:MEF2C:EP300:JAG1:AXIN1:MYH14:PRKAR1A:PHOX2B:FGF6:HES1:BCL9:ARID1A:EPC1:SOX9:FOXP2:KRAS:TBX3:RB1:SMAD4:AKT1:NOTCH1:TCF7L2:MBNL1:TTN:TGFBR2:TSC1:COPS2:CTNNB1:CDH2:PTEN:ZBTB18:NF1	GO:0061061  |  muscle structure development	NA	1.53e-06	NA
644	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:MAP2K4:MEF2C:JAG1:AXIN1:PRKAR1A:FGF6:HES1:BCL9:ARID1A:EPC1:SOX9:KRAS:TBX3:RB1:SMAD4:AKT1:NOTCH1:TCF7L2:MBNL1:TTN:TSC1:CTNNB1:CDH2	GO:0042692  |  muscle cell differentiation	NA	5.37e-05	NA
645	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:FGF6:SOX9:TBX3:RB1:NOTCH1:TCF7L2:MBNL1	GO:0045445  |  myoblast differentiation	NA	0.0269	NA
646	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:ARID1A:KRAS:RB1:SMAD4	GO:0051146  |  striated muscle cell differentiation	NA	0.0378	NA
647	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1A:TP53:EGFR:CTNNB1:NF1	GO:0048144  |  fibroblast proliferation	NA	0.00914	NA
648	CDS	Pancan-no-skin-melanoma-lymph	BAX:CDKN1A:TP53:EGFR:CTNNB1:NF1	GO:0048145  |  regulation of fibroblast proliferation	NA	0.00854	NA
649	CDS	Pancan-no-skin-melanoma-lymph	TP63:GATA3:PHOX2B:HES1:SOX4:TFAP2A:ASCL1:CTNNB1:NF1	GO:0048483  |  autonomic nervous system development	NA	0.00124	NA
650	CDS	Pancan-no-skin-melanoma-lymph	TP63:GATA3:PHOX2B:SOX4:ASCL1:CTNNB1:NF1	GO:0048485  |  sympathetic nervous system development	NA	0.000783	NA
651	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:AXIN1:MEN1:AKT1:EGFR:HRAS:PTPN1:DAXX	GO:0046328  |  regulation of JNK cascade	NA	0.0305	NA
652	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:HSPA5:NUCKS1:MEF2C:BAX:EP300:GATA3:HES1:MEN1:KLF4:RB1:SMAD4:TAF1:TCF7L2:NEUROD1:TERT:B2M:CTNNB1:SMAD2:JUN	GO:0051098  |  regulation of binding	NA	0.000252	NA
653	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:MEF2C:EP300:GATA3:HES1:EIF4G1:MEN1:KLF4:RB1:RPL11:TAF1:TCF7L2:NEUROD1:TERT:B2M:CTNNB1	GO:0051099  |  positive regulation of binding	NA	0.000122	NA
654	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TGFBR2	GO:0003272  |  endocardial cushion formation	NA	0.0455	NA
655	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:NOTCH1:TGFBR2	GO:0003198  |  epithelial to mesenchymal transition involved in endocardial cushion formation	NA	0.0203	NA
656	CDS	Pancan-no-skin-melanoma-lymph	CASP8:MAP2K4:RHOA:MAP3K1:IRF1:SOX9:GDF5:FOXP2:MEIS2:XPA:AKT1:EGFR:TTN:TGFBR2:CITED2:JUP:JUN:PTPN11:PTCH1	GO:0009612  |  response to mechanical stimulus	NA	6.68e-06	NA
657	CDS	Pancan-no-skin-melanoma-lymph	GATA3:KLF4:RB1:NEUROD1:CTNNB1	GO:2000679  |  positive regulation of transcription regulatory region DNA binding	NA	0.0413	NA
658	CDS	Pancan-no-skin-melanoma-lymph	CASP8:MAP2K4:MAP3K1:NFE2L2:CDKN1A:TP53:ARHGAP35:ALB	GO:0071496  |  cellular response to external stimulus	NA	0.00105	NA
659	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:JARID2:SPI1:UBE2D1:TP63:CIC:MEF2C:XPO1:ATRX:EP300:CHD8:ZMYND8:SALL4:CTCF:AXIN1:SALL1:HOXA2:EZH2:GATA3:CPEB3:SUFU:PHF12:CNOT2:CHD4:PRDM13:DUSP22:HES1:PRRX1:HDAC1:SFPQ:ARID1A:DNMT3A:BCL11A:EPC1:SPOP:HNRNPA2B1:USP9X:SOX9:SMARCA4:FOXP2:FOXA1:MEN1:VHL:MEIS2:HNF1A:TBX3:KLF4:MYC:TFAP2A:ASCL1:RB1:TP53:SMAD4:NOTCH1:TCF7L2:MTA2:DRD3:ARHGAP35:NFIA:EN1:RYBP:CITED2:COPS2:CTNNB1:IRF2:EFNA1:CNBP:CXXC5:SMAD2:NR2F1:JUN:SUZ12:ZBTB7A:GATA2:ZBTB18:RBM10:PTCH1:HEXIM1:HIST1H1C:TCF4:DMBX1:NELFE:TXNIP:HNF1B	GO:0000122  |  negative regulation of transcription from RNA polymerase II promoter	NA	1.18e-30	NA
660	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:HDAC1:CTNNB1	GO:0071696  |  ectodermal placode development	NA	0.032	NA
661	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:HDAC1:CTNNB1	GO:0071697  |  ectodermal placode morphogenesis	NA	0.0261	NA
662	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:HDAC1:CTNNB1	GO:0060788  |  ectodermal placode formation	NA	0.0261	NA
663	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:HSPA5:MAP2K4:NUCKS1:MEF2C:SMARCB1:HOXA2:PRKAR1A:CPEB4:NFE2L2:DNMT3A:BCL11A:PIK3CA:SOX9:SMARCA4:MEN1:APC:KLF4:TP53:AKT1:PIK3R1:EGFR:TAF1:ZFP36L2:UBR1:CHRNB2:NEUROD1:COL1A2:TSC1:PRDX2:CTNNB1:PTEN:JUP:NPAS4:JUN:PTPN11:PTCH1:PTPN1:ATP6V1G2	GO:1901701  |  cellular response to oxygen-containing compound	NA	2.47e-05	NA
664	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:HSPA5:NUCKS1:MEF2C:ATRX:PRKAR1A:CPEB4:DNMT3A:BCL11A:PIK3CA:HNRNPA2B1:SOX9:DGCR8:MEN1:APC:KLF4:TP53:AKT1:PIK3R1:EGFR:TAF1:UBR1:CHRNB2:TERT:COL1A2:TSC1:CTNNB1:PTEN:JUP:SMAD2:PTPN11:PTPN1:DAXX:ATP6V1G2	GO:1901699  |  cellular response to nitrogen compound	NA	2.2e-08	NA
665	CDS	Pancan-no-skin-melanoma-lymph	CASP8:RHOA:TP63:MEF2C:EP300:HOXA2:EZH2:PTGES3:CDKN1B:CNOT2:ERRFI1:HDAC1:ARID1A:DNMT3A:INHBA:CDKN1A:SOX9:SMARCA4:YWHAH:FOXP2:FOXA1:KRAS:KLF4:NR5A1:IDH1:ASCL1:RB1:AKT1:EGFR:TAF1:NOTCH1:ZFP36L2:BRINP3:TGFBR2:TNFRSF11B:KMT2D:CTNNB1:PTEN:NPAS4:NR1D2:SMAD2:NR2F1:RPS6KA3:JUN:GATA2:MED12:PTCH1:AKR1C3:ESRRG:DAXX:TXNIP	GO:0033993  |  response to lipid	NA	6.03e-06	NA
666	CDS	Pancan-no-skin-melanoma-lymph	RHOA:TP63:MEF2C:EP300:HOXA2:PTGES3:CNOT2:ERRFI1:HDAC1:ARID1A:INHBA:SOX9:SMARCA4:YWHAH:FOXA1:KLF4:NR5A1:RB1:AKT1:EGFR:TAF1:ZFP36L2:BRINP3:KMT2D:CTNNB1:NPAS4:NR1D2:NR2F1:MED12:PTCH1:AKR1C3:ESRRG:DAXX	GO:0071396  |  cellular response to lipid	NA	0.0011	NA
667	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:HSPA5:CASP8:RHOA:MEF2C:EP300:PTGES3:CDKN1B:CNOT2:HDAC1:ARID1A:DNMT3A:TEK:HNRNPA2B1:CDKN1A:SMARCA4:DGCR8:FOXP2:FOXA1:KRAS:KLF4:NR5A1:IDH1:RB1:AKT1:EGFR:TAF1:NOTCH1:ZFP36L2:BRAF:CHRNB2:SRSF2:TGFBR2:TERT:KMT2D:CTNNB1:PTEN:JUP:NPAS4:SMAD2:NR2F1:JUN:POLR2A:MED12:PTCH1:AKR1C3:DAXX:HNF1B	GO:0014070  |  response to organic cyclic compound	NA	7e-10	NA
668	CDS	Pancan-no-skin-melanoma-lymph	CASP8:CDKN1B:FOXA1:EGFR:CTNNB1:PTEN:PTCH1	GO:0032355  |  response to estradiol	NA	0.00145	NA
669	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:SPI1:RHOA:GATA3:IL2:IL4:DNMT3A:INHBA:KLF4:AKT1:SETDB1:DRD3:CHRNB2:TGFBR2:CTNNB1:PTEN:JUP:SMAD2:PTCH1:GRIN2B	GO:0097305  |  response to alcohol	NA	2.27e-05	NA
670	CDS	Pancan-no-skin-melanoma-lymph	CDH1:SPI1:DNMT3A:INHBA:KLF4:AKT1:CTNNB1:PTEN:JUP:PTCH1	GO:0097306  |  cellular response to alcohol	NA	0.00124	NA
671	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:HSPA5:RHOA:NUCKS1:MEF2C:PSMC5:JAG1:PRKAR1A:CDKN1B:SRSF9:CPEB4:AUP1:NFE2L2:SRSF4:DNMT3A:BCL11A:TEK:PIK3CA:CDKN1A:SOX9:MEN1:APC:OS9:KLF4:TP53:AKT1:PIK3R1:EGFR:TAF1:NOTCH1:BRAF:UBR1:CHRNB2:COL1A2:TSC1:CTNNB1:PTEN:GPRC6A:JUP:JUN:PTPN11:PTPN1:ATP6V1G2	GO:0010243  |  response to organonitrogen compound	NA	3.22e-08	NA
672	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CTNNB1:JUP	GO:0071680  |  response to indole-3-methanol	NA	0.0267	NA
673	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:JAG1:CDKN1B:SRSF4:PIK3CA:MEN1:APC:TP53:AKT1:PIK3R1:NOTCH1:BRAF:TSC1:PTEN:PTPN1:ATP6V1G2	GO:1901652  |  response to peptide	NA	0.0049	NA
674	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:HSPA5:NUCKS1:MEF2C:CPEB3:PRKAR1A:CPEB4:ERRFI1:DNMT3A:BCL11A:PIK3CA:SOX9:MEN1:APC:KLF4:TP53:AKT1:PIK3R1:EGFR:TAF1:FCER1G:UBR1:COL1A2:TSC1:CTNNB1:YWHAG:PTEN:JUP:PTPN11:PTPN1:ATP6V1G2	GO:0071417  |  cellular response to organonitrogen compound	NA	1.08e-05	NA
675	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:HDAC1:ARID1A:PIK3CA:CDKN1A:SMARCA4:FOXA1:H3F3B:KRAS:MEN1:APC:IDH1:RB1:PIK3R1:EGFR:NOTCH1:ZFP36L2:BRAF:TGFBR2:KMT2D:CTNNB1:PTEN	GO:0009725  |  response to hormone	NA	7.37e-10	NA
676	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:ARID1A:CDKN1A:SMARCA4:FOXA1:KRAS:IDH1:RB1:EGFR:NOTCH1:ZFP36L2:TGFBR2:KMT2D:CTNNB1	GO:0048545  |  response to steroid hormone	NA	3.6e-07	NA
677	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:HSPA5:CASP8:RHOA:MEF2C:EP300:PTGES3:CDKN1B:CNOT2:HDAC1:ARID1A:HNRNPA2B1:SMARCA4:DGCR8:FOXA1:KLF4:NR5A1:RB1:AKT1:EGFR:TAF1:ZFP36L2:TERT:KMT2D:CTNNB1:JUP:NPAS4:SMAD2:NR2F1:MED12:PTCH1:AKR1C3:DAXX	GO:0071407  |  cellular response to organic cyclic compound	NA	5e-08	NA
678	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CTNNB1:JUP	GO:0071681  |  cellular response to indole-3-methanol	NA	0.0267	NA
679	CDS	Pancan-no-skin-melanoma-lymph	RHOA:NUCKS1:TP63:MEF2C:EP300:PRKAR1A:PTGES3:CNOT2:ERRFI1:HDAC1:ARID1A:PIK3CA:INHBA:SMARCA4:YWHAH:FOXA1:MEN1:APC:NR5A1:CPEB2:RB1:AKT1:PIK3R1:EGFR:TAF1:NOTCH1:ZFP36L2:CTSS:TSC1:PRKCB:KMT2D:CTNNB1:YWHAG:PTEN:NPAS4:NR1D2:NR2F1:JUN:PTPN11:MED12:AKR1C3:PTPN1:ESRRG:DAXX:ATP6V1G2	GO:0032870  |  cellular response to hormone stimulus	NA	2.31e-08	NA
680	CDS	Pancan-no-skin-melanoma-lymph	RHOA:TP63:EP300:PTGES3:CNOT2:ERRFI1:HDAC1:ARID1A:SMARCA4:YWHAH:FOXA1:NR5A1:RB1:EGFR:TAF1:ZFP36L2:KMT2D:CTNNB1:NPAS4:NR1D2:NR2F1:MED12:AKR1C3:ESRRG:DAXX	GO:0071383  |  cellular response to steroid hormone stimulus	NA	1.41e-06	NA
681	CDS	Pancan-no-skin-melanoma-lymph	PUM2:CASP8:RHOA:TP63:EP300:EZH2:PTGES3:CNOT2:HDAC1:ARID1A:SMARCA4:YWHAH:FOXA1:NR5A1:RB1:TAF1:CITED2:KMT2D:CTNNB1:NR1D2:NR2F1:ALOXE3:MED12:AKR1C3:ESRRG:DAXX	GO:0030522  |  intracellular receptor signaling pathway	NA	3.2e-06	NA
682	CDS	Pancan-no-skin-melanoma-lymph	RHOA:TP63:EP300:PTGES3:CNOT2:HDAC1:ARID1A:SMARCA4:YWHAH:FOXA1:NR5A1:RB1:TAF1:KMT2D:CTNNB1:NR1D2:NR2F1:PTPN11:MED12:ESRRG:DAXX	GO:0009755  |  hormone-mediated signaling pathway	NA	0.000148	NA
683	CDS	Pancan-no-skin-melanoma-lymph	RHOA:TP63:EP300:PTGES3:CNOT2:HDAC1:ARID1A:SMARCA4:YWHAH:FOXA1:NR5A1:RB1:TAF1:KMT2D:CTNNB1:NR1D2:NR2F1:MED12:ESRRG:DAXX	GO:0043401  |  steroid hormone mediated signaling pathway	NA	2.9e-05	NA
684	CDS	Pancan-no-skin-melanoma-lymph	RHOA:EP300:PTGES3:CNOT2:HDAC1:ARID1A:SMARCA4:FOXA1:RB1:TAF1:KMT2D:CTNNB1:MED12:DAXX	GO:0030518  |  intracellular steroid hormone receptor signaling pathway	NA	4.18e-05	NA
685	CDS	Pancan-no-skin-melanoma-lymph	RHOA:EP300:HDAC1:ARID1A:SMARCA4:RB1:TAF1:CTNNB1:MED12:DAXX	GO:0030521  |  androgen receptor signaling pathway	NA	0.000169	NA
686	CDS	Pancan-no-skin-melanoma-lymph	RHOA:EP300:CNOT2:HDAC1:SMARCA4:FOXA1:TAF1:KMT2D	GO:0033143  |  regulation of intracellular steroid hormone receptor signaling pathway	NA	0.0277	NA
687	CDS	Pancan-no-skin-melanoma-lymph	ACVR2A:KRAS:AKT1:EGFR:TERT	GO:0050999  |  regulation of nitric-oxide synthase activity	NA	0.0456	NA
688	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:KRAS:VHL:CDKN2A:TERT:PTEN	GO:0031647  |  regulation of protein stability	NA	4.62e-05	NA
689	CDS	Pancan-no-skin-melanoma-lymph	EP300:FBXW7:PTGES3:RPL5:CDKN1A:SOX4:VHL:RPL11:ATP1B1:PIK3R1:TAF1:CDKN2A:SYVN1:TSC1:PTEN	GO:0050821  |  protein stabilization	NA	0.000915	NA
690	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:XPO1:CHMP4B:STMN2:WASL:CDKN1B:TEK:NCKAP1L:APC:CLTC:SMAD4:PIK3R1:RASA1:BRAF:ARHGAP35:TAOK1:SHANK1:ARPC2:TSC1:CTNNB1:CLIC4:SPTBN2:HRAS:PPM1E:NF2:ARPC1A	GO:0051493  |  regulation of cytoskeleton organization	NA	0.0072	NA
691	CDS	Pancan-no-skin-melanoma-lymph	CDH1:SALL1:HOXA5:GATA3:BMP5:HES1:SOX4:SOX9:MEN1:HNF1A:NR5A1:SIX3:ASCL1:AKT1:BRAF:NEUROD1:CITED2:GATA2:NF1	GO:0035270  |  endocrine system development	NA	3.16e-07	NA
692	CDS	Pancan-no-skin-melanoma-lymph	BMP5:HES1:SOX4:SOX9:MEN1:MEIS2:HNF1A:AKT1:TCF7L2:NEUROD1:CTNNB1:SMAD2	GO:0031016  |  pancreas development	NA	0.000262	NA
693	CDS	Pancan-no-skin-melanoma-lymph	BMP5:HES1:SOX4:SOX9:MEN1:HNF1A:AKT1:NEUROD1	GO:0031018  |  endocrine pancreas development	NA	0.0172	NA
694	CDS	Pancan-no-skin-melanoma-lymph	ACTB:KEAP1:AXIN1:GATA3:USP9X:APC:TP53:SMAD4:BAP1:PTEN	GO:0070646  |  protein modification by small protein removal	NA	0.00103	NA
695	CDS	Pancan-no-skin-melanoma-lymph	ACTB:KEAP1:AXIN1:GATA3:USP9X:APC:TP53:SMAD4:BAP1:PTEN	GO:0016579  |  protein deubiquitination	NA	0.000633	NA
696	CDS	Pancan-no-skin-melanoma-lymph	RHOA:PIP5K1B:GATA3:FGF6:TEK:PIK3CA:SOX9:KLF4:TP53:AKT1:PIK3R1:EGFR:PTEN:PTPN11:RELN:NF1	GO:0048017  |  inositol lipid-mediated signaling	NA	0.00247	NA
697	CDS	Pancan-no-skin-melanoma-lymph	RHOA:PIP5K1B:GATA3:FGF6:TEK:PIK3CA:SOX9:KLF4:TP53:AKT1:PIK3R1:EGFR:PTEN:PTPN11:RELN:NF1	GO:0048015  |  phosphatidylinositol-mediated signaling	NA	0.00204	NA
698	CDS	Pancan-no-skin-melanoma-lymph	PIP5K1B:GATA3:FGF6:TEK:PIK3CA:SOX9:KLF4:AKT1:PIK3R1:EGFR:PTEN:PTPN11:RELN:NF1	GO:0014065  |  phosphatidylinositol 3-kinase signaling	NA	0.00364	NA
699	CDS	Pancan-no-skin-melanoma-lymph	PIP5K1B:FGF6:TEK:PIK3CA:SOX9:KLF4:AKT1:PIK3R1:EGFR:PTEN:PTPN11:RELN	GO:0014066  |  regulation of phosphatidylinositol 3-kinase signaling	NA	0.0296	NA
700	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:CDH1:CASP8:RHOA:NUCKS1:XPO1:BAX:DYNLL1:SMARCB1:EP300:CHMP4B:SMC3:FBXW7:DDX6:RPL22:HDAC1:RPL5:SMARCA4:RB1:TP53:EPHA2:PIK3R1:TAF1:NOTCH1:EIF4A2:NFIA:ALB:B2M:AP1G1:CTNNB1:RPL38:JUN:POLR2A:DAXX:NELFE:HLA-A:DDX3X	GO:0044419  |  interspecies interaction between organisms	NA	1.94e-05	NA
701	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:CDH1:CASP8:RHOA:NUCKS1:XPO1:BAX:DYNLL1:SMARCB1:EP300:CHMP4B:SMC3:FBXW7:DDX6:RPL22:HDAC1:RPL5:SMARCA4:RB1:TP53:EPHA2:PIK3R1:TAF1:NOTCH1:EIF4A2:NFIA:ALB:B2M:AP1G1:CTNNB1:RPL38:JUN:POLR2A:DAXX:NELFE:HLA-A:DDX3X	GO:0044403  |  symbiosis, encompassing mutualism through parasitism	NA	9.5e-06	NA
702	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:CASP8:RHOA:NUCKS1:XPO1:BAX:DYNLL1:SMARCB1:EP300:CHMP4B:SMC3:FBXW7:DDX6:RPL22:HDAC1:RPL5:SMARCA4:RB1:TP53:EPHA2:PIK3R1:TAF1:NOTCH1:EIF4A2:NFIA:B2M:AP1G1:RPL38:JUN:POLR2A:DAXX:NELFE:HLA-A:DDX3X	GO:0016032  |  viral process	NA	6.66e-05	NA
703	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:NUCKS1:SMARCB1:EP300:RPL22:HDAC1:RPL5:SMARCA4:RPL38:JUN:POLR2A:NELFE	GO:0019080  |  viral gene expression	NA	0.0159	NA
704	CDS	Pancan-no-skin-melanoma-lymph	CASP8:NUCKS1:SMARCB1:EP300:SMC3:HDAC1:SMARCA4:ALB:JUN	GO:0051817  |  modification of morphology or physiology of other organism involved in symbiotic interaction	NA	0.0271	NA
705	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:HDAC1:SMARCA4:JUN	GO:0052312  |  modulation of transcription in other organism involved in symbiotic interaction	NA	0.00254	NA
706	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:HDAC1:SMARCA4:JUN	GO:0052472  |  modulation by host of symbiont transcription	NA	0.00197	NA
707	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:CHMP4B:SMC3:SMARCA4:ACVR1B:NOTCH1:JUN:POLR2A:NELFE:DDX3X	GO:0043902  |  positive regulation of multi-organism process	NA	0.00974	NA
708	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:CHMP4B:SMC3:SMARCA4:NOTCH1:JUN:POLR2A:NELFE:DDX3X	GO:0048524  |  positive regulation of viral process	NA	0.000532	NA
709	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:HDAC1:SMARCA4:JUN:POLR2A:NELFE	GO:0046782  |  regulation of viral transcription	NA	0.00354	NA
710	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:HDAC1:SMARCA4:JUN	GO:0043921  |  modulation by host of viral transcription	NA	0.00197	NA
711	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:SMARCA4:JUN:POLR2A:NELFE	GO:0050434  |  positive regulation of viral transcription	NA	0.00187	NA
712	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:SMARCB1:EP300:SMARCA4:JUN	GO:0043923  |  positive regulation by host of viral transcription	NA	0.00292	NA
713	CDS	Pancan-no-skin-melanoma-lymph	CDH1:FBXW7:ARID1A:APC:CDKN2A:CTNNB1:ARID2	GO:0022411  |  cellular component disassembly	NA	0.0132	NA
714	CDS	Pancan-no-skin-melanoma-lymph	BAX:EP300:DBP:CASP2:EZH2:ID2:HDAC1:SFPQ:INHBA:HNRNPR:KDM5C:NR5A1:SIX3:TP53:SMAD4:EGFR:ATM:DRD3:HNRNPU:CHRNB2:CARTPT:PTEN:NR1D2:JUN:HNF1B	GO:0048511  |  rhythmic process	NA	0.000165	NA
715	CDS	Pancan-no-skin-melanoma-lymph	EP300:DBP:EZH2:ID2:HDAC1:SFPQ:HNRNPR:SIX3:TP53:EGFR:DRD3:HNRNPU:CHRNB2:CARTPT:PTEN:NR1D2:JUN:HNF1B	GO:0007623  |  circadian rhythm	NA	0.00126	NA
716	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CSDE1:PTBP1:HNRNPH3:ESRP1:CPEB3:DDX6:CNOT2:SRSF9:EIF4G1:SF3B1:SRSF7:RPL22:SRSF4:SFPQ:RPL5:HNRNPA2B1:APOBEC2:HNRNPR:RBM42:SRSF1:SLTM:MBNL2:TOB1:RPL11:ATM:ZFP36L2:MBNL1:HNRNPU:EIF4A2:U2AF1:SRSF2:ELAVL4:TRA2A:HNRNPK:PCF11:HNRNPA3:RPL38:POLR2A:RBM10:PRPF39:DXO:NELFE	GO:0016071  |  mRNA metabolic process	NA	5.38e-07	NA
717	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:HNRNPR:RBM42:MBNL2:TOB1:ZFP36L2:SRSF2:RBM10:NELFE	GO:1903311  |  regulation of mRNA metabolic process	NA	2.11e-05	NA
718	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:RBM42:TOB1:RBM10:NELFE	GO:1903312  |  negative regulation of mRNA metabolic process	NA	1.52e-06	NA
719	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:HNRNPH3:ESRP1:CPEB3:SRSF9:SF3B1:SRSF7:RPL22:SRSF4:SFPQ:ERI3:RPL5:HNRNPA2B1:APOBEC2:HNRNPR:RBM42:DGCR8:SRSF1:SLTM:MBNL2:RPL11:INTS7:PIK3R1:EGFR:CDKN2A:MBNL1:U2AF1:SRSF2:ELAVL4:TERT:TRA2A:PCF11:HNRNPA3:RPL38:SMAD2:POLR2A:RBM10:PRPF39:NELFE	GO:0006396  |  RNA processing	NA	0.00204	NA
720	CDS	Pancan-no-skin-melanoma-lymph	CPEB3:SRSF9:SRSF7:SRSF4:ERI3:SRSF1:INTS7:U2AF1:SRSF2:PCF11:NELFE	GO:0031123  |  RNA 3'-end processing	NA	0.0283	NA
721	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:HNRNPH3:ESRP1:SRSF9:SF3B1:SRSF7:SRSF4:SFPQ:HNRNPA2B1:HNRNPR:RBM42:MBNL2:PIK3R1:U2AF1:SRSF2:PCF11:HNRNPA3:POLR2A:RBM10:PRPF39	GO:0008380  |  RNA splicing	NA	0.000448	NA
722	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:HNRNPH3:SRSF9:SF3B1:SRSF7:SRSF4:SFPQ:HNRNPA2B1:HNRNPR:RBM42:MBNL2:U2AF1:SRSF2:PCF11:HNRNPA3:POLR2A:RBM10:PRPF39	GO:0000375  |  RNA splicing, via transesterification reactions	NA	0.000144	NA
723	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:HNRNPH3:SRSF9:SF3B1:SRSF7:SRSF4:SFPQ:HNRNPA2B1:HNRNPR:RBM42:MBNL2:U2AF1:SRSF2:PCF11:HNRNPA3:POLR2A:RBM10:PRPF39	GO:0000377  |  RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	NA	0.000124	NA
724	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:ESRP1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:RBM42:SRSF1:MBNL2:PIK3R1:MBNL1:SRSF2:HNRNPK:POLR2A:RBM10	GO:0043484  |  regulation of RNA splicing	NA	1.79e-05	NA
725	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:HNRNPH3:ESRP1:CPEB3:SRSF9:SF3B1:SRSF7:SRSF4:SFPQ:HNRNPA2B1:APOBEC2:HNRNPR:RBM42:SRSF1:SLTM:MBNL2:MBNL1:HNRNPU:U2AF1:SRSF2:ELAVL4:TRA2A:HNRNPK:PCF11:HNRNPA3:POLR2A:RBM10:PRPF39:NELFE	GO:0006397  |  mRNA processing	NA	0.000254	NA
726	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:PTBP1:HNRNPH3:SRSF9:SF3B1:SRSF7:SRSF4:SFPQ:HNRNPA2B1:HNRNPR:RBM42:MBNL2:U2AF1:SRSF2:PCF11:HNRNPA3:POLR2A:RBM10:PRPF39	GO:0000398  |  mRNA splicing, via spliceosome	NA	0.000124	NA
727	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:CPEB3:SRSF9:SRSF7:SRSF4:HNRNPA2B1:RBM42:SLTM:MBNL2:SRSF2:HNRNPK:RBM10:NELFE	GO:0050684  |  regulation of mRNA processing	NA	0.000528	NA
728	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:RBM42:RBM10:NELFE	GO:0050686  |  negative regulation of mRNA processing	NA	3.79e-06	NA
729	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:RBM42:MBNL2:SRSF2:RBM10	GO:0048024  |  regulation of mRNA splicing, via spliceosome	NA	0.000494	NA
730	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:RBM42:RBM10	GO:0033119  |  negative regulation of RNA splicing	NA	3.81e-05	NA
731	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SRSF7:SRSF4:HNRNPA2B1:RBM42:RBM10	GO:0048025  |  negative regulation of mRNA splicing, via spliceosome	NA	6.46e-06	NA
732	CDS	Pancan-no-skin-melanoma-lymph	CBFB:GATA3:HES1:CDKN1A:FOXA1:RB1:CTNNB1:PTEN:NF1	GO:0021700  |  developmental maturation	NA	0.000336	NA
733	CDS	Pancan-no-skin-melanoma-lymph	CBFB:GATA3:HES1:BCL11A:CDKN1A:FOXA1:RB1:CTNNB1	GO:0048469  |  cell maturation	NA	0.00148	NA
734	CDS	Pancan-no-skin-melanoma-lymph	TP53:CDKN2A:PTEN	GO:0071887  |  leukocyte apoptotic process	NA	0.0321	NA
735	CDS	Pancan-no-skin-melanoma-lymph	TP53:CDKN2A:PTEN	GO:2000106  |  regulation of leukocyte apoptotic process	NA	0.0173	NA
736	CDS	Pancan-no-skin-melanoma-lymph	RHOA:GATA3:NFE2L2:TEK:PIK3CA:SOX9:KLF4:AKT1:EPHA2:NOTCH1:TGFBR2:EFNA1:PTEN:JUN:PTPN11:NF1	GO:0090130  |  tissue migration	NA	0.0043	NA
737	CDS	Pancan-no-skin-melanoma-lymph	RHOA:GATA3:NFE2L2:TEK:PIK3CA:SOX9:KLF4:AKT1:EPHA2:NOTCH1:TGFBR2:EFNA1:PTEN:JUN:PTPN11:NF1	GO:0090132  |  epithelium migration	NA	0.00312	NA
738	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:ZMYND8:JAG1:CHMP4B:GATA3:SMC3:ARRDC3:NFE2L2:TEK:SOX9:APC:ACVR1B:KLF4:FAM60A:AKT1:EPHA2:PIK3R1:EGFR:NOTCH1:MTA2:BRAF:TGFBR2:TERT:CITED2:EFNA1:CLIC4:LDB2:PTEN:HRAS:JUN:IDH2:RELN:ARID2:NF1:LDB1	GO:0040012  |  regulation of locomotion	NA	5.35e-05	NA
739	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ZMYND8:WASL:GATA3:BMP5:ARRDC3:IL4:NFE2L2:KLF4:FAM60A:RHOB:NOTCH1:BRAF:CITED2:CLIC4:PTEN:IDH2:NF2:ARID2:NF1	GO:0040013  |  negative regulation of locomotion	NA	0.00889	NA
740	CDS	Pancan-no-skin-melanoma-lymph	RHOA:GATA3:PHOX2B:NFE2L2:TEK:PIK3CA:SOX9:ACVR1B:KLF4:AKT1:EPHA2:NOTCH1:MTA2:BRAF:TGFBR2:EFNA1:PTEN:JUN:PTPN11:NF1	GO:0001667  |  ameboidal-type cell migration	NA	0.00046	NA
741	CDS	Pancan-no-skin-melanoma-lymph	RHOA:GATA3:NFE2L2:TEK:PIK3CA:SOX9:KLF4:AKT1:EPHA2:NOTCH1:TGFBR2:EFNA1:PTEN:JUN:PTPN11:NF1	GO:0010631  |  epithelial cell migration	NA	0.00264	NA
742	CDS	Pancan-no-skin-melanoma-lymph	RHOA:GATA3:NFE2L2:TEK:PIK3CA:KLF4:AKT1:EPHA2:NOTCH1:EFNA1:PTEN:NF1	GO:0043542  |  endothelial cell migration	NA	0.0257	NA
743	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:ZMYND8:JAG1:GATA3:CDKN1B:NFE2L2:TEK:SOX9:APC:ACVR1B:KLF4:FAM60A:AKT1:EPHA2:PIK3R1:EGFR:NOTCH1:MTA2:BRAF:TGFBR2:TERT:CITED2:EFNA1:CLIC4:LDB2:PTEN:JUP:HRAS:JUN:IDH2:RELN:ARID2:NF1:LDB1	GO:0051270  |  regulation of cellular component movement	NA	0.000194	NA
744	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ZMYND8:WASL:GATA3:CDKN1B:BMP5:IL4:NFE2L2:KLF4:FAM60A:RHOB:NOTCH1:BRAF:CITED2:CLIC4:PTEN:IDH2:NF2:ARID2:NF1	GO:0051271  |  negative regulation of cellular component movement	NA	0.00446	NA
745	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:ZMYND8:JAG1:GATA3:NFE2L2:TEK:SOX9:APC:ACVR1B:KLF4:FAM60A:AKT1:EPHA2:PIK3R1:EGFR:NOTCH1:MTA2:BRAF:TGFBR2:TERT:CITED2:EFNA1:CLIC4:LDB2:PTEN:HRAS:JUN:IDH2:RELN:ARID2:NF1:LDB1	GO:2000145  |  regulation of cell motility	NA	0.000223	NA
746	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:ZMYND8:JAG1:GATA3:NFE2L2:TEK:SOX9:APC:ACVR1B:KLF4:FAM60A:AKT1:EPHA2:PIK3R1:EGFR:NOTCH1:MTA2:BRAF:TGFBR2:TERT:CITED2:EFNA1:CLIC4:LDB2:PTEN:HRAS:JUN:IDH2:RELN:ARID2:NF1:LDB1	GO:0030334  |  regulation of cell migration	NA	4.01e-05	NA
747	CDS	Pancan-no-skin-melanoma-lymph	RHOA:GATA3:NFE2L2:TEK:SOX9:KLF4:AKT1:EPHA2:NOTCH1:TGFBR2:EFNA1:PTEN:JUN:NF1	GO:0010632  |  regulation of epithelial cell migration	NA	0.00266	NA
748	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ZMYND8:WASL:GATA3:BMP5:IL4:NFE2L2:KLF4:FAM60A:RHOB:NOTCH1:BRAF:CITED2:CLIC4:PTEN:IDH2:NF2:ARID2:NF1	GO:2000146  |  negative regulation of cell motility	NA	0.00647	NA
749	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ZMYND8:WASL:BMP5:IL4:NFE2L2:KLF4:FAM60A:RHOB:NOTCH1:BRAF:CITED2:CLIC4:PTEN:IDH2:NF2:ARID2:NF1	GO:0030336  |  negative regulation of cell migration	NA	0.00993	NA
750	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:CDKN1A:KRAS:RB1:TP53:SETDB1:RASA1:CDKN2A:ARHGAP35:COL1A2:HRAS:NF1:NRAS	GO:0007265  |  Ras protein signal transduction	NA	0.00893	NA
751	CDS	Pancan-no-skin-melanoma-lymph	EP300:BCL9:HDAC1:SMARCA4:MEN1:MYC:TCF7L2:TERT:KMT2D:CTNNB1:HIST1H4C:HIST1H4K:HIST1H4E	GO:1904837  |  beta-catenin-TCF complex assembly	NA	2.2e-11	NA
752	CDS	Pancan-no-skin-melanoma-lymph	RHOA:NDE1:SMARCA1:ID2:SIX3:ASCL1:NOTCH1:ZNF503:CTNNB1:CDH2:NF2:NF1	GO:0061351  |  neural precursor cell proliferation	NA	0.0338	NA
753	CDS	Pancan-no-skin-melanoma-lymph	RHOA:SMARCA1:ID2:SIX3:ASCL1:NOTCH1:CTNNB1:CDH2:GATA2:NF2:NF1	GO:2000177  |  regulation of neural precursor cell proliferation	NA	0.00484	NA
754	CDS	Pancan-no-skin-melanoma-lymph	NFE2L2:TCF7L2:CTNNB1	GO:0051176  |  positive regulation of sulfur metabolic process	NA	0.0126	NA
755	CDS	Pancan-no-skin-melanoma-lymph	NFE2L2:CDKN1A:KRAS:TP53:CDKN2A:ATM:TGFBR2:TERT:PTEN	GO:0007568  |  aging	NA	4.58e-05	NA
756	CDS	Pancan-no-skin-melanoma-lymph	KRAS:TP53:CDKN2A:TERT:PTEN	GO:0007569  |  cell aging	NA	1.09e-06	NA
757	CDS	Pancan-no-skin-melanoma-lymph	KRAS:CDKN2A:TERT:PTEN	GO:0090342  |  regulation of cell aging	NA	5.1e-06	NA
758	CDS	Pancan-no-skin-melanoma-lymph	CDKN1A:TP53:CDKN2A:ATM:TERT	GO:0090399  |  replicative senescence	NA	1.76e-07	NA
759	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:BAX:AXIN1:FBXW7:NFE2L2:SPOP:KRAS:MEN1:OS9:PIK3R1:EGFR:CDKN2A:ATM:BRAF:TERT:CTNNB1:PTEN:HRAS	GO:0080135  |  regulation of cellular response to stress	NA	2.55e-07	NA
760	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:BAX:NFE2L2:SPOP:OS9:PIK3R1:PTPN1	GO:1905897  |  regulation of response to endoplasmic reticulum stress	NA	0.028	NA
761	CDS	Pancan-no-skin-melanoma-lymph	BAX:NFE2L2:SPOP:PIK3R1:PTPN1	GO:1905898  |  positive regulation of response to endoplasmic reticulum stress	NA	0.0323	NA
762	CDS	Pancan-no-skin-melanoma-lymph	KRAS:TP53:CDKN2A:TERT	GO:0090398  |  cellular senescence	NA	2.53e-05	NA
763	CDS	Pancan-no-skin-melanoma-lymph	KRAS:CDKN2A:TERT	GO:2000772  |  regulation of cellular senescence	NA	0.000899	NA
764	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:HSPA5:RHOA:UBE2D1:MEF2C:ESRP1:STMN2:GATA3:PHOX2B:HES1:ACVR2A:USP9X:SOX9:GDF5:MEN1:MEIS2:KLF4:MYC:TOB1:SMAD4:AKT1:EPHA2:EGFR:NOTCH1:ZFP36L2:EEF1A1:BRAF:TGFBR2:CITED2:COL1A2:CTNNB1:PTEN:SMAD2:JUN:PTPN11:POLR2A:PTPN1	GO:0070848  |  response to growth factor	NA	7.64e-09	NA
765	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:ACVR2A:USP9X:TOB1:SMAD4:NOTCH1	GO:0071772  |  response to BMP	NA	0.00328	NA
766	CDS	Pancan-no-skin-melanoma-lymph	ERRFI1:SOX9:ASCL1:AKT1:EGFR:ZFP36L2:EEF1A1:PTPN11	GO:0070849  |  response to epidermal growth factor	NA	0.00463	NA
767	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:MEF2C:DUSP22:USP9X:SOX9:GDF5:MEN1:SMAD4:ZFP36L2:TGFBR2:CITED2:COL1A2:SMAD2:JUN	GO:0071559  |  response to transforming growth factor beta	NA	0.00649	NA
768	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:HSPA5:RHOA:UBE2D1:MEF2C:ESRP1:STMN2:GATA3:PHOX2B:HES1:ACVR2A:USP9X:SOX9:GDF5:MEN1:KLF4:TOB1:SMAD4:AKT1:EGFR:NOTCH1:ZFP36L2:EEF1A1:BRAF:TGFBR2:CITED2:COL1A2:CTNNB1:PTEN:SMAD2:JUN:PTPN11:POLR2A:PTPN1	GO:0071363  |  cellular response to growth factor stimulus	NA	2.11e-07	NA
769	CDS	Pancan-no-skin-melanoma-lymph	ERRFI1:SOX9:AKT1:EGFR:ZFP36L2:EEF1A1:PTPN11	GO:0071364  |  cellular response to epidermal growth factor stimulus	NA	0.0146	NA
770	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:MEF2C:DUSP22:USP9X:SOX9:GDF5:MEN1:SMAD4:ZFP36L2:TGFBR2:CITED2:COL1A2:SMAD2:JUN	GO:0071560  |  cellular response to transforming growth factor beta stimulus	NA	0.00547	NA
771	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:ACVR2A:MEN1:TOB1:SMAD4:NOTCH1:TGFBR2:CTNNB1	GO:0090287  |  regulation of cellular response to growth factor stimulus	NA	0.000273	NA
772	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:ACTB:ESRP1:GATA3:FBXW7:HES1:PIK3CA:ACVR2A:USP9X:SOX9:GDF5:KRAS:MEN1:APC:ACVR1B:TOB1:SMAD4:AKT1:EPHA2:PIK3R1:RASA1:EGFR:NOTCH1:TGFBR2:CITED2:COL1A2:TSC1:CTNNB1:PTEN:HRAS:SMAD2:POLR2A:PTPN1:NRAS:ATP6V1G2	GO:0007167  |  enzyme linked receptor protein signaling pathway	NA	3.13e-09	NA
773	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:RHOA:NUCKS1:ACTB:ESRP1:WASL:GATA3:FBXW7:FGF6:BMP5:ERRFI1:TEK:PIK3CA:NCKAP1L:SOX9:KRAS:APC:EPHA7:AKT1:EPHA2:PIK3R1:RASA1:EGFR:DDR2:ARPC2:TSC1:PRKCB:CTNNB1:EFNA1:PTEN:HRAS:PTPN11:POLR2A:PTPN1:TCF4:NRAS:ATP6V1G2:ARPC1A:TXNIP:GRIN2B	GO:0007169  |  transmembrane receptor protein tyrosine kinase signaling pathway	NA	0.000247	NA
774	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:PIK3CA:SOX9:KRAS:AKT1:PIK3R1:EGFR:HRAS:NRAS	GO:0038127  |  ERBB signaling pathway	NA	0.0162	NA
775	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:PIK3CA:SOX9:KRAS:AKT1:PIK3R1:EGFR:HRAS:NRAS	GO:0007173  |  epidermal growth factor receptor signaling pathway	NA	0.00427	NA
776	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:EGFR:HRAS:NRAS	GO:0038128  |  ERBB2 signaling pathway	NA	9.22e-05	NA
777	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ACTB:WASL:EPHA7:EPHA2:RASA1:ARPC2:EFNA1:HRAS:PTPN11:ARPC1A:GRIN2B	GO:0048013  |  ephrin receptor signaling pathway	NA	0.00241	NA
778	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:PIK3CA:APC:AKT1:PIK3R1:TSC1:PTPN1:ATP6V1G2	GO:0008286  |  insulin receptor signaling pathway	NA	0.0293	NA
779	CDS	Pancan-no-skin-melanoma-lymph	HES1:ACVR2A:USP9X:GDF5:MEN1:ACVR1B:TOB1:SMAD4:NOTCH1:TGFBR2:CITED2:COL1A2:SMAD2	GO:0007178  |  transmembrane receptor protein serine/threonine kinase signaling pathway	NA	0.0029	NA
780	CDS	Pancan-no-skin-melanoma-lymph	HES1:ACVR2A:GDF5:MEN1:ACVR1B:TOB1:SMAD4:NOTCH1:TGFBR2:CITED2:SMAD2	GO:0090092  |  regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	NA	0.00186	NA
781	CDS	Pancan-no-skin-melanoma-lymph	HES1:ACVR2A:GDF5:MEN1:ACVR1B:SMAD4:NOTCH1:CITED2:SMAD2	GO:0090100  |  positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	NA	0.000213	NA
782	CDS	Pancan-no-skin-melanoma-lymph	ACVR2A:MEN1:ACVR1B:CITED2:SMAD2	GO:0032924  |  activin receptor signaling pathway	NA	0.0273	NA
783	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:DUSP22:USP9X:GDF5:MEN1:SMAD4:TGFBR2:CITED2:COL1A2:SMAD2:JUN	GO:0007179  |  transforming growth factor beta receptor signaling pathway	NA	0.0484	NA
784	CDS	Pancan-no-skin-melanoma-lymph	GATA3:HES1:ACVR2A:USP9X:TOB1:SMAD4:NOTCH1	GO:0071773  |  cellular response to BMP stimulus	NA	0.00328	NA
785	CDS	Pancan-no-skin-melanoma-lymph	HES1:ACVR2A:USP9X:TOB1:SMAD4:NOTCH1	GO:0030509  |  BMP signaling pathway	NA	0.0303	NA
786	CDS	Pancan-no-skin-melanoma-lymph	HES1:ACVR2A:TOB1:SMAD4:NOTCH1	GO:0030510  |  regulation of BMP signaling pathway	NA	0.00738	NA
787	CDS	Pancan-no-skin-melanoma-lymph	HES1:GDF5:SMAD4:NOTCH1:SMAD2	GO:0030513  |  positive regulation of BMP signaling pathway	NA	0.0162	NA
788	CDS	Pancan-no-skin-melanoma-lymph	MAP2K7:HNRNPA2B1:ATM:CTNNB1	GO:1904358  |  positive regulation of telomere maintenance via telomere lengthening	NA	0.0443	NA
789	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:MEF2C:EZH2:CDKN1B:TP53	GO:0071236  |  cellular response to antibiotic	NA	0.042	NA
790	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:KEAP1:SMARCB1:EP300:SUFU:ID2:SPOP:SMARCA4:FOXA1:KRAS:MEN1:KLF4:RB1:AKT1:TAF1:CDKN2A:TCF7L2:NEUROD1:CTNNB1:PTEN:JUP:JUN:PTCH1:RELN	GO:0051090  |  regulation of sequence-specific DNA binding transcription factor activity	NA	5.68e-06	NA
791	CDS	Pancan-no-skin-melanoma-lymph	KEAP1:SUFU:ID2:SPOP:MEN1:RB1:CDKN2A:TCF7L2:PTCH1	GO:0043433  |  negative regulation of sequence-specific DNA binding transcription factor activity	NA	0.00115	NA
792	CDS	Pancan-no-skin-melanoma-lymph	PUM2:CASP8:UBE2D1:ACTB:MEF2C:PTPRC:BAX:PSMC5:MAP3K1:EP300:WASL:PSMA2:GATA3:IL2:DUSP22:IL4:PIK3CA:NCKAP1L:IRF1:BPIFB1:KRAS:IL21:PIK3R1:BRAF:FCER1G:CTSS:ARPC2:PRKCB:B2M:AP1G1:PTEN:THEMIS:HRAS:RPS6KA3:GATA2:NRAS:ARPC1A	GO:0050778  |  positive regulation of immune response	NA	0.0497	NA
793	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:RHOA:ACTB:DYNLL1:YWHAE:PHOX2B:YWHAH:FOXP2:ASCL1:CHRNB2	GO:0048857  |  neural nucleus development	NA	0.00231	NA
794	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:MEF2C:SMARCB1:PYGL:SPOP:PIK3CA:SOX4:SMARCA4:FOXA1:MEN1:HNF1A:AKT1:PIK3R1:TCF7L2:NEUROD1:CARTPT:PTPN11:CSMD1:PTCH1	GO:0033500  |  carbohydrate homeostasis	NA	0.00187	NA
795	CDS	Pancan-no-skin-melanoma-lymph	NUCKS1:MEF2C:SMARCB1:PYGL:SPOP:PIK3CA:SOX4:SMARCA4:FOXA1:MEN1:HNF1A:AKT1:PIK3R1:TCF7L2:NEUROD1:CARTPT:PTPN11:CSMD1:PTCH1	GO:0042593  |  glucose homeostasis	NA	0.00187	NA
796	CDS	Pancan-no-skin-melanoma-lymph	CDH1:HSPA5:CASP8:MEF2C:ATRX:EZH2:CDKN1B:IL4:NFE2L2:DNMT3A:KLF4:TFAP2A:ASCL1:AKT1:RHOB:EGFR:TTN:BRAF:BAP1:TERT:TNFRSF11B:B2M:PRDX2:CLIC4:PTEN:JUN:PTCH1:AKR1C3:DAXX:TXNIP	GO:0010035  |  response to inorganic substance	NA	0.0044	NA
797	CDS	Pancan-no-skin-melanoma-lymph	CDH1:HSPA5:CASP8:MEF2C:CDKN1B:IL4:DNMT3A:TFAP2A:ASCL1:AKT1:EGFR:TTN:BRAF:TERT:TNFRSF11B:B2M:CLIC4:PTEN:JUN:AKR1C3:DAXX:TXNIP	GO:0010038  |  response to metal ion	NA	0.0152	NA
798	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:AKT1:EGFR:TERT:B2M:JUN:AKR1C3:DAXX	GO:0046686  |  response to cadmium ion	NA	0.00974	NA
799	CDS	Pancan-no-skin-melanoma-lymph	CDH1:HSPA5:MEF2C:ATRX:CDKN1B:AKT1:EGFR:BRAF:B2M:CLIC4:JUN:AKR1C3:DAXX	GO:0071241  |  cellular response to inorganic substance	NA	0.0138	NA
800	CDS	Pancan-no-skin-melanoma-lymph	CDH1:HSPA5:MEF2C:CDKN1B:IL4:TFAP2A:AKT1:EGFR:BRAF:B2M:CLIC4:JUN:AKR1C3:DAXX	GO:0071248  |  cellular response to metal ion	NA	0.0149	NA
801	CDS	Pancan-no-skin-melanoma-lymph	CASP8:MAP2K4:ACTB:MAP2K7:BAX:PSMC5:MAP3K1:GATA3:PIK3CA:KRAS:PIK3R1:BRAF:PTEN:HRAS:RPS6KA3:NRAS	GO:0002764  |  immune response-regulating signaling pathway	NA	0.00215	NA
802	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:ACTB:MAP2K7:BAX:MAP3K1:GATA3:PIK3CA:KRAS:PIK3R1:BRAF:PTEN:HRAS:NRAS	GO:0002768  |  immune response-regulating cell surface receptor signaling pathway	NA	0.000723	NA
803	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:ACTB:MAP2K7:PSMC5:MAP3K1:PIK3CA:KRAS:PIK3R1:HRAS:NRAS	GO:0038093  |  Fc receptor signaling pathway	NA	0.0067	NA
804	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:PSMC5:MAP3K1:PSMA2:PIK3CA:KRAS:PIK3R1:HRAS:NRAS	GO:0038095  |  Fc-epsilon receptor signaling pathway	NA	0.00373	NA
805	CDS	Pancan-no-skin-melanoma-lymph	PUM2:CASP8:UBE2D1:ACTB:MEF2C:PTPRC:BAX:PSMC5:MAP3K1:EP300:WASL:PSMA2:GATA3:DUSP22:PIK3CA:NCKAP1L:IRF1:BPIFB1:KRAS:PIK3R1:BRAF:FCER1G:CTSS:ARPC2:PRKCB:PTEN:THEMIS:HRAS:RPS6KA3:NRAS:ARPC1A	GO:0002757  |  immune response-activating signal transduction	NA	0.0175	NA
806	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:BAX:PSMC5:DYNLL1:ZMYND8:CHMP4B:STMN2:WASL:TBC1D12:CDKN1B:CNOT2:EIF4G1:TEK:NCKAP1L:SOX9:RAB33A:APC:HNF1A:EPHA7:XPA:RB1:TP53:SMAD4:EPHA2:PIK3R1:RASA1:TAF1:NOTCH1:ATM:BRAF:ARHGAP35:CHRNB2:SHANK1:ARPC2:VDAC2:TSC1:CTNNB1:LDB2:PTEN:SPTBN2:HRAS:PPM1E:JUN:SLITRK1:PTPN11:NF2:CCDC151:LDB1:LRRTM3:DDX3X:ARPC1A:HNF1B	GO:0044087  |  regulation of cellular component biogenesis	NA	1.37e-08	NA
807	CDS	Pancan-no-skin-melanoma-lymph	RHOA:BAX:PSMC5:DYNLL1:ZMYND8:WASL:CDKN1B:CNOT2:EIF4G1:TEK:NCKAP1L:SOX9:APC:HNF1A:XPA:TP53:TAF1:ATM:BRAF:ARHGAP35:ARPC2:TSC1:CTNNB1:LDB2:HRAS:PPM1E:JUN:SLITRK1:NF2:LRRTM3:ARPC1A:HNF1B	GO:0044089  |  positive regulation of cellular component biogenesis	NA	0.000116	NA
808	CDS	Pancan-no-skin-melanoma-lymph	RHOA:MEF2C:JAG1:AXIN1:HOXA2:GATA3:SUFU:HES1:ID2:SOX9:FOXA1:TBX3:KLF4:SMAD4:NOTCH1:TCF7L2:BRAF:NEUROD1:CTNNB1:SMAD2:PTCH1:ZNF521:HNF1B	GO:0045165  |  cell fate commitment	NA	5.73e-09	NA
809	CDS	Pancan-no-skin-melanoma-lymph	MEF2C:JAG1:HOXA2:GATA3:HES1:PRRX1:KLF4:ASCL1:CTNNB1:GATA2:PTCH1	GO:0001709  |  cell fate determination	NA	4.21e-06	NA
810	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:SUFU:HES1:ID2:FOXA1:SMAD4:NOTCH1:ZNF521	GO:0048663  |  neuron fate commitment	NA	6.6e-05	NA
811	CDS	Pancan-no-skin-melanoma-lymph	SUFU:SOX9:FOXA1:NOTCH1:CTNNB1:PTCH1:HNF1B	GO:0001708  |  cell fate specification	NA	0.0172	NA
812	CDS	Pancan-no-skin-melanoma-lymph	SMARCB1:EP300:ARID1A:SMARCA4	CORUM:570  |  p300-CBP-p270-SWI/SNF complex	NA	0.0198	NA
813	CDS	Pancan-no-skin-melanoma-lymph	ACTB:SMARCB1:SMARCA4:PBRM1:ARID2	CORUM:149  |  PBAF complex (Polybromo- and BAF containing complex)	NA	0.0011	NA
814	CDS	Pancan-no-skin-melanoma-lymph	CTNNB1:JUN:TCF4	CORUM:1816  |  JUN-TCF4-CTNNB1 complex	NA	0.0375	NA
815	CDS	Pancan-no-skin-melanoma-lymph	ACTB:SMARCB1:ARID1A:SMARCA4	CORUM:566  |  BAF complex	NA	0.0203	NA
816	CDS	Pancan-no-skin-melanoma-lymph	EP300:SOX4:CTNNB1	CORUM:6354  |  Sox4-beta-catenin-p300 complex	NA	0.0404	NA
817	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:SMARCA4:RB1	CORUM:3269  |  RB1-HDAC1-BRG1 complex	NA	0.00103	NA
818	CDS	Pancan-no-skin-melanoma-lymph	ACTB:SMARCB1:ARID1A:SMARCA4	CORUM:86  |  NUMAC complex (nucleosomal methylation activator complex)	NA	0.0332	NA
819	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:TP53:DAXX	CORUM:3170  |  Daxx-Axin-p53 complex	NA	0.00363	NA
820	CDS	Pancan-no-skin-melanoma-lymph	SMARCB1:SMARCA4:PBRM1:ARID2	CORUM:556  |  PBAF complex (Polybromo- and BAF containing complex)	NA	0.0203	NA
821	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:TP53:DAXX	CORUM:2842  |  DAXX-Axin-p53-HIPK2 complex	NA	0.0143	NA
822	CDS	Pancan-no-skin-melanoma-lymph	SMARCB1:SMARCA4:PBRM1:ARID2	CORUM:554  |  PBAF complex (Polybromo- and BAF containing complex)	NA	0.0332	NA
823	CDS	Pancan-no-skin-melanoma-lymph	SMARCB1:SMARCA4:PBRM1:ARID2	CORUM:1238  |  PBAF complex (Polybromo- and BAF containing complex)	NA	0.0203	NA
824	CDS	Pancan-no-skin-melanoma-lymph	SMARCB1:SMARCA4:PBRM1:ARID2	CORUM:565  |  PBAF complex (Polybromo- and BAF containing complex)	NA	0.0203	NA
825	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	CORUM:3166  |  AXIN-APC-betaCatenin-GSK3B complex	NA	0.000903	NA
826	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	CORUM:6353  |  beta-Catenin destruction complex	NA	0.000903	NA
827	CDS	Pancan-no-skin-melanoma-lymph	EP300:CTNNB1:TCF4	CORUM:5261  |  TCF4-CTNNB1-EP300 complex	NA	0.0375	NA
828	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:HNRNPR:CALM2:SSRP1:HIST1H4C:CALM1:HIST1H4K:HIST1H4E	CORUM:1223  |  H2AX complex, isolated from cells without IR exposure	NA	0.00981	NA
829	CDS	Pancan-no-skin-melanoma-lymph	ACTB:SMARCB1:HDAC1:ARID1A:SMARCA4:MTA2	CORUM:778  |  LARC complex (LCR-associated remodeling complex)	NA	0.00263	NA
830	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	CORUM:3004  |  APC-Axin-1-beta-catenin complex	NA	0.000227	NA
831	CDS	Pancan-no-skin-melanoma-lymph	ACVR2A:ACVR1B:SMAD4:SMAD2	REAC:1181150  |  Signaling by NODAL	NA	0.0259	NA
832	CDS	Pancan-no-skin-melanoma-lymph	ACVR2A:ACVR1B:SMAD4:SMAD2	REAC:1502540  |  Signaling by Activin	NA	0.00272	NA
833	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:AKT1:PIK3R1:EGFR:HRAS:NRAS	REAC:1227986  |  Signaling by ERBB2	NA	0.00032	NA
834	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:PIK3R1:EGFR	REAC:1963642  |  PI3K events in ERBB2 signaling	NA	0.0411	NA
835	CDS	Pancan-no-skin-melanoma-lymph	KRAS:EGFR:HRAS:NRAS	REAC:1963640  |  GRB2 events in ERBB2 signaling	NA	0.00169	NA
836	CDS	Pancan-no-skin-melanoma-lymph	KRAS:EGFR:HRAS:NRAS	REAC:1250196  |  SHC1 events in ERBB2 signaling	NA	0.00658	NA
837	CDS	Pancan-no-skin-melanoma-lymph	TP53:AKT1:CDKN2A:ATM:DAXX	REAC:6806003  |  Regulation of TP53 Expression and Degradation	NA	0.0154	NA
838	CDS	Pancan-no-skin-melanoma-lymph	TP53:AKT1:CDKN2A:ATM:DAXX	REAC:6804757  |  Regulation of TP53 Degradation	NA	0.0135	NA
839	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:RB1:CDKN2A	REAC:69236  |  G1 Phase	NA	0.0216	NA
840	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:RB1:CDKN2A	REAC:69231  |  Cyclin D associated events in G1	NA	0.0216	NA
841	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:TP63:BAX:PSMC5:DYNLL1:PSMA2:YWHAE:YWHAH:APC:TP53:AKT1:YWHAB:CTNNB1:YWHAG:MED12:HIST1H1C	REAC:5357801  |  Programmed Cell Death	NA	0.00609	NA
842	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:TP63:BAX:PSMC5:DYNLL1:PSMA2:YWHAE:YWHAH:APC:TP53:AKT1:YWHAB:CTNNB1:YWHAG:MED12:HIST1H1C	REAC:109581  |  Apoptosis	NA	0.00483	NA
843	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:APC:CTNNB1	REAC:75153  |  Apoptotic execution  phase	NA	0.0194	NA
844	CDS	Pancan-no-skin-melanoma-lymph	CDH1:CASP8:APC:CTNNB1	REAC:111465  |  Apoptotic cleavage of cellular proteins	NA	0.0055	NA
845	CDS	Pancan-no-skin-melanoma-lymph	CASP8:TP63:BAX:DYNLL1:YWHAE:YWHAH:TP53:AKT1:YWHAB:YWHAG	REAC:109606  |  Intrinsic Pathway for Apoptosis	NA	0.000151	NA
846	CDS	Pancan-no-skin-melanoma-lymph	TP63:DYNLL1:YWHAE:YWHAH:TP53:AKT1:YWHAB:YWHAG	REAC:114452  |  Activation of BH3-only proteins	NA	0.000737	NA
847	CDS	Pancan-no-skin-melanoma-lymph	YWHAE:YWHAH:AKT1:YWHAB:YWHAG	REAC:111447  |  Activation of BAD and translocation to mitochondria 	NA	0.0171	NA
848	CDS	Pancan-no-skin-melanoma-lymph	TEK:PIK3CA:KRAS:PIK3R1:HRAS:PTPN11:NRAS	REAC:210993  |  Tie2 Signaling	NA	8.39e-06	NA
849	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:RHOA:NDE1:ACTB:XPO1:LIN7B:MYH14:WASL:YWHAE:CDKN1B:NCKAP1L:YWHAH:H3F3B:MEN1:RHOB:CALM2:HIST1H2BD:ARHGAP35:TAOK1:ARPC2:YWHAB:CTNNB1:YWHAG:ARHGAP1:HIST1H2AC:HIST2H3D:NF2:HIST1H4C:CALM1:ARPC1A:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:194315  |  Signaling by Rho GTPases	NA	3.22e-07	NA
850	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CDH1:RHOA:NDE1:ACTB:XPO1:LIN7B:MYH14:WASL:YWHAE:CDKN1B:NCKAP1L:YWHAH:H3F3B:MEN1:RHOB:CALM2:HIST1H2BD:TAOK1:ARPC2:YWHAB:CTNNB1:YWHAG:HIST1H2AC:HIST2H3D:NF2:HIST1H4C:CALM1:ARPC1A:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:195258  |  RHO GTPase Effectors	NA	1.08e-10	NA
851	CDS	Pancan-no-skin-melanoma-lymph	CDH1:MEN1:CALM2:CTNNB1	REAC:5626467  |  RHO GTPases activate IQGAPs	NA	0.000163	NA
852	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:RHOA:MYH14:YWHAE:YWHAH:H3F3B:RHOB:HIST1H2BD:YWHAB:YWHAG:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5625740  |  RHO GTPases activate PKNs	NA	9.05e-10	NA
853	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5625886  |  Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	NA	9.92e-06	NA
854	CDS	Pancan-no-skin-melanoma-lymph	CHD4:HDAC1:H3F3B:MTA2:HIST1H2BD:NFIA:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:504046  |  RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	NA	7.86e-05	NA
855	CDS	Pancan-no-skin-melanoma-lymph	CHD4:HDAC1:H3F3B:MTA2:HIST1H2BD:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:73864  |  RNA Polymerase I Transcription	NA	9.51e-06	NA
856	CDS	Pancan-no-skin-melanoma-lymph	CHD4:HDAC1:H3F3B:MTA2:HIST1H2BD:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:73854  |  RNA Polymerase I Promoter Clearance	NA	7.4e-06	NA
857	CDS	Pancan-no-skin-melanoma-lymph	H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:73728  |  RNA Polymerase I Promoter Opening	NA	5.05e-05	NA
858	CDS	Pancan-no-skin-melanoma-lymph	H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:73777  |  RNA Polymerase I Chain Elongation	NA	0.000287	NA
859	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:UBE2D1:RASAL2:MAP2K7:PSMC5:MAP3K1:PSMA2:PIP5K1B:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:FCER1G:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:JUN:PTPN11:NF1:CALM1:NRAS	REAC:2454202  |  Fc epsilon receptor (FCERI) signaling	NA	9.74e-06	NA
860	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RASAL2:MAP2K7:PSMC5:MAP3K1:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:JUN:NF1:CALM1:NRAS	REAC:2871796  |  FCERI mediated MAPK activation	NA	0.00803	NA
861	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:EIF4G1:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:TSC1:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS:ATP6V1G2	REAC:74752  |  Signaling by Insulin receptor	NA	7.47e-05	NA
862	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:EIF4G1:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:TSC1:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:74751  |  Insulin receptor signalling cascade	NA	6.69e-05	NA
863	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:RASAL2:PSMC5:ESRP1:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:POLR2A:NF1:CALM1:NRAS	REAC:190236  |  Signaling by FGFR	NA	7.99e-07	NA
864	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654743  |  Signaling by FGFR4	NA	5.74e-06	NA
865	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654716  |  Downstream signaling of activated FGFR4	NA	4.74e-06	NA
866	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:5654720  |  PI-3K cascade:FGFR4	NA	0.00425	NA
867	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654712  |  FRS-mediated FGFR4 signaling	NA	0.00231	NA
868	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654736  |  Signaling by FGFR1	NA	7.85e-06	NA
869	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654687  |  Downstream signaling of activated FGFR1	NA	5.74e-06	NA
870	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:5654689  |  PI-3K cascade:FGFR1	NA	0.00425	NA
871	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654693  |  FRS-mediated FGFR1 signaling	NA	0.00231	NA
872	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:RASAL2:PSMC5:ESRP1:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:POLR2A:NF1:CALM1:NRAS	REAC:5654738  |  Signaling by FGFR2	NA	5.43e-07	NA
873	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654696  |  Downstream signaling of activated FGFR2	NA	4.74e-06	NA
874	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654700  |  FRS-mediated FGFR2 signaling	NA	0.00231	NA
875	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:5654695  |  PI-3K cascade:FGFR2	NA	0.00425	NA
876	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654741  |  Signaling by FGFR3	NA	6.11e-06	NA
877	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654708  |  Downstream signaling of activated FGFR3	NA	4.74e-06	NA
878	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:5654710  |  PI-3K cascade:FGFR3	NA	0.00425	NA
879	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5654706  |  FRS-mediated FGFR3 signaling	NA	0.00231	NA
880	CDS	Pancan-no-skin-melanoma-lymph	RHOA:RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:CTNNB1:JUP:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:194138  |  Signaling by VEGF	NA	0.000669	NA
881	CDS	Pancan-no-skin-melanoma-lymph	RHOA:RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:CTNNB1:JUP:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:4420097  |  VEGFA-VEGFR2 Pathway	NA	0.000436	NA
882	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:5218921  |  VEGFR2 mediated cell proliferation	NA	0.0162	NA
883	CDS	Pancan-no-skin-melanoma-lymph	RHOA:RASAL2:ACTB:PTPRC:PSMC5:MYH14:WASL:PSMA2:IL2:FGF6:TEK:PIK3CA:KRAS:EPHA7:CLTC:EPHA2:RHOB:CALM2:PIK3R1:RASA1:EGFR:BRAF:ARHGAP35:ARPC2:DUSP7:YWHAB:EFNA1:SPTBN2:HRAS:RPS6KA3:PTPN11:RELN:NF1:CALM1:NRAS:ARPC1A:GRIN2B	REAC:422475  |  Axon guidance	NA	0.00205	NA
884	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ACTB:MYH14:WASL:EPHA7:CLTC:EPHA2:RASA1:ARPC2:EFNA1:HRAS:ARPC1A:GRIN2B	REAC:2682334  |  EPH-Ephrin signaling	NA	0.0024	NA
885	CDS	Pancan-no-skin-melanoma-lymph	RHOA:ACTB:WASL:RASA1:ARPC2:HRAS:ARPC1A:GRIN2B	REAC:3928662  |  EPHB-mediated forward signaling	NA	0.0149	NA
886	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:375165  |  NCAM signaling for neurite out-growth	NA	0.0411	NA
887	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:XPO1:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:MYC:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:JUN:PTPN11:NF1:CALM1:NRAS	REAC:5683057  |  MAPK family signaling cascades	NA	0.00077	NA
888	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:5684996  |  MAPK1/MAPK3 signaling	NA	0.0031	NA
889	CDS	Pancan-no-skin-melanoma-lymph	RHOA:RASAL2:MEF2C:PSMC5:CASP2:PSMA2:PIP5K1B:PRKAR1A:YWHAE:IL2:FGF6:CDKN1B:HDAC1:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:RPS6KA3:PTPN11:NF1:CALM1:NRAS	REAC:166520  |  Signalling by NGF	NA	5.11e-05	NA
890	CDS	Pancan-no-skin-melanoma-lymph	RHOA:RASAL2:MEF2C:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:RPS6KA3:PTPN11:NF1:CALM1:NRAS	REAC:187037  |  NGF signalling via TRKA from the plasma membrane	NA	1.41e-06	NA
891	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:198203  |  PI3K/AKT activation	NA	0.00494	NA
892	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:187687  |  Signalling to ERKs	NA	0.0209	NA
893	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:169893  |  Prolonged ERK activation events	NA	0.0118	NA
894	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:170984  |  ARMS-mediated activation	NA	0.0101	NA
895	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:170968  |  Frs2-mediated activation	NA	0.0106	NA
896	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:187706  |  Signalling to p38 via RIT and RIN	NA	0.0101	NA
897	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:167044  |  Signalling to RAS	NA	0.0146	NA
898	CDS	Pancan-no-skin-melanoma-lymph	KRAS:HRAS:NRAS	REAC:171007  |  p38MAPK events	NA	0.0387	NA
899	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:186797  |  Signaling by PDGF	NA	4.06e-05	NA
900	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:186763  |  Downstream signal transduction	NA	1e-05	NA
901	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RASAL2:MAP2K7:MEF2C:PSMC5:PSMA2:GATA3:IL2:FGF6:EIF4G1:TEK:PIK3CA:CDKN1A:IRF1:SMARCA4:KRAS:MYC:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:EIF4A2:BRAF:IL17RC:DUSP7:COL1A2:TNFRSF11B:B2M:YWHAB:IRF2:SPTBN2:HRAS:RPS6KA3:JUN:PTPN11:HIST2H3D:PTPN1:NF1:CALM1:HLA-A:NRAS:IL10RB:HIST1H3C	REAC:1280215  |  Cytokine Signaling in Immune system	NA	7.19e-06	NA
902	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RASAL2:MAP2K7:MEF2C:PSMC5:PSMA2:GATA3:IL2:FGF6:TEK:PIK3CA:CDKN1A:SMARCA4:KRAS:MYC:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:IL17RC:DUSP7:COL1A2:YWHAB:SPTBN2:HRAS:RPS6KA3:JUN:PTPN11:HIST2H3D:NF1:CALM1:NRAS:IL10RB:HIST1H3C	REAC:449147  |  Signaling by Interleukins	NA	3.46e-06	NA
903	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:PIK3CA:KRAS:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:512988  |  Interleukin-3, 5 and GM-CSF signaling	NA	0.000801	NA
904	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:RASAL2:MAP2K7:MEF2C:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:IL17RC:DUSP7:YWHAB:SPTBN2:HRAS:RPS6KA3:JUN:PTPN11:NF1:CALM1:NRAS	REAC:448424  |  Interleukin-17 signaling	NA	2.77e-05	NA
905	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:PIK3CA:KRAS:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:451927  |  Interleukin-2 signaling	NA	0.00177	NA
906	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:PIK3CA:KRAS:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:912526  |  Interleukin receptor SHC signaling	NA	0.00117	NA
907	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:VHL:TP53:PTEN	REAC:1280218  |  Adaptive Immune System	NA	0.00892	NA
908	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:PSMA2:CDKN1B:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:EGFR:PTEN:HRAS:NRAS	REAC:983705  |  Signaling by the B Cell Receptor (BCR)	NA	0.00191	NA
909	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:PSMA2:CDKN1B:PIK3CA:CDKN1A:KRAS:TP53:AKT1:PIK3R1:EGFR:PTEN:HRAS:NRAS	REAC:1168372  |  Downstream signaling events of B Cell Receptor (BCR)	NA	0.000149	NA
910	CDS	Pancan-no-skin-melanoma-lymph	KRAS:HRAS:NRAS	REAC:1169092  |  Activation of RAS in B cells	NA	0.00141	NA
911	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:1433557  |  Signaling by SCF-KIT	NA	1.57e-05	NA
912	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:EIF4G1:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:TSC1:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:2404192  |  Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	NA	7.12e-05	NA
913	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:EIF4G1:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:TSC1:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:2428924  |  IGF1R signaling cascade	NA	6.69e-05	NA
914	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:EIF4G1:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:TSC1:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:2428928  |  IRS-related events triggered by IGF1R	NA	6.69e-05	NA
915	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:EIF4G1:TEK:PIK3CA:KRAS:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:TSC1:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:112399  |  IRS-mediated signalling	NA	5.19e-05	NA
916	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:112412  |  SOS-mediated signalling	NA	0.00807	NA
917	CDS	Pancan-no-skin-melanoma-lymph	KRAS:HRAS:NRAS	REAC:2428933  |  SHC-related events triggered by IGF1R	NA	0.0116	NA
918	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:B2M:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:2172127  |  DAP12 interactions	NA	6.8e-06	NA
919	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:B2M:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:2424491  |  DAP12 signaling	NA	3.24e-06	NA
920	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:PRKAR1A:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:SH3GL3:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:177929  |  Signaling by EGFR	NA	5.33e-06	NA
921	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:180336  |  SHC1 events in EGFR signaling	NA	0.00807	NA
922	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:179812  |  GRB2 events in EGFR signaling	NA	0.00807	NA
923	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:180292  |  GAB1 signalosome	NA	0.00494	NA
924	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:PIP5K1B:IL2:FGF6:CDKN1B:TEK:PIK3CA:CDKN1A:KRAS:TP53:AKT1:CALM2:PIK3R1:RASA1:EGFR:BRAF:DUSP7:YWHAB:PTEN:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:1236394  |  Signaling by ERBB4	NA	2e-05	NA
925	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:1250342  |  PI3K events in ERBB4 signaling	NA	0.00425	NA
926	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:PIK3CA:CDKN1A:TP53:PIK3R1:EGFR:PTEN	REAC:1257604  |  PIP3 activates AKT signaling	NA	0.00425	NA
927	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:1250347  |  SHC1 events in ERBB4 signaling	NA	0.00807	NA
928	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:PTPN11:NF1:CALM1:NRAS	REAC:2586552  |  Signaling by Leptin	NA	0.00348	NA
929	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:IL2:FGF6:TEK:KRAS:CALM2:RASA1:EGFR:BRAF:DUSP7:YWHAB:SPTBN2:HRAS:NF1:CALM1:NRAS	REAC:5673001  |  RAF/MAP kinase cascade	NA	0.00807	NA
930	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:PSMA2:KRAS:RASA1:HRAS:NF1:NRAS	REAC:5658442  |  Regulation of RAS by GAPs	NA	0.000434	NA
931	CDS	Pancan-no-skin-melanoma-lymph	KRAS:BRAF:HRAS:NRAS	REAC:5673000  |  RAF activation	NA	0.0112	NA
932	CDS	Pancan-no-skin-melanoma-lymph	CALM2:BRAF:HRAS:RPS6KA3	REAC:442742  |  CREB phosphorylation through the activation of Ras	NA	0.0332	NA
933	CDS	Pancan-no-skin-melanoma-lymph	RHOA:IL2:PIK3CA:AKT1:RHOB:PIK3R1:FCER1G:PTPN11	REAC:114604  |  GPVI-mediated activation cascade	NA	0.0333	NA
934	CDS	Pancan-no-skin-melanoma-lymph	SALL4:SALL1:KLF4:NR5A1:SMAD4:SMAD2:POLR2A	REAC:452723  |  Transcriptional regulation of pluripotent stem cells	NA	0.0218	NA
935	CDS	Pancan-no-skin-melanoma-lymph	KRAS:EGFR:HRAS:NRAS	REAC:2179392  |  EGFR Transactivation by Gastrin	NA	0.000122	NA
936	CDS	Pancan-no-skin-melanoma-lymph	TTR:USP9X:H3F3B:HIST1H2BD:B2M:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:977225  |  Amyloid fiber formation	NA	1.87e-05	NA
937	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:CDKN1B:KRAS:AKT1:RASA1:EGFR:ARHGAP35:HRAS:PTPN1:NF1:NRAS	REAC:8848021  |  Signaling by PTK6	NA	1.98e-07	NA
938	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:KRAS:RASA1:ARHGAP35:HRAS:NF1:NRAS	REAC:8849471  |  PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	NA	6.32e-06	NA
939	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:U2AF1:SRSF2:PCF11	REAC:73856  |  RNA Polymerase II Transcription Termination	NA	0.0486	NA
940	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:U2AF1:SRSF2:PCF11	REAC:109688  |  Cleavage of Growing Transcript in the Termination Region 	NA	0.0486	NA
941	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:KMT2C:ACTB:SMARCB1:EP300:CHD4:HDAC1:ARID1A:SUPT7L:DNMT3A:KANSL1:EPC1:KDM5C:SMARCA4:SETDB1:KDM6A:MTA2:HIST1H2BD:PBRM1:KMT2D:KDM2A:SUZ12:HIST1H2AC:SETD2:HIST2H3D:ARID2:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	REAC:4839726  |  Chromatin organization	NA	1.53e-14	NA
942	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:KMT2C:ACTB:SMARCB1:EP300:CHD4:HDAC1:ARID1A:SUPT7L:DNMT3A:KANSL1:EPC1:KDM5C:SMARCA4:SETDB1:KDM6A:MTA2:HIST1H2BD:PBRM1:KMT2D:KDM2A:SUZ12:HIST1H2AC:SETD2:HIST2H3D:ARID2:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	REAC:3247509  |  Chromatin modifying enzymes	NA	1.53e-14	NA
943	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:SETDB1:KMT2D:SUZ12:SETD2:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	REAC:3214841  |  PKMTs methylate histone lysines	NA	0.00148	NA
944	CDS	Pancan-no-skin-melanoma-lymph	ARID1B:SMARCB1:ARID1A:DNMT3A:SMARCA4:PBRM1:HIST1H2AC:HIST2H3D:ARID2:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	REAC:3214858  |  RMTs methylate histone arginines	NA	3.46e-08	NA
945	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:KDM5C:KDM6A:KDM2A:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H4E:HIST1H3C	REAC:3214842  |  HDMs demethylate histones	NA	0.000658	NA
946	CDS	Pancan-no-skin-melanoma-lymph	ACTB:EP300:SUPT7L:KANSL1:EPC1:HIST1H2BD:HIST1H2AC:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	REAC:3214847  |  HATs acetylate histones	NA	3.09e-06	NA
947	CDS	Pancan-no-skin-melanoma-lymph	KDM1A:CHD4:HDAC1:MTA2:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H2AI:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C:HIST1H2AM	REAC:3214815  |  HDACs deacetylate histones	NA	9.71e-08	NA
948	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:EP300:CTCF:HOXA1:HOXA2:H3F3B:KDM6A:HIST1H2BD:KMT2D:JUN:SUZ12:HIST1H2AC:POLR2A:HIST1H4C:HOXA4:HOXC4:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5619507  |  Activation of HOX genes during differentiation	NA	1.96e-13	NA
949	CDS	Pancan-no-skin-melanoma-lymph	KMT2C:EP300:CTCF:HOXA1:HOXA2:H3F3B:KDM6A:HIST1H2BD:KMT2D:JUN:SUZ12:HIST1H2AC:POLR2A:HIST1H4C:HOXA4:HOXC4:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5617472  |  Activation of anterior HOX genes in hindbrain development during early embryogenesis	NA	1.96e-13	NA
950	CDS	Pancan-no-skin-melanoma-lymph	UBE2D1:NDE1:XPO1:PDS5B:PSMC5:DYNLL1:EP300:STAG2:PSMA2:SMC3:CDKN1B:HDAC1:CDKN1A:PSMC3IP:H3F3B:MYC:RB1:TP53:AKT1:CDKN2A:ATM:HIST1H2BD:RFC4:TERT:CTDNEP1:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:1640170  |  Cell Cycle	NA	8.01e-05	NA
951	CDS	Pancan-no-skin-melanoma-lymph	STAG2:SMC3:PSMC3IP:H3F3B:ATM:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:1500620  |  Meiosis	NA	2.77e-05	NA
952	CDS	Pancan-no-skin-melanoma-lymph	PSMC3IP:H3F3B:ATM:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:912446  |  Meiotic recombination	NA	2.84e-05	NA
953	CDS	Pancan-no-skin-melanoma-lymph	STAG2:SMC3:HIST1H2BD:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE	REAC:1221632  |  Meiotic synapsis	NA	0.0012	NA
954	CDS	Pancan-no-skin-melanoma-lymph	HIST1H2BD:RFC4:TERT:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE	REAC:73886  |  Chromosome Maintenance	NA	0.0134	NA
955	CDS	Pancan-no-skin-melanoma-lymph	HIST1H2BD:RFC4:TERT:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE	REAC:157579  |  Telomere Maintenance	NA	0.00104	NA
956	CDS	Pancan-no-skin-melanoma-lymph	HIST1H2BD:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE	REAC:171306  |  Packaging Of Telomere Ends	NA	0.00183	NA
957	CDS	Pancan-no-skin-melanoma-lymph	HIST1H2BD:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE	REAC:774815  |  Nucleosome assembly	NA	0.0234	NA
958	CDS	Pancan-no-skin-melanoma-lymph	HIST1H2BD:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE	REAC:606279  |  Deposition of new CENPA-containing nucleosomes at the centromere	NA	0.0234	NA
959	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:PSMC5:PSMA2:YWHAE:CDKN1B:CDKN1A:TP53:CDKN2A:ATM:HIST1H2BD:RFC4:YWHAB:YWHAG:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E	REAC:69620  |  Cell Cycle Checkpoints	NA	0.000398	NA
960	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:PSMA2:YWHAE:YWHAH:TP53:ATM:HIST1H2BD:RFC4:YWHAB:YWHAG:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E	REAC:69481  |  G2/M Checkpoints	NA	0.0413	NA
961	CDS	Pancan-no-skin-melanoma-lymph	YWHAE:YWHAH:TP53:ATM:HIST1H2BD:RFC4:YWHAB:YWHAG:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E	REAC:69473  |  G2/M DNA damage checkpoint	NA	0.00124	NA
962	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:PSMA2:CDKN1B:CDKN1A:TP53:CDKN2A:ATM	REAC:69615  |  G1/S DNA Damage Checkpoints	NA	0.00438	NA
963	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:PSMA2:CDKN1B:CDKN1A:TP53:CDKN2A:ATM	REAC:69580  |  p53-Dependent G1/S DNA damage checkpoint	NA	0.00359	NA
964	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:PSMA2:CDKN1B:CDKN1A:TP53:CDKN2A:ATM	REAC:69563  |  p53-Dependent G1 DNA Damage Response	NA	0.00359	NA
965	CDS	Pancan-no-skin-melanoma-lymph	UBE2D1:NDE1:XPO1:PDS5B:PSMC5:DYNLL1:EP300:STAG2:PSMA2:SMC3:CDKN1B:HDAC1:CDKN1A:H3F3B:MYC:RB1:TP53:AKT1:CDKN2A:HIST1H2BD:RFC4:CTDNEP1:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:69278  |  Cell Cycle, Mitotic	NA	4.1e-05	NA
966	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:NDE1:XPO1:PDS5B:PSMC5:STAG2:PSMA2:SMC3:H3F3B:RB1:HIST1H2BD:CTDNEP1:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:68886  |  M Phase	NA	0.000568	NA
967	CDS	Pancan-no-skin-melanoma-lymph	H3F3B:RB1:HIST1H2BD:CTDNEP1:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:68875  |  Mitotic Prophase	NA	0.00475	NA
968	CDS	Pancan-no-skin-melanoma-lymph	H3F3B:RB1:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:2299718  |  Condensation of Prophase Chromosomes	NA	3.16e-05	NA
969	CDS	Pancan-no-skin-melanoma-lymph	JARID2:ACTB:EP300:CHD4:SF3B1:HDAC1:DNMT3A:H3F3B:MTA2:HIST1H2BD:SUZ12:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:212165  |  Epigenetic regulation of gene expression	NA	5.24e-09	NA
970	CDS	Pancan-no-skin-melanoma-lymph	DNMT3A:H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5334118  |  DNA methylation	NA	6.93e-06	NA
971	CDS	Pancan-no-skin-melanoma-lymph	JARID2:EZH2:DNMT3A:H3F3B:HIST1H2BD:SUZ12:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:212300  |  PRC2 methylates histones and DNA	NA	1.08e-07	NA
972	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5250941  |  Negative epigenetic regulation of rRNA expression	NA	0.000364	NA
973	CDS	Pancan-no-skin-melanoma-lymph	H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:427359  |  SIRT1 negatively regulates rRNA Expression	NA	0.000114	NA
974	CDS	Pancan-no-skin-melanoma-lymph	HDAC1:H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:427413  |  NoRC negatively regulates rRNA expression	NA	0.000263	NA
975	CDS	Pancan-no-skin-melanoma-lymph	ACTB:EP300:CHD4:SF3B1:HDAC1:H3F3B:MTA2:HIST1H2BD:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5250913  |  Positive epigenetic regulation of rRNA expression	NA	7.37e-09	NA
976	CDS	Pancan-no-skin-melanoma-lymph	ACTB:EP300:SF3B1:H3F3B:HIST1H2BD:HIST1H2AC:HIST2H3D:POLR1D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5250924  |  B-WICH complex positively regulates rRNA expression	NA	5.72e-07	NA
977	CDS	Pancan-no-skin-melanoma-lymph	CHD4:HDAC1:H3F3B:MTA2:HIST1H2BD:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:427389  |  ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	NA	4.48e-07	NA
978	CDS	Pancan-no-skin-melanoma-lymph	DGCR8:H3F3B:ASZ1:HIST1H2BD:HIST1H2AC:POLR2A:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:211000  |  Gene Silencing by RNA	NA	0.00051	NA
979	CDS	Pancan-no-skin-melanoma-lymph	H3F3B:HIST1H2BD:HIST1H2AC:POLR2A:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:5578749  |  Transcriptional regulation by small RNAs	NA	0.00164	NA
980	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:TP53	REAC:6804116  |  TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	NA	0.0142	NA
981	CDS	Pancan-no-skin-melanoma-lymph	HES1:NOTCH1:HNF1B	REAC:210744  |  Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	NA	0.0247	NA
982	CDS	Pancan-no-skin-melanoma-lymph	RHOA:UBE2D1:XPO1:HDAC1:USP9X:MEN1:MYC:SMAD4:TGFBR2:SMAD2	REAC:170834  |  Signaling by TGF-beta Receptor Complex	NA	0.000599	NA
983	CDS	Pancan-no-skin-melanoma-lymph	TFAP2D:CBFB:UBE2D1:BAX:PSMC5:EP300:JAG1:ELL:CASP2:PSMA2:YWHAE:CDKN1B:CNOT2:CHD4:COX6A1:HES1:HDAC1:TFAP2E:USP9X:CDKN1A:YWHAH:KRAS:MEN1:NR5A1:MYC:TFAP2A:TP53:SMAD4:AKT1:EGFR:TAF1:CDKN2A:NOTCH1:TCF7L2:SSRP1:ATM:MTA2:RFC4:CITED2:TSC1:YWHAB:PRDX2:CTNNB1:YWHAG:PTEN:NR1D2:SMAD2:NR2F1:JUN:POLR2A:MED12:ESRRG:ZNF627:DAXX:NELFE:ZNF688:ZNF595	REAC:212436  |  Generic Transcription Pathway	NA	1e-05	NA
984	CDS	Pancan-no-skin-melanoma-lymph	TP63:BAX:EP300:ELL:CASP2:YWHAE:CDKN1B:CNOT2:CHD4:COX6A1:HDAC1:CDKN1A:YWHAH:TP53:AKT1:TAF1:CDKN2A:TAF5:SSRP1:ATM:MTA2:RFC4:TSC1:YWHAB:PRDX2:YWHAG:PTEN:JUN:POLR2A:DAXX:NELFE	REAC:3700989  |  Transcriptional Regulation by TP53	NA	9.57e-05	NA
985	CDS	Pancan-no-skin-melanoma-lymph	TP63:YWHAE:COX6A1:YWHAH:TP53:AKT1:TSC1:YWHAB:PRDX2:YWHAG:PTEN	REAC:5628897  |  TP53 Regulates Metabolic Genes	NA	0.0307	NA
986	CDS	Pancan-no-skin-melanoma-lymph	UBE2D1:HDAC1:USP9X:MEN1:MYC:SMAD4:SMAD2	REAC:2173793  |  Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	NA	0.00854	NA
987	CDS	Pancan-no-skin-melanoma-lymph	UBE2D1:HDAC1:USP9X:SMAD4:SMAD2	REAC:2173795  |  Downregulation of SMAD2/3:SMAD4 transcriptional activity	NA	0.0282	NA
988	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:CALM2	REAC:5210891  |  Uptake and function of anthrax toxins	NA	0.0267	NA
989	CDS	Pancan-no-skin-melanoma-lymph	SRSF9:SRSF7:SRSF4:U2AF1:SRSF2:PCF11	REAC:72187  |  mRNA 3'-end processing	NA	0.0215	NA
990	CDS	Pancan-no-skin-melanoma-lymph	CDH1:MAP2K4:RASAL2:MAP2K7:PSMC5:JAG1:CHMP4B:AXIN1:ESRP1:PSMA2:RNF43:FBXW7:CDKN1B:HES1:RPL22:HDAC1:TTR:PIK3CA:RPL5:CDKN1A:KRAS:APC:OS9:IDH1:SMAD4:AKT1:CALM2:PIK3R1:RASA1:EGFR:NOTCH1:TCF7L2:BRAF:TGFBR2:ALB:B2M:PRDX2:CTNNB1:RPL38:HRAS:SMAD2:POLR2A:NF1:NELFE:HLA-A:NRAS	REAC:1643685  |  Disease	NA	3.43e-14	NA
991	CDS	Pancan-no-skin-melanoma-lymph	CDH1:MAP2K4:MAP2K7:XPO1:PSMC5:CHMP4B:PSMA2:RPL22:RPL5:SH3GL3:CALM2:B2M:CTNNB1:RPL38:POLR2A:NELFE:HLA-A	REAC:5663205  |  Infectious disease	NA	0.0422	NA
992	CDS	Pancan-no-skin-melanoma-lymph	RASAL2:PSMC5:JAG1:AXIN1:ESRP1:PSMA2:RNF43:FBXW7:CDKN1B:HES1:HDAC1:TTR:PIK3CA:CDKN1A:KRAS:APC:OS9:SMAD4:AKT1:PIK3R1:RASA1:EGFR:NOTCH1:TCF7L2:BRAF:TGFBR2:CTNNB1:HRAS:SMAD2:NF1:NRAS	REAC:5663202  |  Diseases of signal transduction	NA	2.15e-16	NA
993	CDS	Pancan-no-skin-melanoma-lymph	EP300:JAG1:FBXW7:HES1:HDAC1:MYC:NOTCH1	REAC:2644603  |  Signaling by NOTCH1 in Cancer	NA	0.0261	NA
994	CDS	Pancan-no-skin-melanoma-lymph	EP300:JAG1:FBXW7:HES1:HDAC1:MYC:NOTCH1	REAC:2894858  |  Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	NA	0.0261	NA
995	CDS	Pancan-no-skin-melanoma-lymph	EP300:JAG1:FBXW7:HES1:HDAC1:MYC:NOTCH1	REAC:2894862  |  Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	NA	0.0261	NA
996	CDS	Pancan-no-skin-melanoma-lymph	EP300:JAG1:FBXW7:HES1:HDAC1:MYC:NOTCH1	REAC:2644602  |  Signaling by NOTCH1 PEST Domain Mutants in Cancer	NA	0.0261	NA
997	CDS	Pancan-no-skin-melanoma-lymph	EP300:JAG1:FBXW7:HES1:HDAC1:MYC:NOTCH1	REAC:2644606  |  Constitutive Signaling by NOTCH1 PEST Domain Mutants	NA	0.0261	NA
998	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:EGFR:HRAS:NRAS	REAC:1643713  |  Signaling by EGFR in Cancer	NA	1.16e-06	NA
999	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:EGFR:HRAS:NRAS	REAC:5637815  |  Signaling by Ligand-Responsive EGFR Variants in Cancer	NA	1.16e-06	NA
1000	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:EGFR:HRAS:NRAS	REAC:1236382  |  Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	NA	1.16e-06	NA
1001	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:EGFR:HRAS:NRAS	REAC:5637812  |  Signaling by EGFRvIII in Cancer	NA	2.2e-07	NA
1002	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:EGFR:HRAS:NRAS	REAC:5637810  |  Constitutive Signaling by EGFRvIII	NA	2.2e-07	NA
1003	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:RNF43:APC:CTNNB1	REAC:4791275  |  Signaling by WNT in cancer	NA	0.00209	NA
1004	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	REAC:5339716  |  Misspliced GSK3beta mutants stabilize beta-catenin	NA	0.0067	NA
1005	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	REAC:4839743  |  phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	NA	0.0067	NA
1006	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	REAC:5358752  |  T41 mutants of beta-catenin aren't phosphorylated	NA	0.0067	NA
1007	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	REAC:5358749  |  S37 mutants of beta-catenin aren't phosphorylated	NA	0.0067	NA
1008	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	REAC:5358751  |  S45 mutants of beta-catenin aren't phosphorylated	NA	0.0067	NA
1009	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	REAC:5358747  |  S33 mutants of beta-catenin aren't phosphorylated	NA	0.0067	NA
1010	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:HRAS:NRAS	REAC:1226099  |  Signaling by FGFR in disease	NA	0.0346	NA
1011	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:HRAS:NRAS	REAC:5655291  |  Signaling by FGFR4 in disease	NA	3.05e-06	NA
1012	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:HRAS:NRAS	REAC:5655253  |  Signaling by FGFR2 in disease	NA	0.0053	NA
1013	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:HRAS:NRAS	REAC:5655332  |  Signaling by FGFR3 in disease	NA	0.000163	NA
1014	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:HRAS:NRAS	REAC:8853338  |  Signaling by FGFR3 point mutants in cancer	NA	0.000163	NA
1015	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:HRAS:NRAS	REAC:8853334  |  Signaling by FGFR3 fusions in cancer	NA	1.67e-06	NA
1016	CDS	Pancan-no-skin-melanoma-lymph	PIK3CA:KRAS:PIK3R1:HRAS:NRAS	REAC:5655302  |  Signaling by FGFR1 in disease	NA	0.00284	NA
1017	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:TGFBR2:SMAD2	REAC:3304351  |  Signaling by TGF-beta Receptor Complex in Cancer	NA	0.0221	NA
1018	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:TGFBR2:SMAD2	REAC:3304349  |  Loss of Function of SMAD2/3 in Cancer	NA	0.0139	NA
1019	CDS	Pancan-no-skin-melanoma-lymph	SMAD4:TGFBR2:SMAD2	REAC:3315487  |  SMAD2/3 MH2 Domain Mutants in Cancer	NA	0.0139	NA
1020	CDS	Pancan-no-skin-melanoma-lymph	RHOA:XPO1:PSMC5:EP300:CHD8:AXIN1:DKK4:PSMA2:PIP5K1B:RNF43:BCL9:HDAC1:SOX4:SOX9:SMARCA4:H3F3B:MEN1:APC:MYC:CLTC:AKT1:CALM2:TCF7L2:HIST1H2BD:TERT:PRKCB:KMT2D:CTNNB1:CXXC4:HIST1H2AC:HIST2H3D:TCF4:HIST1H4C:CALM1:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:195721  |  Signaling by Wnt	NA	1.69e-12	NA
1021	CDS	Pancan-no-skin-melanoma-lymph	PSMC5:AXIN1:PSMA2:HDAC1:APC:TCF7L2:CTNNB1	REAC:195253  |  Degradation of beta-catenin by the destruction complex	NA	0.0173	NA
1022	CDS	Pancan-no-skin-melanoma-lymph	AXIN1:APC:CTNNB1	REAC:196299  |  Beta-catenin phosphorylation cascade	NA	0.00997	NA
1023	CDS	Pancan-no-skin-melanoma-lymph	XPO1:PSMC5:EP300:CHD8:AXIN1:DKK4:PSMA2:PIP5K1B:RNF43:BCL9:HDAC1:SOX4:SOX9:SMARCA4:H3F3B:MEN1:APC:MYC:AKT1:TCF7L2:HIST1H2BD:TERT:KMT2D:CTNNB1:CXXC4:HIST1H2AC:HIST2H3D:TCF4:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H2AJ:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:201681  |  TCF dependent signaling in response to WNT	NA	8.38e-14	NA
1024	CDS	Pancan-no-skin-melanoma-lymph	XPO1:BCL9:HDAC1:SOX9:MEN1:APC:AKT1:TCF7L2:KMT2D:CTNNB1	REAC:3769402  |  Deactivation of the beta-catenin transactivating complex	NA	2.31e-07	NA
1025	CDS	Pancan-no-skin-melanoma-lymph	EP300:BCL9:HDAC1:SMARCA4:H3F3B:MEN1:MYC:TCF7L2:HIST1H2BD:TERT:KMT2D:CTNNB1:HIST1H2AC:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:201722  |  Formation of the beta-catenin:TCF transactivating complex	NA	9.7e-14	NA
1026	CDS	Pancan-no-skin-melanoma-lymph	HSPA5:MAP2K4:MAP2K7:PSMC5:DYNLL1:EP300:CHMP4B:PSMA2:PTGES3:CDKN1B:CDKN1A:H3F3B:VHL:RB1:TP53:CDKN2A:ATM:EEF1A1:HIST1H2BD:CITED2:TSC1:PRDX2:RPS6KA3:JUN:SUZ12:HIST1H2AC:HIST1H1C:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:2262752  |  Cellular responses to stress	NA	6.16e-09	NA
1027	CDS	Pancan-no-skin-melanoma-lymph	CDC27:MAP2K4:UBE2D1:MAP2K7:CDKN1B:CDKN1A:H3F3B:RB1:TP53:CDKN2A:ATM:TNIK:HIST1H2BD:RPS6KA3:JUN:SUZ12:HIST1H2AC:HIST2H3D:HIST1H1C:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:2559583  |  Cellular Senescence	NA	1.68e-10	NA
1028	CDS	Pancan-no-skin-melanoma-lymph	CDC27:UBE2D1:CDKN1B:CDKN1A:H3F3B:CDKN2A:HIST1H2BD:RPS6KA3:JUN:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:2559582  |  Senescence-Associated Secretory Phenotype (SASP)	NA	1.41e-08	NA
1029	CDS	Pancan-no-skin-melanoma-lymph	MAP2K4:MAP2K7:H3F3B:TP53:CDKN2A:TNIK:HIST1H2BD:JUN:SUZ12:HIST1H2AC:HIST2H3D:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE:HIST1H3C	REAC:2559580  |  Oxidative Stress Induced Senescence	NA	2.29e-07	NA
1030	CDS	Pancan-no-skin-melanoma-lymph	CDKN1B:CDKN1A:RB1:TP53:ATM:HIST1H2BD:HIST1H2AC:HIST1H1C:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E:HIST1H2AE	REAC:2559586  |  DNA Damage/Telomere Stress Induced Senescence	NA	7.63e-08	NA
1031	CDS	Pancan-no-skin-melanoma-lymph	CDKN1A:RB1:TP53	REAC:2559584  |  Formation of Senescence-Associated Heterochromatin Foci (SAHF)	NA	0.00472	NA
1032	CDS	Pancan-no-skin-melanoma-lymph	RB1:TP53:CDKN2A	REAC:2559585  |  Oncogene Induced Senescence	NA	0.00357	NA
1033	CDS	Pancan-no-skin-melanoma-lymph	TP53:ATM:HIST1H2BD:BAP1:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E	REAC:5693606  |  DNA Double Strand Break Response	NA	0.00474	NA
1034	CDS	Pancan-no-skin-melanoma-lymph	TP53:ATM:HIST1H2BD:BAP1:HIST1H4C:HIST1H4K:HIST1H2BG:HIST1H2BO:HIST1H4E	REAC:5693565  |  Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	NA	0.00426	NA
1035	CDS	Pancan-no-skin-melanoma-lymph	FBXW7:HES1:HDAC1:NOTCH1	REAC:2122947  |  NOTCH1 Intracellular Domain Regulates Transcription	NA	0.0171	NA
1036	CDS	Pancan-no-skin-melanoma-lymph	EP300:CHD4:HDAC1:TP53:AKT1:MTA2	REAC:6804758  |  Regulation of TP53 Activity through Acetylation	NA	0.0167	NA
1037	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SF3B1:SRSF7:SRSF4:HNRNPA2B1:HNRNPR:U2AF1:SRSF2:PCF11:HNRNPA3:POLR2A	REAC:72172  |  mRNA Splicing	NA	0.0131	NA
1038	CDS	Pancan-no-skin-melanoma-lymph	PTBP1:SRSF9:SF3B1:SRSF7:SRSF4:HNRNPA2B1:HNRNPR:U2AF1:SRSF2:PCF11:HNRNPA3:POLR2A	REAC:72163  |  mRNA Splicing - Major Pathway	NA	0.00655	NA
